TW201350529A - Stabilizer compositions containing substituted chroman compounds and methods of use - Google Patents

Stabilizer compositions containing substituted chroman compounds and methods of use Download PDF

Info

Publication number
TW201350529A
TW201350529A TW101121208A TW101121208A TW201350529A TW 201350529 A TW201350529 A TW 201350529A TW 101121208 A TW101121208 A TW 101121208A TW 101121208 A TW101121208 A TW 101121208A TW 201350529 A TW201350529 A TW 201350529A
Authority
TW
Taiwan
Prior art keywords
group
bis
tetramethyl
triazine
hydroxy
Prior art date
Application number
TW101121208A
Other languages
Chinese (zh)
Other versions
TWI637017B (en
Inventor
Ram Gupta
Sari-Beth Samuels
J Mon Hei Eng
Thomas Steele
Original Assignee
Cytec Tech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytec Tech Corp filed Critical Cytec Tech Corp
Priority to TW101121208A priority Critical patent/TWI637017B/en
Publication of TW201350529A publication Critical patent/TW201350529A/en
Application granted granted Critical
Publication of TWI637017B publication Critical patent/TWI637017B/en

Links

Landscapes

  • Compositions Of Macromolecular Compounds (AREA)

Abstract

Stabilizer compositions having a chroman-based compound according to Formula (V): and their use in processes for stabilizing organic materials subject to degradation and/or discoloration due to the effects from light, oxygen and heat, and in processes for producing articles from organic materials blended therewith, are provided herein.

Description

含經取代之 唍化合物的安定劑組合物及使用方法Stabilizer composition containing substituted hydrazine compound and method of use thereof

本文所述之本發明係關於用於非生命有機材料之安定劑組合物。更特定而言,本發明係關於安定劑組合物,其具有某些經取代之唍化合物及若需要用於使非生命有機材料對抗光、氧及/或熱之作用安定、藉此改良該等材料之顏色、性能及/或處理之其他添加劑,包括塑膠。 The invention described herein relates to stabilizer compositions for non-living organic materials. More particularly, the present invention relates to stabilizer compositions having certain substituted Antimony compounds and other additives, including plastics, that are used to stabilize the action of non-living organic materials against light, oxygen and/or heat, thereby improving the color, performance and/or handling of such materials.

已知非生命有機材料(例如塑膠及塗層材料)之機械、化學及/或美學性質因光、氧及熱之效應而受損。對於該等聚合材料,此損害通常係表現為變黃或其他變色、材料破裂或脆化及/或光澤喪失。另外,在處理成物件期間使等聚合有機材料經受高溫及高壓,其可不利地影響自該等材料製得之成品物件之物理性質及/或特性以及外觀。 The mechanical, chemical and/or aesthetic properties of non-living organic materials such as plastics and coating materials are known to be impaired by the effects of light, oxygen and heat. For such polymeric materials, this damage typically manifests as yellowing or other discoloration, cracking or embrittlement of the material, and/or loss of gloss. Additionally, the isopolymeric organic materials are subjected to elevated temperatures and pressures during processing into articles which can adversely affect the physical properties and/or characteristics and appearance of the finished articles made from such materials.

因此,該等材料需要向其添加各種添加劑系統,以用於處理且保持長期穩定性,從而保持期望服務性質。已知業內眾多種物質用作該等添加劑及安定劑。在許多情況下,採用該等添加劑之混合物。例如,已知安定劑包括空間受阻胺,例如受阻胺光安定劑(HALS)、紫外(UV)光吸收劑及抗氧化劑。 Therefore, such materials require the addition of various additive systems to them for processing and maintaining long-term stability to maintain desired service properties. A wide variety of materials are known in the industry for use as such additives and stabilizers. In many cases, a mixture of such additives is employed. For example, stabilizers are known to include sterically hindered amines such as hindered amine light stabilizers (HALS), ultraviolet (UV) light absorbers, and antioxidants.

儘管藉由使用該等類別化合物中之一或多者與各種其他添加劑達成有機材料之一定程度的安定,但有效保護所需之高濃度經常導致所正安定之材料之性質的不期望改變以及相容性問題,該等相容性問題包括滲出、粉化、形成塗 層、顏色改變。諸如抗氧化劑等安定劑傳統上包括空間阻酚、芳香族胺、有機-亞磷酸酯/膦酸酯及/或硫醚。然而,必須基於終物件應具有之期望最終性質仔細選擇適當組合之安定劑。 Although a certain degree of stability of the organic material is achieved by the use of one or more of these classes of compounds with various other additives, the high concentration required for effective protection often results in undesirable changes in the properties of the material being stabilized and the phase. Capacitive problems, such compatibility problems include bleed, pulverization, and coating Layer and color change. Stabilizers such as antioxidants conventionally include sterically hindered phenols, aromatic amines, organic-phosphites/phosphonates and/or thioethers. However, the proper combination of stabilizers must be carefully selected based on the desired final properties of the final article.

例如,先前技術中有大量含有6-羥基唍化合物(包括α-生育酚)之有機聚合物單獨或與其他添加劑(例如,酚及/或有機-亞磷酸酯/膦酸酯)組合之安定劑組合物之實例。除其固有安全性(其可使用且通常認為係安全的(「GRAS」))及其適宜物理性質以外,α-生育酚係氧基自由基之有效捕獲劑。其亦對諸如烷基等較不親電子基團、對氫過氧化物、酮之激發態、臭氧、過氧化氫、氮氧化物及與氧化性損傷相關之其他反應性種類極具反應性。然而,儘管認為其為優良處理安定劑及顏色安定劑,但其固有地具有黏性且係已知導致有機聚合物變色之黑琥珀色油狀物。如Laermer及Zambetti在Alpha-Tocopherol(Vitamin E)-the Natural Antioxidant for Polyolefins,Journal of Plastic Film and Sheeting 1992 8:228-248,247中所述,若聚合物顏色並不關鍵,則α-生育酚係適宜安定劑。 For example, a large amount of 6-hydroxyl groups in the prior art An example of a stabilizer composition of an organic polymer of a ruthenium compound (including alpha-tocopherol) alone or in combination with other additives (e.g., phenol and/or organic-phosphite/phosphonate). In addition to its inherent safety (which can be used and generally considered safe ("GRAS")) and its suitable physical properties, alpha-tocopherol is an effective capture agent for oxy radicals. It is also highly reactive with less electrophilic groups such as alkyl groups, with hydroperoxides, excited states of ketones, ozone, hydrogen peroxide, nitrogen oxides, and other reactive species associated with oxidative damage. However, although it is considered to be an excellent treatment stabilizer and color stabilizer, it is inherently viscous and is a black amber oil known to cause discoloration of organic polymers. As described by Laermer and Zambetti in Alpha-Tocopherol (Vitamin E)-the Natural Antioxidant for Polyolefins, Journal of Plastic Film and Sheeting 1992 8:228-248,247, if the color of the polymer is not critical, the alpha-tocopherol is suitable. Stabilizer.

其他先前技術參考文獻詳述在有機聚合物材料中使用α-生育酚之類似問題。美國專利第4,806,580號詳述不適宜使用α-生育酚使無色塑膠安定(單獨或與其他添加劑組合),此乃因其引起變色。 Other prior art references detail similar problems with the use of alpha-tocopherol in organic polymeric materials. U.S. Patent No. 4,806,580, the disclosure of which is incorporated herein by reference in its entirety to the extent that it is not suitable for the use of alpha-tocopherol to stabilize colorless plastics, either alone or in combination with other additives, as it causes discoloration.

美國專利第5,807,504號詳述唍衍生物及有機亞磷酸酯或膦酸酯之安定劑混合物,但其由於在儲存時及在納入所 正安定之材料中後不穩定而為不利的。 US Patent No. 5,807,504 An anthraquinone derivative and a stabilizer mixture of an organic phosphite or phosphonate, but which is disadvantageous due to instability upon storage and incorporation into the material being stabilized.

美國專利第6,465,548號詳述6-羥基唍化合物尚未為使有機聚合物材料安定而廣泛地用作抗氧化劑,此乃因不必克服其對該等材料之顯著著色。 6-hydroxyl detail in U.S. Patent No. 6,465,548 Bismuth compounds have not been widely used as antioxidants for stabilizing organic polymeric materials because they do not have to overcome significant coloration of such materials.

因此,用於使光、氧及/或熱在非生命有機材料中之效應最小化之安定劑組合物需要進一步改良。因此,具體加強該等材料之顏色、性能及/或處理、同時准許較高處理溫度及/或較短冷卻時間及較快射出速度用於較高速度模製或有效減少模製週期時間之安定劑組合物及製程將係該領域內之有用進步,且將在化學添加劑及各種工業模製行業中得到快速接受。 Therefore, stabilizer compositions for minimizing the effects of light, oxygen and/or heat in non-living organic materials require further improvement. Therefore, the color, performance and/or processing of the materials are specifically enhanced while permitting higher processing temperatures and/or shorter cooling times and faster exit speeds for higher speed molding or effective reduction of molding cycle time stability Compositions and processes will be a useful advance in the field and will be rapidly accepted in chemical additives and various industrial molding industries.

如下文所詳細闡述,本發明者已發現加強非生命有機材料對抗光、氧及/或熱之有害效應之特性及性能的安定劑組合物,以及該等組合物用於減少與聚烯烴物件有關之各種模製製程之週期時間的用途。該等安定劑組合物意外地具有改良物件及/或製程之多重效應,其包括:達成最優物理及/或機械性質所需之時間減少;使得改良樹脂流動及模具填充時間較快之經改良黏度;及經改良之材料顏色安定,包括由於變黃導致之變色較少或無變色。 As set forth in detail below, the present inventors have discovered stabilizer compositions which enhance the properties and properties of non-living organic materials against the harmful effects of light, oxygen and/or heat, and the use of such compositions for reducing polyolefin articles The use of cycle time for various molding processes. The stabilizer compositions unexpectedly have multiple effects of improving the article and/or process, including: reduced time required to achieve optimal physical and/or mechanical properties; improved improvements in improved resin flow and mold fill time Viscosity; and improved color stability of the material, including less discoloration or discoloration due to yellowing.

因此,在態樣中,本發明提供具有安定量之基於唍之式(V)化合物的安定劑組合物: 其中R21係選自COR28或Si(R29)3,其中R28係選自H或C1-C20烴基;且R29係選自C1-C12烴基或烷氧基;R22係在式V之芳香族部分之n=0個至3個位置處可相同或不同之取代基,且係獨立地選自H或C1-C12烴基;R23係選自H或C1-C12烴基;R24係選自H或C1-C20烴基;且R25至R27中之每一者係獨立地選自選自由H;C1-C12烴基;及OR30組成之群之成員,其中R30係選自H或C1-C12烴基;且R27係H或與R26一起形成=O之鍵。 Therefore, in an aspect, the present invention provides a basis for having an amperage Stabilizer composition of the compound of formula (V): Wherein R 21 is selected from the group consisting of COR 28 or Si(R 29 ) 3 , wherein R 28 is selected from H or C 1 -C 20 hydrocarbyl; and R 29 is selected from C 1 -C 12 hydrocarbyl or alkoxy; R 22 a substituent which may be the same or different at n=0 to 3 positions of the aromatic moiety of formula V, and is independently selected from H or a C 1 -C 12 hydrocarbon group; and R 23 is selected from H or C 1 a -C 12 hydrocarbyl group; R 24 is selected from H or a C 1 -C 20 hydrocarbyl group; and each of R 25 to R 27 is independently selected from the group consisting of H; C 1 -C 12 hydrocarbyl; and OR 30 A member of the group wherein R 30 is selected from H or a C 1 -C 12 hydrocarbyl group; and R 27 is H or together with R 26 forms a bond of =0.

在某些實施例中,安定劑組合物可視情況包括選自(但不限於)以下之其他安定劑:有機亞磷酸酯/膦酸酯;受阻酚;光安定劑;及其他唍類型化合物,例如維生素E或其異構體中之任一者或異構體之混合物,以及某些改良劑,例如(但不限於)共添加劑、成核劑、填充劑、強化劑及聚合物添加劑。 In certain embodiments, the stabilizer composition may optionally include other stabilizers selected from, but not limited to, the following: organic phosphites/phosphonates; hindered phenols; light stabilizers; Any of a quinone-type compounds, such as vitamin E or an isomer thereof, or a mixture of isomers, and certain modifiers such as, but not limited to, co-additives, nucleating agents, fillers, strengthening agents, and polymerizations Additives.

在另一態樣中,本發明提供用於使由於光、氧及/或熱之效應而經受降解及/或變色之有機材料安定的製程,該製程藉由添加安定量之如上文及下文所述具有基於唍之 式(V)化合物之安定劑組合物來達成。 In another aspect, the present invention provides a process for stabilizing an organic material that undergoes degradation and/or discoloration due to the effects of light, oxygen, and/or heat, by adding an ampoule as described above and below. Have a basis This is achieved by a stabilizer composition of the compound of formula (V).

在某些實施例中,該有機材料可係聚烯烴類型聚合物或共聚物、有機染料、蠟或油墨。 In certain embodiments, the organic material can be a polyolefin type polymer or copolymer, an organic dye, a wax, or an ink.

本發明之又一態樣提供用於加強有機材料之處理穩定性之方法,該方法藉由在處理之前或期間將安定量之如上文及下文所述具有基於唍之式(V)化合物之安定劑組合物混合於其中來達成。 Yet another aspect of the present invention provides a method for enhancing the processing stability of an organic material by having an ampoule as described above and below, prior to or during processing A stabilizer composition of the compound of the formula (V) is mixed therein to achieve.

在另一態樣中,本發明提供用於減少或防止有機材料變色之方法,該方法藉由在處理之前或期間將有效量之如上文及下文所述具有基於唍之式(V)化合物之安定劑組合物混合於其中來達成。 In another aspect, the present invention provides a method for reducing or preventing discoloration of an organic material, the method having an effective amount as described above and below, prior to or during processing A stabilizer composition of the compound of the formula (V) is mixed therein to achieve.

在又一態樣中,本發明提供具有安定劑組合物及有機材料之母料組合物,該安定劑組合物如上文及下文所述具有基於唍之式(V)化合物,該有機材料與欲安定之有機材料相同或相容。 In yet another aspect, the present invention provides a masterbatch composition having a stabilizer composition and an organic material, the stabilizer composition having a basis as described above and below A compound of the formula (V) which is the same or compatible with the organic material to be stabilized.

本文所述之組合物及製程亦用於藉由(例如)包括以下之業內公認工業模製製程中之任一者產生聚合物件:例如旋轉模製、射出模製、吹塑模製、捲對捲模製、壓縮模製、微模製、金屬射出模製等,亦用於減少用於產生聚合中空物件之旋轉模製製程之週期時間及/或維持其較寬製程窗口。 The compositions and processes described herein are also useful for producing polymeric articles by, for example, any of the following industry-recognized industrial molding processes: for example, rotational molding, injection molding, blow molding, roll-to-roll Roll molding, compression molding, micromolding, metal injection molding, etc., are also used to reduce the cycle time of the rotational molding process used to produce the polymeric hollow article and/or to maintain its wider process window.

因此,在另一態樣中,本發明提供用於藉由以下方式來產生模製物件之製程:將聚合有機材料及聚合物安定量之如上文及下文所述具有基於唍之式(V)化合物之安定劑 組合物添加至模製器件或工業模製製程中,並藉助該器件及/或製程使經安定聚合有機材料循環。 Accordingly, in another aspect, the present invention provides a process for producing a molded article by assessing a polymeric organic material and a polymer as described above and below The stabilizer composition of the compound of formula (V) is added to a molding device or an industrial molding process, and the stabilized polymeric organic material is recycled by means of the device and/or process.

根據結合附圖及實例對本發明各種態樣之以下詳細說明,本發明之該等及其他目的、特徵及優勢將變得顯而易見。 The above and other objects, features and advantages of the present invention will become apparent from the accompanying drawings.

如上文及本揭示內容通篇所採用,提供以下術語以幫助讀者。除非另有定義,否則本文所用之所有業內術語、符號及其他科學術語均意欲具有化學領域中熟習此項技術者所通常瞭解之含義。除非上下文另外明確指出,否則本文及隨附申請專利範圍中所用之單數形式包括複數個指示物。 As used above and throughout the disclosure, the following terms are provided to assist the reader. Unless otherwise defined, all terms, symbols, and other scientific terms used herein are intended to have a meaning that is commonly understood by those skilled in the art. The singular forms used herein and the scope of the appended claims are in the

在本說明書通篇中,術語及取代基保持其定義不變。有機化學家(即熟習此項技術者)所用縮寫之全面清單出現在Journal of Organic Chemistry之每一卷之第一期中。通常以標題為「Standard List of Abbreviations」之表形式呈現之清單以引用的方式併入本文中。 Throughout the specification, the terms and substituents remain as defined. A comprehensive list of abbreviations used by organic chemists (ie those skilled in the art) appears in the first issue of each of the Journal of Organic Chemistry . A list that is generally presented in the form of a table entitled "Standard List of Abbreviations" is incorporated herein by reference.

術語「烴基」係涵蓋具有全碳主鏈且由碳及氫原子組成之脂肪族、脂環族及芳香族基團之通用術語。在某些情形中,如本文所定義,構成碳主鏈之碳原子中之一或多者可由指定原子或原子基團、例如由N、O及/或S中之一或多個雜原子替代或雜有其。烴基之實例包括烷基、環烷基、環烯基、碳環芳基、烯基、炔基、烷基環烷基、環烷基烷基、環烯基烷基及碳環芳烷基、烷芳基、芳烯基及芳炔 基。該等烴基亦可視情況經一或多個本文所定義之取代基取代。因此,本說明書及申請專利範圍中所論述之化學基團或部分應理解為包括經取代或未經取代之形式。除非上下文另外說明,否則下文所表述之實例及優先性亦適用於在本文所述各式化合物之取代基之各種定義中所提及之烴基取代基或含烴基取代基中之每一者。 The term "hydrocarbyl" is intended to encompass the general term for aliphatic, alicyclic and aromatic groups having an all carbon backbone and consisting of carbon and hydrogen atoms. In certain instances, as defined herein, one or more of the carbon atoms constituting the carbon backbone may be replaced by a specified atom or atom group, such as one or more heteroatoms of N, O, and/or S. Or mixed with it. Examples of the hydrocarbon group include an alkyl group, a cycloalkyl group, a cycloalkenyl group, a carbocyclic aryl group, an alkenyl group, an alkynyl group, an alkylcycloalkyl group, a cycloalkylalkyl group, a cycloalkenylalkyl group, and a carbocyclic aralkyl group. Alkaryl, aralkenyl and alkyne base. The hydrocarbyl groups may also be substituted, as appropriate, with one or more substituents as defined herein. Accordingly, chemical groups or moieties discussed in the specification and claims are to be construed as including substituted or unsubstituted forms. Unless otherwise indicated by the context, the examples and preferences set forth below also apply to each of the hydrocarbyl substituents or hydrocarbyl-containing substituents mentioned in the various definitions of the substituents of the various compounds described herein.

較佳非芳香族烴基係飽和基團,例如烷基及環烷基。除非上下文另外要求,否則通常且舉例而言,烴基可具有最多50個碳原子。具有1個至30個碳原子之烴基較佳。在具有1個至30個碳原子之烴基亞組內,特定實例係C1-20烴基,例如C1-12烴基(例如C1-6烴基或C1-4烴基),具體實例係選自C1至C30烴基之任一個別值或值之組合。 Preferred are non-aromatic hydrocarbon-based saturated groups such as an alkyl group and a cycloalkyl group. Unless otherwise required by the context, typically and by way of example, a hydrocarbyl group can have up to 50 carbon atoms. A hydrocarbon group having 1 to 30 carbon atoms is preferred. In the hydrocarbyl subgroup having from 1 to 30 carbon atoms, a specific example is a C 1-20 hydrocarbyl group, for example, a C 1-12 hydrocarbyl group (for example, a C 1-6 hydrocarbyl group or a C 1-4 hydrocarbyl group), and specific examples are selected from Any individual value or combination of values of a C 1 to C 30 hydrocarbyl group.

烷基意欲包括直鏈、具支鏈或環狀烴結構及其組合。較低碳數烷基係指具有1個至6個碳原子之烷基。較低碳數烷基之實例包括甲基、乙基、丙基、異丙基、丁基、第二-及第三-丁基及諸如此類。較佳烷基係彼等具有C30或更低者。 Alkyl is intended to include straight chain, branched or cyclic hydrocarbon structures, and combinations thereof. The lower alkyl group means an alkyl group having 1 to 6 carbon atoms. Examples of lower alkyl groups include methyl, ethyl, propyl, isopropyl, butyl, second- and third-butyl, and the like. Preferred alkyl groups have C 30 or lower.

烷氧基或烷氧基烷基係指1個至20個碳原子之基團,其具有直鏈、具支鏈、環狀組態及其組合,藉助氧附接至母體結構。實例包括甲氧基、乙氧基、丙氧基、異丙氧基、環丙氧基、環己氧基及諸如此類。 Alkoxy or alkoxyalkyl refers to a radical of from 1 to 20 carbon atoms having a straight chain, branched chain, cyclic configuration, and combinations thereof, attached to the parent structure by oxygen. Examples include methoxy, ethoxy, propoxy, isopropoxy, cyclopropoxy, cyclohexyloxy, and the like.

醯基係指甲醯基且係指1個、2個、3個、4個、5個、6個、7個、8個、9個、10個、11個及12個碳原子之基團,其具有直鏈、具支鏈、環狀組態、飽和、不飽和及芳香族 及其組合,藉助羰基官能性附接至母體結構。實例包括乙醯基、苯甲醯、丙醯基、異丁醯基、第三丁氧基羰基、苄氧基羰基及諸如此類。較低碳數醯基係指含有1個至6個碳之基團。 A thiol-based nail base and refers to a group of 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12 carbon atoms. It has a linear, branched, cyclic configuration, saturated, unsaturated and aromatic And combinations thereof, attached to the parent structure by carbonyl functionality. Examples include ethenyl, benzamidine, propyl sulfonyl, isobutyl decyl, tert-butoxycarbonyl, benzyloxycarbonyl and the like. The lower carbon number is a group containing from 1 to 6 carbons.

除非上下文另外說明,否則提及本文所用之「碳環」或「環烷基」基團之內容應包括芳香族及非芳香族環系統二者。因此,例如,在其範圍內該術語包括芳香族、非芳香族、不飽和、部分飽和及完全飽和碳環系統。一般而言,該等基團可係單環或二環的,且可含有(例如)3個至12個環成員,更通常5個至10個環成員。單環基團之實例係含有3個、4個、5個、6個、7個及8個環成員、更通常3個至7個且較佳5個或6個環成員之基團。二環基團之實例係彼等含有8個、9個、10個、11個及12個環成員且更通常9個或10個環成員者。非芳香族碳環/環烷基之實例包括c-丙基、c-丁基、c-戊基、c-己基及諸如此類。C7至C10多環烴之實例包括諸如降莰基及金剛烷基等環系統。 Unless the context indicates otherwise, reference to a "carbocyclic" or "cycloalkyl" group as used herein shall include both aromatic and non-aromatic ring systems. Thus, for example, the term includes within its scope aromatic, non-aromatic, unsaturated, partially saturated, and fully saturated carbocyclic systems. In general, the groups may be monocyclic or bicyclic and may contain, for example, from 3 to 12 ring members, more typically from 5 to 10 ring members. Examples of monocyclic groups are those containing 3, 4, 5, 6, 7, and 8 ring members, more typically 3 to 7, and preferably 5 or 6 ring members. Examples of bicyclic groups are those which contain 8, 9, 10, 11 and 12 ring members and more typically 9 or 10 ring members. Examples of the non-aromatic carbocyclic/cycloalkyl group include c-propyl group, c-butyl group, c-pentyl group, c-hexyl group, and the like. Examples of the C 7 to C 10 polycyclic hydrocarbon include ring systems such as a thiol group and an adamantyl group.

芳基(碳環芳基)係指5-或6-員芳香族碳環含有;二環9-或10-員芳香族環系統;或三環13-或14-員芳香族環系統。芳香族6-至14-員碳環包括(例如)經取代或未經取代之苯基、苯、萘、二氫茚、四氫萘及茀。 Aryl (carbocyclic aryl) means a 5- or 6-membered aromatic carbocyclic ring; a bicyclic 9- or 10-membered aromatic ring system; or a tricyclic 13- or 14-membered aromatic ring system. Aromatic 6- to 14-membered carbocycles include, for example, substituted or unsubstituted phenyl, benzene, naphthalene, indoline, tetrahydronaphthalene, and anthracene.

經取代之烴基、烷基、芳基、環烷基、烷氧基等係指其中每一殘基中最多3個H原子係由以下基團來替代之具體取代基:烷基、鹵素、鹵代烷基、羥基、烷氧基、羧基、烷氧羰基(亦稱為烷氧基羰基)、甲醯胺基(亦稱為烷基胺基羰 基)、氰基、羰基、硝基、胺基、烷基胺基、二烷基胺基、巰基、烷基硫基、亞碸、碸、醯基胺基、甲脒基、苯基、苄基、鹵代苄基、雜芳基、苯氧基、苄氧基、雜芳氧基、苯甲醯、鹵代苯甲醯或較低碳數烷基羥基。 The substituted hydrocarbyl group, alkyl group, aryl group, cycloalkyl group, alkoxy group and the like mean a specific substituent in which up to 3 H atoms in each residue are replaced by the following groups: alkyl group, halogen, halogenated alkane Base, hydroxy, alkoxy, carboxy, alkoxycarbonyl (also known as alkoxycarbonyl), formamidine (also known as alkylaminocarbonyl) , cyano, carbonyl, nitro, amine, alkylamino, dialkylamino, fluorenyl, alkylthio, amidoxime, fluorene, decylamino, decyl, phenyl, benzyl Alkyl, halobenzyl, heteroaryl, phenoxy, benzyloxy, heteroaryloxy, benzamidine, halobenzil or a lower alkylhydroxyl group.

術語「鹵素」意指氟、氯、溴或碘。 The term "halogen" means fluoro, chloro, bromo or iodo.

本文所用術語「唍」或「基於唍之化合物」係指彼等具有唍官能性作為化合物之一部分之化合物。在某些實施例中,基於唍之化合物將經取代。在其他實施例中,基於唍之化合物可包括唍酮。香豆素、生育酚及生育三烯酚係基於唍之化合物之具體實例。 The term used in this article 唍" or "based on "唍 compounds" means that they have A compound that is functional as part of a compound. In some embodiments, based on The compound of hydrazine will be substituted. In other embodiments, based on Compounds of bismuth can include Anthrone. Coumarin, tocopherol and tocotrienol are based on Specific examples of compounds of hydrazine.

本文所用術語「週期時間」或「模製週期」具有其工業模製領域中熟習此項技術者所通常瞭解之通常含義,且係指模製週期中之一點至下一重複順序中之相應點之時間(即在模製操作中產生一零件所需之時間,如自一操作之一點至該操作之第一次重複之相同點所量測)。 The term "cycle time" or "molding cycle" as used herein has its ordinary meaning as commonly understood by those skilled in the art of molding, and refers to a point from one point in the molding cycle to the next. Time (i.e., the time required to produce a part in a molding operation, such as measured from one point of an operation to the same point of the first iteration of the operation).

本文所用術語「最優機械性質」或「最優物理性質」係指模製零件具有最期望的:耐衝擊強度、聚合物顆粒之聚結或燒結及諸如顏色等一般外觀。 As used herein, the term "optimal mechanical properties" or "optimal physical properties" refers to molded parts having the most desirable properties: impact strength, coalescence or sintering of polymer particles, and general appearance such as color.

本文所用術語「有機材料」或「欲安定之材料」係指非生命有機材料,其包括(例如)諸如軟膏及洗劑等化妝品製劑、諸如丸劑及栓劑等藥物調配物、照相記錄材料、有機染料、油墨及纖維以及合成及天然有機聚合物及生物聚合物。合成有機聚合物係由諸如熱塑性樹脂、熱固性樹脂及諸如此類等合成樹脂例示。各種該等樹脂為熟習此項技術 者所已知且適宜與本發明一起使用。天然有機聚合物係由天然橡膠、蛋白質、纖維素衍生物、礦物油、動物或植物油、蠟、脂肪及油及諸如此類例示。 The term "organic material" or "material to be stabilized" as used herein refers to a non-living organic material including, for example, cosmetic preparations such as ointments and lotions, pharmaceutical preparations such as pills and suppositories, photographic recording materials, organic dyes. , inks and fibers, as well as synthetic and natural organic polymers and biopolymers. The synthetic organic polymer is exemplified by a synthetic resin such as a thermoplastic resin, a thermosetting resin, and the like. Various such resins are familiar with this technology It is known and suitable for use with the present invention. Natural organic polymers are exemplified by natural rubber, proteins, cellulose derivatives, mineral oils, animal or vegetable oils, waxes, fats and oils, and the like.

本說明書和申請專利範圍中用於表示成份數量、反應條件等之所有數值在所有情形下均應理解為受術語「約」修飾。因此,除非指示相反情形,否則本說明書及隨附申請專利範圍中所列之數值參數均為可視本發明試圖獲得之期望性質而變之近似值。最低限度地且並非試圖限制申請專利範圍之範疇之等效內容之教義的應用,每一數值參數均應根據有效數位之數量及普通含入方法來解釋。 All numerical values used in the specification and claims to indicate the number of ingredients, the reaction conditions, and the like, should be understood in all instances as modified by the term "about." Accordingly, the numerical parameters set forth in the specification and the appended claims are intended to The application of the teachings of the equivalents of the scope of the claims is not limited, and each numerical parameter should be interpreted according to the number of significant digits and ordinary inclusion methods.

根據本發明且適用於使由於光、氧及熱之效應而經受降解及/或變色之有機材料安定且適用於自摻和於其中之有機材料產生物件之製程的安定劑組合物包括至少一種基於唍之式V化合物: 其中R21係選自COR28或Si(R29)3,其中R28係選自H或C1-C20烴基;且R29係選自C1-C12烴基或烷氧基;R22係在式V之芳香族部分之n=0個至3個位置處可相同或不同之取代基,且係獨立地選自H或C1-C12烴基;R23係選自H或C1-C12烴基; R24係選自H或C1-C20烴基;且R25至R27中之每一者係獨立地選自選自由H;C1-C12烴基;及OR30組成之群之成員,其中R30係選自H或C1-C12烴基;且R27係H或與R26一起形成=O之鍵。 The stabilizer composition according to the present invention and suitable for the process of setting up an organic material which undergoes degradation and/or discoloration due to the effects of light, oxygen and heat and which is suitable for the process of self-doping the organic material-generating article therein comprises at least one based on 唍式式V compound: Wherein R 21 is selected from the group consisting of COR 28 or Si(R 29 ) 3 , wherein R 28 is selected from H or C 1 -C 20 hydrocarbyl; and R 29 is selected from C 1 -C 12 hydrocarbyl or alkoxy; R 22 a substituent which may be the same or different at n=0 to 3 positions of the aromatic moiety of formula V, and is independently selected from H or a C 1 -C 12 hydrocarbon group; and R 23 is selected from H or C 1 a -C 12 hydrocarbyl group; R 24 is selected from H or a C 1 -C 20 hydrocarbyl group; and each of R 25 to R 27 is independently selected from the group consisting of H; C 1 -C 12 hydrocarbyl; and OR 30 A member of the group wherein R 30 is selected from H or a C 1 -C 12 hydrocarbyl group; and R 27 is H or together with R 26 forms a bond of =0.

在某些實施例中,R24係C1-C18烴基。 In certain embodiments, R 24 is a C 1 -C 18 hydrocarbyl group.

在一些實施例中,基於唍之化合物係式(Va)維生素E乙酸酯 或其異構體及/或混合物,包括異構體之混合物。 In some embodiments, based on Compound of formula (Va) vitamin E acetate Or isomers and/or mixtures thereof, including mixtures of isomers.

在某些實施例中,安定劑組合物包括兩種或更多種基於唍之式(V)化合物或者基於唍之式(V)化合物及另一唍化合物。在某些實施例中,其他唍化合物係生育酚或生育三烯酚。 In certain embodiments, the stabilizer composition comprises two or more based on a compound of formula (V) or based on Compound of formula (V) and another 唍 compound. In some embodiments, other The hydrazine compound is tocopherol or tocotrienol.

基於唍之化合物可以安定劑組合物之總重量之0.001重量%至5.0重量%、較佳安定劑組合物之總重量之0.01重量%至2.0重量%、且更佳安定劑組合物之總重量之0.01重量%至1.0重量%存在。在某些實施例中,基於唍之化合物係以安定劑組合物之總重量之0.05重量%存在。 based on The compound of cerium may be from 0.001% by weight to 5.0% by weight based on the total weight of the stabilizer composition, from 0.01% by weight to 2.0% by weight based on the total weight of the preferred stabilizer composition, and more preferably 0.01% by weight based on the total weight of the stabilizer composition. It is present in weight % to 1.0% by weight. In some embodiments, based on The compound of hydrazine is present at 0.05% by weight of the total weight of the stabilizer composition.

在某些實施例中,安定劑組合物可進一步包括至少一種選自有機亞磷酸酯或膦酸酯之群之化合物。在一些實施例 中,有機亞磷酸酯或膦酸酯化合物包括至少一種選自式1至7化合物之有機亞磷酸酯或膦酸酯: 其中下標為整數且n係2、3或4;p係1或2;q係2或3;r係4至12;y係1、2或3;且z係1至6;若n係2,則A1係C2-C18伸烷基;雜有氧、硫或-NR4-之C2-C12伸烷基;下式之基團 或伸苯基;若n係3,則A1係式-CrH2r-1-之基團;若n係4,則A1 若n係2,則A2係如針對A1所定義;B係直接鍵、-CH2-、-CHR4-、-CR1R4-、硫、C5-C7亞環烷基或在3、4及/或5位處經1至4個C1-C4烷基取代之亞環己基;若p係1,則D1係C1-C4烷基,且若p係2,則D1係-CH2OCH2-;若p係1,則D2係C1-C4烷基; 若y係1,則E係C1-C18烷基、-OR1或鹵素;若y係2,則E係-O-A2-O-,若y係3,則E係式R4C(CH2O-)3或N(CH2CH2O-)3之基團;Q係至少z價醇或酚之基團,此基團經由氧原子附接至磷原子;R1、R2及R3彼此獨立地係未經取代或經鹵素、-COOR4、-CN或-CONR4R4取代之C1-C18烷基;雜有氧、硫或-NR4-之C2-C18烷基;C7-C9苯基烷基;C5-C12環烷基、苯基或萘基;經鹵素、1個至3個具有總共1個至18個碳原子之烷基或烷氧基或經C7-C9苯基烷基取代之萘基或苯基;或下式之基團 其中m係在3至6之範圍內之整數;R4係氫、C1-C8烷基、C5-C12環烷基或C7-C9苯基烷基,R5及R6彼此獨立地係氫、C1-C8烷基或C5-C6環烷基,若q係2,則R7及R8彼此獨立地係C1-C4烷基或一起為2,3-去氫五亞甲基;且若q係3,則R7及R8係甲基;R14係氫、C1-C9烷基或環己基,R15係氫或甲基,且若存在兩個或更多個基團R14及R15, 則該等基團相同或不同,X及Y各自係直接鍵或氧,Z係直接鍵、亞甲基、-C(R16)2-或硫,且R16係C1-C8烷基;式8之亞磷酸叁芳基酯: 其中R17係在式8之芳香族部分之0個至5個位置處相同或不同之取代基,且係獨立地選自C1-C20烷基、C3-C20環烷基、C4-C20烷基環烷基、C6-C10芳基及C7-C20烷基芳基;及其組合。 In certain embodiments, the stabilizer composition can further comprise at least one compound selected from the group of organophosphites or phosphonates. In some embodiments, the organophosphite or phosphonate compound comprises at least one organic phosphite or phosphonate selected from the group consisting of compounds of Formulas 1 to 7: Wherein subscript is an integer and n is 2, 3 or 4; p is 1 or 2; q is 2 or 3; r is 4 to 12; y is 1, 2 or 3; and z is 1 to 6; 2, then A 1 is a C 2 -C 18 alkylene group; a heteroatomous aerobic, sulfur or -NR 4 -C 2 -C 12 alkyl group; a group of the formula Or phenyl; if n is 3, the A 1 is a group of -C r H 2r-1 -; if n is 4, the A 1 is If n is 2, A 2 is as defined for A 1 ; B is a direct bond, -CH 2 -, -CHR 4 -, -CR 1 R 4 -, sulfur, C 5 -C 7 cycloalkylene or a cyclohexylene group substituted with 1 to 4 C 1 -C 4 alkyl groups at the 3, 4 and/or 5 positions; if the p system is 1, the D 1 is a C 1 -C 4 alkyl group, and if the p system is 2 , D 1 is -CH 2 OCH 2 -; if p is 1, D 2 is C 1 -C 4 alkyl; if y is 1, E is C 1 -C 18 alkyl, -OR 1 or halogen If y is 2, then E is -OA 2 -O-, and if y is 3, then E is a group of formula R 4 C(CH 2 O-) 3 or N(CH 2 CH 2 O-) 3 ; Q is a group of at least a z-valent alcohol or phenol which is attached to the phosphorus atom via an oxygen atom; R 1 , R 2 and R 3 are independently unsubstituted or halogen, -COOR 4 , -CN or -CONR 4 R 4 substituted C 1 -C 18 alkyl; hetero aerobic, sulfur or -NR 4 -C 2 -C 18 alkyl; C 7 -C 9 phenylalkyl; C 5 -C 12 ring An alkyl group, a phenyl group or a naphthyl group; a naphthyl group or a benzene group substituted by halogen, one to three alkyl groups or alkoxy groups having a total of from 1 to 18 carbon atoms or substituted with a C 7 -C 9 phenylalkyl group; a group; or a group of the formula Wherein m is an integer in the range of from 3 to 6; R 4 is hydrogen, C 1 -C 8 alkyl, C 5 -C 12 cycloalkyl or C 7 -C 9 phenylalkyl, R 5 and R 6 Independently from each other, hydrogen, C 1 -C 8 alkyl or C 5 -C 6 cycloalkyl, if q is 2, then R 7 and R 8 are independently C 1 -C 4 alkyl or 2 together. 3-dehydropentamethylene; and if q is 3, then R 7 and R 8 are methyl; R 14 is hydrogen, C 1 -C 9 alkyl or cyclohexyl, R 15 is hydrogen or methyl, and If two or more groups R 14 and R 15 are present , the groups are the same or different, X and Y are each a direct bond or oxygen, Z is a direct bond, a methylene group, -C(R 16 ) 2- or sulphur, and R 16 is C 1 -C 8 alkyl; arylene phosphite of formula 8: Wherein R 17 is the same or different substituent at 0 to 5 positions of the aromatic moiety of Formula 8, and is independently selected from C 1 -C 20 alkyl, C 3 -C 20 cycloalkyl, C 4- C 20 alkylcycloalkyl, C 6 -C 10 aryl and C 7 -C 20 alkylaryl; and combinations thereof.

在一些實施例中,以下有機亞磷酸酯或膦酸酯較佳:亞磷酸三苯酯;亞磷酸二苯基烷基酯;亞磷酸苯基二烷基酯;亞磷酸三月桂基酯;亞磷酸三-十八烷基酯;二硬脂醯基新戊四醇亞磷酸酯;亞磷酸叁(2,4-二-第三-丁基苯基)酯;亞磷酸叁(壬基苯基)酯;式(A)、(B)、(C)、(D)、(E)、(F)、(G)、(H)、(J)、(K)及(L)之化合物: 2-丁基-2-乙基-1,3-丙二醇2,4,6-三-第三-丁基苯酚亞磷酸酯;雙-(2,6-二-第三-丁基-4-甲基苯基)新戊四醇二亞磷酸酯;2-丁基-2-乙基-1,3-丙二醇2,4-二-異丙苯基苯酚亞磷酸酯;2-丁基-2-乙基-1,3-丙二醇4-甲基-2,6-二-第三-丁基苯酚亞磷酸酯;及雙-(2,4,6-三-第三-丁基-苯基)新戊四醇二亞磷酸酯。 In some embodiments, the following organic phosphites or phosphonates are preferably: triphenyl phosphite; diphenylalkyl phosphite; phenyl dialkyl phosphite; trilauryl phosphite; Tri-octadecyl phosphate; distearyl decyl neopentyl phosphite; bismuth (2,4-di-tert-butylphenyl) phosphite; bismuth phosphite (nonylphenyl) Ester; compounds of formula (A), (B), (C), (D), (E), (F), (G), (H), (J), (K) and (L): 2-butyl-2-ethyl-1,3-propanediol 2,4,6-tri-tert-butylphenol phosphite; bis-(2,6-di-t-butyl-4- Methylphenyl) pentaerythritol diphosphite; 2-butyl-2-ethyl-1,3-propanediol 2,4-di-cumylphenol phosphite; 2-butyl-2 -ethyl-1,3-propanediol 4-methyl-2,6-di-tertiary-butylphenol phosphite; and bis-(2,4,6-tri-tertiary-butyl-phenyl ) Pentaerythritol diphosphite.

以下有機亞磷酸酯及膦酸酯尤其適用於本文所述之旋轉模製製程:亞磷酸叁(2,4-二-第三-丁基苯基)酯(IRGAFOS® 168);雙(2,4-二異丙苯基苯基)新戊四醇二亞磷酸酯(DOVERPHOS® S9228);及4,4'-伸聯苯基-二膦酸四(2,4-二-第三-丁基苯基)酯(IRGAFOS® P-EPQ)。 The following organic phosphites and phosphonates are particularly suitable for use in the rotational molding process described herein: bismuth (2,4-di-tert-butylphenyl) phosphite (IRGAFOS® 168); double (2, 4-diisopropylphenylphenyl neopentaerythritol diphosphite (DOVERPHOS® S9228); and 4,4'-extended biphenyl-diphosphonic acid tetrakis(2,4-di-third-butyl Phenyl phenyl) ester (IRGAFOS® P-EPQ).

有機亞磷酸酯或膦酸酯可基於欲安定有機材料之總重量以0.01重量%至10重量%之量存在。較佳地,基於欲安定有機材料之總重量,有機亞磷酸酯或膦酸酯之量可為0.05%至5%、且更佳0.1重量%至3重量%。 The organic phosphite or phosphonate may be present in an amount from 0.01% to 10% by weight, based on the total weight of the organic material to be stabilized. Preferably, the amount of the organic phosphite or phosphonate may be from 0.05% to 5%, and more preferably from 0.1% to 3% by weight, based on the total weight of the organic material to be stabilized.

在某些實施例中,安定劑組合物可進一步包括至少一種受阻酚化合物。與本文所述之旋轉模製製程一起使用之適宜受阻酚包括(但不限於)彼等具有式(IVa)、(IVb)或(IVc)中之一或多者之分子片段者: 其中「」指示分子片段附接(經由碳鍵)至母體化合物之點,且其中R18係選自氫及C1-4烴基;R19及R20相同或不同且係獨立地選自氫及C1-C20烴基;且R37係選自C1-C12烴基。在一些實施例中,R18及R37係獨立地選自甲基及第三丁基。 In certain embodiments, the stabilizer composition can further comprise at least one hindered phenol compound. Suitable hindered phenols for use with the rotational molding processes described herein include, but are not limited to, those having one or more of the molecular fragments of formula (IVa), (IVb) or (IVc): among them" a point at which the molecular fragment is attached (via a carbon bond) to the parent compound, and wherein R 18 is selected from the group consisting of hydrogen and a C 1-4 hydrocarbon group; R 19 and R 20 are the same or different and are independently selected from hydrogen and C 1 a -C 20 hydrocarbyl group; and R 37 is selected from a C 1 -C 12 hydrocarbyl group. In some embodiments, R 18 and R 37 are independently selected from the group consisting of methyl and tert-butyl.

以下化合物例示適用於本發明之組合物及製程之一些受阻酚:(1,3,5-叁(4-第三-丁基-3-羥基-2,6-二甲基苄基)-1,3,5-三嗪-2,4,6-(1H,3H,5H)-三酮;1,3,5-叁(3,5-二-第三-丁基-4-羥基苄基)-1,3,5-三嗪-2,4,6(1H,3H,5H)-三酮(IRGANOX® 3114);1,1,3-叁(2'-甲基-4'-羥基-5'-第三-丁基苯基)丁烷;三乙二醇雙[3-(3-第三-丁基-4-羥基-5-甲基苯基)丙酸酯];4,4'-硫基雙(2-第三-丁基-5-甲基苯酚);2,2'-硫基二伸乙基雙[3-(3-第三-丁基-4-羥基-5-甲基苯基)丙酸酯];3-(3'-第三-丁基-4'-羥基-5'-甲基苯基)丙酸十八烷基酯;四亞甲基(3-第三-丁基-4-羥基-5-甲基氫化桂皮酸酯)甲烷;N,N'-六亞甲基雙[3-(3-第三-丁基-4-羥基-5-甲基苯基)丙醯胺];硫基二丙酸二(4-第三丁基-3-羥基-2,6-二甲基苄基)酯;及3,5-二-(第三)-丁基-4-羥基氫化桂皮酸十八烷基酯。 The following compounds illustrate some of the hindered phenols suitable for use in the compositions and processes of the present invention: (1,3,5-indole (4-tris-butyl-3-hydroxy-2,6-dimethylbenzyl)-1 ,3,5-triazine-2,4,6-(1H,3H,5H)-trione; 1,3,5-anthracene (3,5-di-t-butyl-4-hydroxybenzyl) -1,3,5-triazine-2,4,6(1H,3H,5H)-trione (IRGANOX® 3114); 1,1,3-叁(2'-methyl-4'-hydroxyl -5'-Third-butylphenyl)butane; triethylene glycol bis[3-(3-tris-butyl-4-hydroxy-5-methylphenyl)propionate]; 4'-thiobis(2-tert-butyl-5-methylphenol); 2,2'-thiodiethylidene [3-(3-tri-butyl-4-hydroxy-) 5-methylphenyl)propionate]; octadecyl 3-(3'-tris-butyl-4'-hydroxy-5'-methylphenyl)propanoate; tetramethylene ( 3-tert-butyl-4-hydroxy-5-methylhydrocinnamate)methane; N,N'-hexamethylenebis[3-(3-tri-butyl-4-hydroxy-5) -methylphenyl)propanamide]; bis(4-tert-butyl-3-hydroxy-2,6-dimethylbenzyl) thiodipropionate; and 3,5-di-( Tris-butyl-4-hydroxyhydrocinnamate octadecyl ester.

亦適宜與本發明之製程及組合物一起使用之其他酚為熟習此項技術者所已知且包括(例如):2,6-二-第三-丁基-4-甲基苯酚;2-第三-丁基-4,6-二甲基苯酚;2,6-二-第三-丁基-4-乙基苯酚;2,6-二-第三-丁基-4-正-丁基苯酚;2,6-二-第三-丁基-4異丁基苯酚;2,6-二環戊基-4-甲基苯酚;2-(α-甲基環己基)-4,6二甲基苯酚;2,6-二-十八烷基-4-甲基苯酚;2,4,6,-三環己基苯酚;及2,6-二-第三-丁基-4-甲氧基甲基苯酚;2,2'-亞甲基-雙-(6-第三-丁基-4-甲基苯酚)(CYANOX® 2246);2,2'-亞甲基-雙-(6-第三-丁基-4-乙基苯酚)(CYANOX® 425);2,2'-亞甲基-雙-(4-甲基-6-(α-甲基環己基)酚);2,2'-亞甲基-雙-(4-甲基-6-環己基苯酚);2,2'-亞甲基-雙-(6-壬基-4-甲基苯酚);2,2'-亞甲基-雙-(6-壬基-4甲基苯酚);2,2'-亞甲基-雙-(6-(α-甲基苄基)-4-壬基苯酚);2,2'-亞甲基-雙-(6-(α,α-二甲基苄基)-4-壬基-酚);2,2'-亞甲基-雙-(4,6-二-第三-丁基苯酚);2,2'-亞乙基-雙-(6-第三-丁基-4-異丁基苯酚);4,4'亞甲基-雙-(2,6-二-第三-丁基苯酚);4,4'-亞甲基-雙-(6-第三-丁基-2-甲基苯酚);1,1-雙-(5-第三-丁基-4-羥基-2-甲基苯酚)丁烷;2,6-二-(3-第三-丁基-5-甲基-2-羥基苄基)-4-甲基苯酚;1,1,3-叁-(5-第三-丁基-4-羥基-2-甲基苯基)丁烷;1,1-雙-(5-第三-丁基-4-羥基2-甲基苯基)-3-十二烷基-巰基丁烷;乙二醇-雙-(3,3,-雙-(3'-第三-丁基-4'-羥基苯基)-丁酸酯)-二-(3-第三-丁基-4-羥基-5-甲基苯基)-二環戊二烯;二-(2-(3'-第三-丁基-2'羥 基-5'甲基苄基)-6-第三-丁基-4-甲基苯基)對苯二甲酸酯;及諸如雙酚之單丙烯酸酯等其他酚,例如亞乙基雙-2,4-二-第三-丁基苯酚單丙烯酸酯;對苯二酚,例如2,6-二-第三-丁基-4-甲氧基苯酚;2,5-二-第三-丁基對苯二酚;2,5-二-第三-戊基-對苯二酚;及2,6-二苯基-4-十八烷氧基苯酚;及硫基二苯基醚,例如2,2'-硫基-雙-(6-第三-丁基-4-甲基苯酚);2,2'-硫基-雙-(4-辛基苯酚);4,4'硫基-雙-(6-第三-丁基-3-甲基苯酚);及4,4'-硫基-雙-(6-第三-丁基-2-甲基苯酚)。 Other phenols which are also suitable for use with the processes and compositions of the present invention are known to those skilled in the art and include, for example, 2,6-di-t-butyl-4-methylphenol; Third-butyl-4,6-dimethylphenol; 2,6-di-tertiary-butyl-4-ethylphenol; 2,6-di-t-butyl-4-n-butyl Phenyl; 2,6-di-t-butyl-4-isobutylphenol; 2,6-dicyclopentyl-4-methylphenol; 2-(α-methylcyclohexyl)-4,6 Dimethylphenol; 2,6-di-octadecyl-4-methylphenol; 2,4,6,-tricyclohexylphenol; and 2,6-di-tertiary-butyl-4-methyl Oxymethylphenol; 2,2'-methylene-bis-(6-tri-butyl-4-methylphenol) (CYANOX® 2246); 2,2'-methylene-bis-( 6-tert-butyl-4-ethylphenol) (CYANOX® 425); 2,2'-methylene-bis-(4-methyl-6-(α-methylcyclohexyl)phenol); 2,2'-methylene-bis-(4-methyl-6-cyclohexylphenol); 2,2'-methylene-bis-(6-fluorenyl-4-methylphenol); 2'-methylene-bis-(6-fluorenyl-4-methylphenol); 2,2'-methylene-bis-(6-(α-methylbenzyl)-4-nonylphenol) ; 2,2'-methylene-bis-(6-(α,α-dimethylbenzyl)-4-mercapto-phenol); 2,2'-methylene-bis-(4,6 - -T-butylphenol); 2,2'-ethylidene-bis-(6-tri-butyl-4-isobutylphenol); 4,4'methylene-bis-(2, 6-di-tert-butylphenol); 4,4'-methylene-bis-(6-tri-butyl-2-methylphenol); 1,1-bis-(5-third -butyl-4-hydroxy-2-methylphenol)butane; 2,6-di-(3-tert-butyl-5-methyl-2-hydroxybenzyl)-4-methylphenol; 1,1,3-indole-(5-tris-butyl-4-hydroxy-2-methylphenyl)butane; 1,1-bis-(5-tri-butyl-4-hydroxy 2 -methylphenyl)-3-dodecyl-decylbutane; ethylene glycol-bis-(3,3,-bis-(3'-tri-butyl-4'-hydroxyphenyl)- Butyrate)-di-(3-tert-butyl-4-hydroxy-5-methylphenyl)-dicyclopentadiene; di-(2-(3'-tris-butyl-2) 'hydroxyl -5'-methylbenzyl)-6-tert-butyl-4-methylphenyl)terephthalate; and other phenols such as bisphenol monoacrylates, such as ethylene bis- 2,4-di-tert-butylphenol monoacrylate; hydroquinone, such as 2,6-di-tertiary-butyl-4-methoxyphenol; 2,5-di-third Butyl hydroquinone; 2,5-di-tris-pentyl-hydroquinone; and 2,6-diphenyl-4-octadecyloxyphenol; and thiodiphenyl ether, For example 2,2'-thio-bis-(6-tri-butyl-4-methylphenol); 2,2'-thio-bis-(4-octylphenol); 4,4' sulfur Base-bis-(6-tri-butyl-3-methylphenol); and 4,4'-thio-bis-(6-tri-butyl-2-methylphenol).

本發明安定劑組合物可進一步以有效地使有機材料對抗可見光及/或紫外光輻射之降解效應而安定之量包括一或多種共安定劑及/或添加劑,其包括(但不限於):受阻胺光安定劑、受阻羥基苯甲酸酯、酚鎳、紫外光安定劑、抗氧化劑及其組合。 The stabilizer composition of the present invention may further comprise one or more co-stabilizers and/or additives in an amount effective to stabilize the organic material against degradation by visible light and/or ultraviolet radiation, including but not limited to: hindered Amine light stabilizer, hindered hydroxybenzoate, phenol nickel, UV stabilizer, antioxidant and combinations thereof.

與本發明之製程及安定劑組合物一起使用之適宜受阻胺光安定劑包括(例如)化合物,其具有式(VI)之分子片段: 其中 R62係選自選自由以下組成之群之成員:氫;OH;C1-C20烴基;-CH2CN;C1-C12醯基;及C1-C18烷氧基;R65係選自選自由氫;及C1-C8烴基組成之群之成員;且R60、R61、R63及R64中之每一者係獨立地選自C1-C20烴基,或R60及R61及/或R63及R64與其所附接之碳一起形成C5-C10環烷基;或式(VIa)之分子片段 其中m係1至2之整數;R39係選自:氫;OH;C1-C20烴基;-CH2CN;C1-C12醯基;及C1-C18烷氧基;且G1至G4中之每一者係獨立地選自C1-C20烴基。 Suitable hindered amine light stabilizers for use with the process and stabilizer compositions of the present invention include, for example, compounds having a molecular fragment of formula (VI): Wherein R 62 is selected from the group consisting of: hydrogen; OH; C 1 -C 20 hydrocarbyl; -CH 2 CN; C 1 -C 12 mercapto; and C 1 -C 18 alkoxy; R 65 And is selected from the group consisting of hydrogen; and a C 1 -C 8 hydrocarbon group; and each of R 60 , R 61 , R 63 and R 64 is independently selected from a C 1 -C 20 hydrocarbon group, or R 60 and R 61 and/or R 63 and R 64 together with the carbon to which they are attached form a C 5 -C 10 cycloalkyl group; or a molecular fragment of formula (VIa) Wherein m is an integer from 1 to 2; R 39 is selected from the group consisting of: hydrogen; OH; C 1 -C 20 hydrocarbyl; -CH 2 CN; C 1 -C 12 mercapto; and C 1 -C 18 alkoxy; Each of G 1 to G 4 is independently selected from a C 1 - C 20 hydrocarbyl group.

尤其適宜與本發明一起使用之受阻胺光安定劑包括(但不限於):癸二酸雙(2,2,6,6-四甲基六氫吡啶-4-基)酯;琥珀酸雙(2,2,6,6-四甲基六氫吡啶-4-基)酯;癸二酸雙(1,2,2,6,6-五甲基六氫吡啶-4-基)酯;癸二酸雙(1-辛氧基-2,2,6,6-四甲基六氫吡啶-4-基)酯;正-丁基3,5-二-第三-丁基-4-羥基苄基丙二酸雙(1,2,2,6,6-五甲基六氫吡啶-4-基)酯;1-(2-羥基乙基)-2,2,6,6-四甲基-4-羥基六氫吡啶與琥 珀酸之縮合物;硬脂酸2,2,6,6-四甲基六氫吡啶-4-基酯;十二烷酸2,2,6,6-四甲基六氫吡啶-4-基酯;硬脂酸1,2,2,6,6-五甲基六氫吡啶-4-基酯;十二烷酸1,2,2,6,6-五甲基六氫吡啶-4-基酯;N,N'-雙(2,2,6,6-四甲基六氫吡啶-4-基)六亞甲基二胺與4-第三-辛基胺基-2,6-二氯-1,3,5-三嗪之縮合物;氮基三乙酸叁(2,2,6,6-四甲基六氫吡啶-4-基)酯;1,2,3,4-丁烷四甲酸四(2,2,6,6-四甲基六氫吡啶-4-基)酯;4-苯甲醯-2,2,6,6-四甲基六氫吡啶;4-硬脂醯基氧基-2,2,6,6-四甲基六氫吡啶;2-正-丁基-2-(2-羥基-3,5-二-第三-丁基苄基)丙二酸雙(1,2,2,6,6-五甲基六氫吡啶基)酯;3-正-辛基-7,7,9,9-四甲基-1,3,8-三氮雜螺[4.5]癸烷-2,4-二酮;癸二酸雙(1-辛氧基-2,2,6,6-四甲基六氫吡啶基)酯;琥珀酸雙(1-辛氧基-2,2,6,6-四甲基六氫吡啶基)酯;N,N'-雙(2,2,6,6-四甲基六氫吡啶-4-基)六亞甲基二胺與4-嗎啉基-2,6-二氯-1,3,5-三嗪之縮合物;2-氯-4,6-雙(4-正-丁基胺基-2,2,6,6-四甲基六氫吡啶基)-1,3,5-三嗪與1,2-雙(3-胺基丙基胺基)乙烷之縮合物;2-氯-4,6-雙(4-正-丁基胺基-1,2,2,6,6-五甲基六氫吡啶基)-1,3,5-三嗪與1,2-雙-(3-胺基丙基胺基)乙烷之縮合物;8-乙醯基-3-十二烷基-7,7,9,9-四甲基-1,3,8-三氮雜螺[4.5]癸烷-2,4-二酮;3-十二烷基-1-(2,2,6,6-四甲基六氫吡啶-4-基)吡咯啶-2,5-二酮;3-十二烷基-1-(1-乙醯基-2,2,6,6-四甲基六氫吡啶-4-基)吡咯啶-2,5-二酮;3-十二烷基-1-(1,2,2,6,6-五甲基六氫吡啶-4-基)吡咯啶-2,5-二酮;4-十六烷氧基-2,2,6,6-四甲基六氫吡啶與4- 硬脂醯基氧基-2,2,6,6-四甲基六氫吡啶之混合物;N,N'-雙(2,2,6,6-四甲基六氫吡啶-4-基)六亞甲基二胺與4-環己基胺基-2,6-二氯-1,3,5-三嗪之縮合物;1,2-雙(3-胺基丙基胺基)乙烷、2,4,6-三氯-1,3,5-三嗪與4-丁基胺基-2,2,6,6-四甲基六氫吡啶之縮合物;2-十一烷基-7,7,9,9-四甲基-1-氧雜-3,8-二氮雜-4-側氧基螺[4.5]癸烷;側氧基-六氫吡嗪基-三嗪;7,7,9,9-四甲基-2-環十一烷基-1-氧雜-3,8-二氮雜-4-側氧基螺[4.5]癸烷與環氧氯丙烷之反應產物;N-烷氧基受阻胺光安定劑,其包括(但不限於):丁烷-1,2,3,4-四甲酸四(2,2,6,6-四甲基-4-六氫吡啶基)酯(MARK® LA-57);1,2,3,4-丁烷四甲酸四(1,2,2,6,6-五甲基-4-六氫吡啶基)酯(MARK® LA-52);1,2,3,4-丁烷四甲酸1,2,2,6,6-五甲基-4-六氫吡啶基十三烷基酯(MARK® LA-62);1,2,3,4-丁烷四甲酸2,2,6,6-四甲基-4-六氫吡啶基十三烷基酯(MARK® LA-67);1,2,3,4-丁烷四甲酸、2,2,6,6-四甲基-2,4,8,10-四氧雜螺[5.5]-十一烷-3,9-二乙醇與1,2,2,6,6-五甲基-4-六氫吡啶基酯之聚合物(MARK® LA-63);1,2,3,4-丁烷四甲酸、2,2,6,6-四甲基-2,4,8,10-四氧雜螺[5.5]-十一烷-3,9-二乙醇與2,2,6,6-四甲基-4-六氫吡啶基酯之聚合物(MARK® LA-68);碳酸雙(1-十一烷氧基-2,2,6,6-四甲基六氫吡啶-4-基)酯(MARK® LA-81;亦稱STAB® LA-81,自Adeka Palmarole,Saint-Louis,France購得);TINUVIN® 123;TINUVIN® NOR 371;TINUVIN ® XT-850/XT-855;FLAMESTAB® NOR 116;及 彼等EP 0 889 085中所揭示者;羥基取代之N-烷氧基HALS,其包括(但不限於)彼等在美國專利第6,271,377號中所揭示者,例如1-(2-羥基-2-甲基丙氧基)-2,2,6,6-四甲基-4-六氫吡啶醇;1-(2-羥基-2-甲基丙氧基)-4-十八醯基氧基-2,2,6,6-四甲基六氫吡啶;1-(4-十八醯基氧基-2,2,6,6-四甲基六氫吡啶-1-基氧基)-2-十八醯基氧基-2-甲基丙烷;1-(2-羥基乙基)-2,2,6,6-四甲基-4-六氫吡啶醇;1-(2-羥基乙基)-2,2,6,6-四甲基-4-六氫吡啶醇與琥珀酸二甲酯之反應產物;WO 2007/104689中所揭示之四甲基六氫吡啶基中之任一者,其包括(但不限於):2,2,4,4-四甲基-7-氧雜-3,20-二氮雜二螺[5.1.11.2]二十一烷-21-酮(HOSTAVIN® N20);2,2,6,6-四甲基-4-六氫吡啶醇與高脂肪酸之酯(CYASORB® 3853);3-十二烷基-1-(2,2,6,6-四甲基-4-六氫吡啶基)吡咯啶-2,5-二酮(SANDUVOR® 3055);及其蠟狀反應產物,例如HALS NOW(LS X-N-O-W1);美國專利第6,843,939號;第7,109,259號;第4,240,961號;第4,480,092號;第4,629,752號;第4,639,479號;第5,013,836號;第5,310,771號;及第WO 88/08863號中所揭示之六氫吡嗪酮化合物及其衍生物,其包括(但不限於):1-十八烷基-1H-吡咯-2,5-二酮與(1-甲基乙烯基)苯及1-(2,2,6,6-四甲基-4-六氫吡啶基)-1H-吡咯-2,5-二酮之聚合物;1,1',1"-[1,3,5-三嗪-2,4,6-三基叁[(環己基亞胺基)-2,1-乙烷二基]]叁[3,3,5,5-四甲基-六氫吡嗪酮];1,1',1"-[1,3,5- 三嗪-2,4,6-三基叁[(環己基亞胺基)-2,1-乙烷二基]]叁[3,3,4,5,5-五甲基-六氫吡嗪酮];7,7,9,9-四甲基-2-環十一烷基-1-氧雜-3,8-二氮雜-4-側氧基螺[4.5]癸烷與環氧氯丙烷之反應產物;N,N'-雙(2,2,6,6-四甲基六氫吡啶-4-基)六亞甲基二胺與4-環己基胺基-2,6-二氯-1,3,5-三嗪之縮合物;1,2-雙(3-胺基丙基胺基)乙烷、2,4,6-三氯-1,3,5-三嗪及4-丁基胺基-2,2,6,6-四甲基六氫吡啶之縮合物;N,N'-雙(2,2,6,6-四甲基六氫吡啶-4-基)六亞甲基二胺與4-嗎啉基-2,6-二氯-1,3,5-三嗪之縮合物;2-氯-4,6-雙(4-正-丁基胺基-2,2,6,6-四甲基六氫吡啶基)-1,3,5-三嗪與1,2-雙(3-胺基丙基胺基)乙烷之縮合物;2-氯-4,6-雙(4-正-丁基胺基-1,2,2,6,6-五甲基六氫吡啶基)-1,3,5-三嗪與1,2-雙-(3-胺基丙基胺基)乙烷之縮合物;2-[(2-羥基乙基)胺基]-4,6-雙[N-(1-環己氧基-2,2,6,6-四甲基六氫吡啶-4-基)丁基胺基-1,3,5-三嗪;丙二酸[(4-甲氧基苯基)-亞甲基]-雙-(1,2,2,6,6-五甲基-4-六氫吡啶基)酯;1,2,3,4-丁烷四甲酸四(2,2,6,6-四甲基六氫吡啶-4-基)酯;3,5-雙(1,1-二甲基乙基)-4-羥基-苯丙酸1-[2-[3-[3,5-雙(1,1-二甲基乙基)-4-羥基苯基]-1-側氧基丙氧基]乙基]-2,2,6,6-四甲基-4-六氫吡啶基酯;N-(1-辛氧基-2,2,6,6-四甲基六氫吡啶-4-基)-N'-十二烷基草醯胺;氮基三乙酸叁(2,2,6,6-四甲基六氫吡啶-4-基)酯;1,5-二氧雜螺{5,5}十一烷-3,3-二甲酸雙(1,2,2,6,6-五甲基-4-六氫吡啶基)酯;1,5-二氧雜螺{5,5}十一烷-3,3-二甲酸雙(2,2,6,6-四甲基-4-六氫吡啶基)酯;1-(2-羥基乙基) -2,2,6,6-四甲基-4-羥基六氫吡啶與琥珀酸之縮合物;N,N'-雙(2,2,6,6-四甲基六氫吡啶-4-基)六亞甲基二胺與4-第三-辛基胺基-2,6-二氯-1,3,5-三嗪之縮合物;1,2,3,4-丁烷四甲酸1,2,2,6,6-五甲基-4-六氫吡啶基十三烷基酯;1,2,3,4-丁烷四甲酸四(2,2,6,6-四甲基六氫吡啶-4-基)酯;1,2,3,4-丁烷四甲酸2,2,6,6-四甲基-4-六氫吡啶基十三烷基酯;1,2,3,4-丁烷四甲酸四(1,2,2,6,6-五甲基六氫吡啶-4-基)酯;2,2,4,4-四甲基-21-側氧基-7-氧雜-3.20-二氮雜螺(5.1.11.2)-二十一烷-20-丙酸-十二烷基酯與2,2,4,4-四甲基-21-側氧基-7-氧雜-3.20-二氮雜螺(5.1.11.2)-二十一烷-20-丙酸-十四烷基酯之混合物;六氫-2,6-雙(2,2,6,6-四甲基-4-六氫吡啶基)-1H,4H,5H,8H-2,3a,4a,6,7a,8a-六氮雜環戊并[def]茀-4,8-二酮;聚甲基[丙基-3-氧基(2',2',6',6'-四甲基-4,4'-六氫吡啶基)]矽氧烷;聚甲基[丙基-3-氧基(1',2',2',6',6'-五甲基-4,4'-六氫吡啶基)]矽氧烷;甲基丙烯酸甲酯與丙烯酸乙酯及丙烯酸2,2,6,6-四甲基六氫吡啶-4-基酯之共聚物;C20至C24混合α-烯烴與(2,2,6,6-四甲基六氫吡啶-4-基)琥珀醯亞胺之共聚物;1,2,3,4-丁烷四甲酸、β,β,β',β'-四甲基-2,4,8,10-四氧雜螺[5.5]十一烷-3,9-二乙醇與1,2,2,6,6-五甲基-4-六氫吡啶基酯之聚合物;1,2,3,4-丁烷四甲酸、β,β,β',β'-四甲基-2,4,8,10-四氧雜螺[5.5]十一烷-3,9-二乙醇與2,2,6,6-四甲基-4-六氫吡啶基酯共聚物之聚合物;N,N'-雙(2,2,6,6-四甲基-4-六氫吡啶基)1,3-苯二甲醯胺;1,1'-(1,10-二側氧基-1,10-癸烷二基)-雙 (六氫-2,2,4,4,6-五甲基嘧啶);N-(1-乙醯基-2,2,6,6-四甲基六氫吡啶基)-N'-十二烷基乙烷二醯胺;N,N'-1,6-己烷二基雙[N-(2,2,6,6-四甲基-4-六氫吡啶基)甲醯胺;1,3:2,4-雙-O-(2,2,6,6-四甲基-4-亞六氫吡啶基)-D-葡萄糖醇;2,2,4,4-四甲基-7-氧雜-3,20-二氮雜-21-側氧基-二螺[5.1.11.2]二十一烷;2-甲基-N-(2,2,6,6-四甲基-4-六氫吡啶基)-2-[(2,2,6,6-四甲基-4-六氫吡啶基)胺基]-丙醯胺;2,2,4,4-四甲基-21-側氧基-7-氧雜-3,20-二氮雜二螺[5.1.11.2]二十一烷-20-丙酸十二烷基酯;N-(2,2,6,6-四甲基六氫吡啶-4-基)-β-胺基丙酸十二烷基酯;N-(2,2,6,6-四甲基六氫吡啶-4-基)-N'-胺基草醯胺;N-(2,2,6,6-四甲基-4-六氫吡啶基)-3-[(2,2,6,6-四甲基-4-六氫吡啶基)胺基]-丙醯胺;4-十六烷氧基-2,2,6,6-四甲基六氫吡啶與4-硬脂醯基氧基-2,2,6,6-四甲基六氫吡啶之混合物;3-十二烷基-1-(1,2,2,6,6-五甲基六氫吡啶-4-基)吡咯啶-2,5-二酮;3-十二烷基-1-(1-乙醯基-2,2,6,6-五甲基六氫吡啶-4-基)吡咯啶-2,5-二酮;琥珀酸雙(2,2,6,6-四甲基六氫吡啶-4-基)酯;正丁基3,5-二-第三-丁基-4-羥基苄基丙二酸雙(1,2,2,6,6-五甲基六氫吡啶-4-基)酯;氮基三乙酸叁(2,2,6,6-四甲基六氫吡啶-4-基)酯;1,1'-(1,2-乙烷二基)雙(3,3,5,5-四甲基六氫吡嗪酮);4-苯甲醯-2,2,6,6-四甲基六氫吡啶;4-硬脂醯基氧基-2,2,6,6-四甲基六氫吡啶;2-正-丁基-2-(2-羥基-3,5-二-第三-丁基苄基)丙二酸雙(1,2,2,6,6-五甲基六氫吡啶基)酯;3-正-辛基-7,7,9,9-四甲基-1,3,8-三氮雜螺[4.5] 癸烷-2,4-二酮;癸二酸雙(1-辛氧基-2,2,6,6-四甲基六氫吡啶基)酯;琥珀酸雙(1-辛氧基-2,2,6,6-四甲基六氫吡啶基)酯;8-乙醯基-3-十二烷基-7,7,9,9-四甲基-1,3,8-三氮雜螺[4.5]癸烷-2,4-二酮;3-十二烷基-1-(2,2,6,6-四甲基六氫吡啶-4-基)吡咯啶-2,5-二酮;3-十二烷基-1-(1-乙醯基-2,2,6,6-四甲基六氫吡啶-4-基)吡咯啶-2,5-二酮;3-十二烷基-1-(1,2,2,6,6-五甲基六氫吡啶-4-基)吡咯啶-2,5-二酮;4-十六烷氧基-2,2,6,6-四甲基六氫吡啶與4-硬脂醯基氧基-2,2,6,6-四甲基六氫吡啶之混合物;2-十一烷基-7,7,9,9-四甲基-1-氧雜-3,8-二氮雜-4-側氧基螺[4.5]癸烷;1,5-二氧雜螺{5,5}十一烷-3,3-二甲酸雙(2,2,6,6-四甲基-4-六氫吡啶基)酯及1,5-二氧雜螺{5,5}十一烷-3,3-二甲酸雙(1,2,2,6,6-五甲基-4-六氫吡啶基)酯;N1-(β-羥基乙基)3,3-五亞甲基-5,5-二甲基六氫吡嗪-2-酮;N1-第三-辛基-3,3,5,5-四甲基-二氮呯-2-酮;N1-第三-辛基-3,3-五亞甲基-5,5-六亞甲基-二氮呯-2-酮;N1-第三-辛基-3,3-五亞甲基-5,5-二甲基六氫吡嗪-2-酮;反式-1,2-環己烷-雙-(N1-5,5-二甲基-3,3-五亞甲基-2-六氫吡嗪酮);反式-1,2-環己烷-雙-(N1-3,3,5,5-二螺五亞甲基-2-六氫吡嗪酮);N1-異丙基-1,4-二氮雜二螺-(3,3,5,5)五亞甲基-2-六氫吡嗪酮;N1-異丙基-1,4-二氮雜二螺-3,3-五亞甲基-5,5-四亞甲基-2-六氫吡嗪酮;N1-異丙基-5,5-二甲基-3,3-五亞甲基-2-六氫吡嗪酮;反式-1,2-環己烷-雙-N1-(二甲基-3,3-五亞甲基-2-六氫吡嗪酮);N1-辛基-5,5-二甲基-3,3-五亞甲基-1,4- 二氮呯-2-酮;及N1-辛基-1,4-二氮雜二螺-(3,3,5,5)五亞甲基-1,5-二氮呯-2-酮。適宜與本發明一起使用之其他空間受阻胺包括(例如)彼等在EP 1 308 084中所揭示者中之任一者。 Hindered amine light stabilizers particularly suitable for use with the present invention include, but are not limited to, bis(2,2,6,6-tetramethylhexahydropyridin-4-yl) sebacate; succinic acid bis ( 2,2,6,6-tetramethylhexahydropyridin-4-yl) ester; bis(1,2,2,6,6-pentamethylhexahydropyridin-4-yl) sebacate; Bis(1-octyloxy-2,2,6,6-tetramethylhexahydropyridin-4-yl) diester; n-butyl 3,5-di-tertiary-butyl-4-hydroxyl Benzylmalonate bis(1,2,2,6,6-pentamethylhexahydropyridin-4-yl) ester; 1-(2-hydroxyethyl)-2,2,6,6-tetramethyl a condensate of keto-4-hydroxyhexahydropyridine with succinic acid; 2,2,6,6-tetramethylhexahydropyridin-4-yl stearate; dodecanoic acid 2,2,6,6- Tetramethylhexahydropyridin-4-yl ester; 1,2,2,6,6-pentamethylhexahydropyridin-4-yl stearate; dodecanoic acid 1,2,2,6,6 -pentamethylhexahydropyridin-4-yl ester; N,N'-bis(2,2,6,6-tetramethylhexahydropyridin-4-yl)hexamethylenediamine and 4-third a condensate of octylamino-2,6-dichloro-1,3,5-triazine; ruthenium ruthenium triacetate (2,2,6,6-tetramethylhexahydropyridin-4-yl) Ester; 1,2,3,4-butanetetracarboxylic acid tetrakis(2,2,6,6-tetramethylhexahydropyridin-4-yl) ester; 4-benzylidene-2,2,6,6 -tetramethyl Hydropyridine; 4-stearyl yloxy-2,2,6,6-tetramethylhexahydropyridine; 2-n-butyl-2-(2-hydroxy-3,5-di-third- Butylbenzyl)malonic acid bis(1,2,2,6,6-pentamethylhexahydropyridyl) ester; 3-n-octyl-7,7,9,9-tetramethyl-1 ,3,8-triazaspiro[4.5]decane-2,4-dione; bis(1-octyloxy-2,2,6,6-tetramethylhexahydropyridinyl) sebacate Bis(1-octyloxy-2,2,6,6-tetramethylhexahydropyridinyl) succinate; N,N'-bis(2,2,6,6-tetramethylhexahydropyridine) a condensate of -4-yl)hexamethylenediamine with 4-morpholinyl-2,6-dichloro-1,3,5-triazine; 2-chloro-4,6-bis(4-positive) -butylamino-2,2,6,6-tetramethylhexahydropyridyl)-1,3,5-triazine and 1,2-bis(3-aminopropylamino)ethane Condensate; 2-chloro-4,6-bis(4-n-butylamino-1,2,2,6,6-pentamethylhexahydropyridinyl)-1,3,5-triazine a condensate of 1,2-bis-(3-aminopropylamino)ethane; 8-ethylindolyl-3-dodecyl-7,7,9,9-tetramethyl-1,3 , 8-triazaspiro[4.5]decane-2,4-dione; 3-dodecyl-1-(2,2,6,6-tetramethylhexahydropyridin-4-yl)pyrrole Pyridin-2,5-dione; 3-dodecyl-1-(1-ethylindenyl-2,2,6,6-tetramethylhexahydropyridin-4-yl)pyrrolidine- 2,5-dione; 3-dodecyl-1-(1,2,2,6,6-pentamethylhexahydropyridin-4-yl)pyrrolidine-2,5-dione; 4- a mixture of cetyloxy-2,2,6,6-tetramethylhexahydropyridine and 4-stearylnonyloxy-2,2,6,6-tetramethylhexahydropyridine; N,N '-Bis(2,2,6,6-tetramethylhexahydropyridin-4-yl)hexamethylenediamine and 4-cyclohexylamino-2,6-dichloro-1,3,5- a condensate of triazine; 1,2-bis(3-aminopropylamino)ethane, 2,4,6-trichloro-1,3,5-triazine and 4-butylamino-2 a condensate of 2,6,6-tetramethylhexahydropyridine; 2-undecyl-7,7,9,9-tetramethyl-1-oxa-3,8-diaza-4 - pendant oxose [4.5] decane; pendant oxy-hexahydropyrazinyl-triazine; 7,7,9,9-tetramethyl-2-cycloundecyl-1-oxa-3 , a reaction product of 8-diaza-4-oxooxyspiro[4.5]decane with epichlorohydrin; an N-alkoxy hindered amine light stabilizer comprising (but not limited to): butane-1 , 2,3,4-tetracarboxylic acid tetrakis(2,2,6,6-tetramethyl-4-hexahydropyridyl) ester (MARK® LA-57); 1,2,3,4-butane IV Tetrakis(1,2,2,6,6-pentamethyl-4-hexahydropyridyl)carboxylate (MARK® LA-52); 1,2,3,4-butanetetracarboxylic acid 1,2,2 6,6-pentamethyl-4-hexahydropyridyltridecyl ester ( MARK® LA-62); 1,2,3,4-butanetetracarboxylic acid 2,2,6,6-tetramethyl-4-hexahydropyridyltridecyl ester (MARK® LA-67); 1,2,3,4-butanetetracarboxylic acid, 2,2,6,6-tetramethyl-2,4,8,10-tetraoxaspiro[5.5]-undecane-3,9-di Polymer of ethanol and 1,2,2,6,6-pentamethyl-4-hexahydropyridyl ester (MARK® LA-63); 1,2,3,4-butanetetracarboxylic acid, 2,2 6,6-Tetramethyl-2,4,8,10-tetraoxaspiro[5.5]-undecane-3,9-diethanol and 2,2,6,6-tetramethyl-4- Polymer of hexahydropyridyl ester (MARK® LA-68); bis(1-undecyloxy-2,2,6,6-tetramethylhexahydropyridin-4-yl) carbonate (MARK® LA-81; also known as STAB® LA-81, available from Adeka Palmarole, Saint-Louis, France); TINUVIN® 123; TINUVIN® NOR 371; TINUVIN® XT-850/XT-855; FLAMESTAB® NOR 116; Those disclosed in EP 0 889 085; hydroxy-substituted N-alkoxy HALS, which include, but are not limited to, those disclosed in U.S. Patent No. 6,271,377, for example, 1-(2-hydroxy-2) -methylpropoxy)-2,2,6,6-tetramethyl-4-hexahydropyridinol; 1-(2-hydroxy-2-methylpropoxy)-4-octadecyloxy Base-2,2,6,6-tetramethylhexahydropyridine; 1-(4-octadecyloxy) -2,2,6,6-tetramethylhexahydropyridin-1-yloxy)-2-octadecyloxy-2-methylpropane; 1-(2-hydroxyethyl)-2 , 2,6,6-tetramethyl-4-hexahydropyridinol; 1-(2-hydroxyethyl)-2,2,6,6-tetramethyl-4-hexahydropyridinol and succinic acid a reaction product of a methyl ester; any of the tetramethylhexahydropyridyl groups disclosed in WO 2007/104689, including but not limited to: 2,2,4,4-tetramethyl-7-oxygen Hetero-3,20-diazabispiro[5.1.11.2] eicosane-21-one (HOSTAVIN® N20); 2,2,6,6-tetramethyl-4-hexahydropyridinol and high Fatty acid ester (CYASORB® 3853); 3-dodecyl-1-(2,2,6,6-tetramethyl-4-hexahydropyridyl)pyrrolidine-2,5-dione (SANDUVOR® 3055); and its waxy reaction product, such as HALS NOW (LS XNO-W1); U.S. Patent No. 6,843,939; No. 7,109,259; No. 4,240,961; No. 4,480,092; No. 4,629,752; No. 4,639,479; No. 5,013,836; a hexahydropyrazinone compound and a derivative thereof as disclosed in WO 88/08863, including but not limited to: 1-octadecyl-1H-pyrrole-2,5-di Ketones with (1-methylvinyl)benzene and 1-(2,2,6,6-tetramethyl-4-hexa a polymer of pyridyl)-1H-pyrrole-2,5-dione; 1,1',1"-[1,3,5-triazine-2,4,6-triyloxime [(cyclohexyl) Amino)-2,1-ethanediyl]]indole [3,3,5,5-tetramethyl-hexahydropyrazinone]; 1,1',1"-[1,3,5- Triazine-2,4,6-triyloxime [(cyclohexylimylidene)-2,1-ethanediyl]]indole [3,3,4,5,5-pentamethyl-hexahydropyridyl Benzazinone; 7,7,9,9-tetramethyl-2-cycloundecyl-1-oxa-3,8-diaza-4-oxooxyspiro[4.5]decane and ring Reaction product of oxychloropropane; N,N'-bis(2,2,6,6-tetramethylhexahydropyridin-4-yl)hexamethylenediamine and 4-cyclohexylamino-2,6 a condensate of dichloro-1,3,5-triazine; 1,2-bis(3-aminopropylamino)ethane, 2,4,6-trichloro-1,3,5-three Condensate of azine and 4-butylamino-2,2,6,6-tetramethylhexahydropyridine; N,N'-bis(2,2,6,6-tetramethylhexahydropyridine-4 a condensate of hexamethylenediamine and 4-morpholinyl-2,6-dichloro-1,3,5-triazine; 2-chloro-4,6-bis(4-n-butyl) Condensate of arylamino-2,2,6,6-tetramethylhexahydropyridyl)-1,3,5-triazine with 1,2-bis(3-aminopropylamino)ethane 2-chloro-4,6-bis(4-n-butylamino-1,2,2,6,6-pentamethylhexahydropyridyl)-1,3,5-triazine with 1, 2-bis-(3-amine a condensate of propylamino)ethane; 2-[(2-hydroxyethyl)amino]-4,6-bis[N-(1-cyclohexyloxy-2,2,6,6- Tetramethylhexahydropyridin-4-yl)butylamino-1,3,5-triazine; malonic acid [(4-methoxyphenyl)-methylene]-bis-(1,2 ,2,6,6-pentamethyl-4-hexahydropyridinyl); 1,2,3,4-butanetetracarboxylic acid tetrakis(2,2,6,6-tetramethylhexahydropyridine-4 -yl)ester; 3,5-bis(1,1-dimethylethyl)-4-hydroxy-phenylpropionic acid 1-[2-[3-[3,5-bis(1,1-dimethyl) (ethyl)-4-hydroxyphenyl]-1-oxopropoxy]ethyl]-2,2,6,6-tetramethyl-4-hexahydropyridyl ester; N-(1- Octyloxy-2,2,6,6-tetramethylhexahydropyridin-4-yl)-N'-dodecyloxazamide; hydrazinium triacetate (2,2,6,6-tetra Methylhexahydropyridin-4-yl)ester; 1,5-dioxaspiro{5,5}undecane-3,3-dicarboxylic acid bis(1,2,2,6,6-pentamethyl -4-hexahydropyridyl)ester; 1,5-dioxaspiro{5,5}undecane-3,3-dicarboxylic acid bis(2,2,6,6-tetramethyl-4-hexa Hydrogen pyridyl) ester; condensate of 1-(2-hydroxyethyl)-2,2,6,6-tetramethyl-4-hydroxyhexahydropyridine and succinic acid; N,N'-bis(2, 2,6,6-tetramethylhexahydropyridin-4-yl)hexamethylenediamine and 4-tris-octylamino-2,6-dichloro-1,3,5-tri Condensate; 1,2,3,4-butanetetracarboxylic acid 1,2,2,6,6-pentamethyl-4-hexahydropyridyltridecyl ester; 1,2,3,4- Butyltetracarboxylic acid tetrakis(2,2,6,6-tetramethylhexahydropyridin-4-yl) ester; 1,2,3,4-butanetetracarboxylic acid 2,2,6,6-tetramethyl 4-tetrahydropyridyltridecyl ester; 1,2,3,4-butanetetracarboxylic acid tetrakis(1,2,2,6,6-pentamethylhexahydropyridin-4-yl) ester; 2,2,4,4-Tetramethyl-21-o-oxy-7-oxa-3.20-diazaspiro (5.1.11.2)-icosane-20-propionic acid-dodecyl ester And 2,2,4,4-tetramethyl-21-oxo-7-oxa-3.20-diazaspiro (5.1.11.2)-icosane-20-propionic acid-tetradecyl a mixture of esters; hexahydro-2,6-bis(2,2,6,6-tetramethyl-4-hexahydropyridinyl)-1H,4H,5H,8H-2,3a,4a,6,7a , 8a-hexazacyclo[def]indole-4,8-dione; polymethyl[propyl-3-oxy(2',2',6',6'-tetramethyl-4 , 4'-hexahydropyridinyl)]oxane;polymethyl[propyl-3-oxy(1',2',2',6',6'-pentamethyl-4,4'-Hexahydropyridyl)]oxane; a copolymer of methyl methacrylate with ethyl acrylate and 2,2,6,6-tetramethylhexahydropyridin-4-yl acrylate; C 20 to C 24 mixed --olefin and (2,2,6,6-tetramethylhexahydropyridin-4-yl) Copolymer of peracetimimine; 1,2,3,4-butanetetracarboxylic acid, β,β,β',β'-tetramethyl-2,4,8,10-tetraoxaspiro[5.5] a polymer of undecane-3,9-diethanol and 1,2,2,6,6-pentamethyl-4-hexahydropyridyl ester; 1,2,3,4-butanetetracarboxylic acid, β ,β,β',β'-tetramethyl-2,4,8,10-tetraoxaspiro[5.5]undecane-3,9-diethanol and 2,2,6,6-tetramethyl a polymer of a -4-hexahydropyridyl ester copolymer; N,N'-bis(2,2,6,6-tetramethyl-4-hexahydropyridinyl)1,3-benzenedimethylamine;1,1'-(1,10-di-oxy-1,10-decanediyl)-bis(hexahydro-2,2,4,4,6-pentamethylpyrimidine); N-(1 -Ethyl 2,2,6,6-tetramethylhexahydropyridyl)-N'-dodecylethanediamine;N,N'-1,6-hexanediyl bis[ N-(2,2,6,6-tetramethyl-4-hexahydropyridinyl)carbenamide; 1,3:2,4-bis-O-(2,2,6,6-tetramethyl 4-i-hexahydropyridyl)-D-glucitol; 2,2,4,4-tetramethyl-7-oxa-3,20-diaza-21-sideoxy-dispiro[5.1 .11.2] icosane; 2-methyl-N-(2,2,6,6-tetramethyl-4-hexahydropyridinyl)-2-[(2,2,6,6-tetramethyl) Benzyl-4-hexahydropyridinyl)amino]-propionamide; 2,2,4,4-tetramethyl-21-oxyl-7-oxa-3,20-diazabispiro[ 5.1.11.2] II Dodecane-20-propionic acid lauryl ester; N-(2,2,6,6-tetramethylhexahydropyridin-4-yl)-β-aminopropionic acid lauryl ester; N- (2,2,6,6-tetramethylhexahydropyridin-4-yl)-N'-aminoglyoxime; N-(2,2,6,6-tetramethyl-4-hexahydropyridine 3-[(2,2,6,6-tetramethyl-4-hexahydropyridinyl)amino]-propanamine; 4-hexadecyloxy-2,2,6,6- a mixture of tetramethylhexahydropyridine and 4-stearylnonyloxy-2,2,6,6-tetramethylhexahydropyridine; 3-dodecyl-1-(1,2,2,6 ,6-pentamethylhexahydropyridin-4-yl)pyrrolidine-2,5-dione; 3-dodecyl-1-(1-ethenyl-2,2,6,6-penta Hexahydropyridin-4-yl)pyrrolidine-2,5-dione; bis(2,2,6,6-tetramethylhexahydropyridin-4-yl) succinate; n-butyl 3,5 -Bis-tert-butyl-4-hydroxybenzylmalonate bis(1,2,2,6,6-pentamethylhexahydropyridin-4-yl); hydrazinium triacetate (2, 2,6,6-tetramethylhexahydropyridin-4-yl)ester; 1,1'-(1,2-ethanediyl)bis(3,3,5,5-tetramethylhexahydropyridyl 4- benzopyridin-2,2,6,6-tetramethylhexahydropyridine; 4-stearyl yloxy-2,2,6,6-tetramethylhexahydropyridine; - n-butyl-2-(2-hydroxy-3,5-di-tri-butylbenzyl)malonic acid bis (1,2 , 2,6,6-pentamethylhexahydropyridinyl); 3-n-octyl-7,7,9,9-tetramethyl-1,3,8-triazaspiro[4.5] Alkane-2,4-dione; bis(1-octyloxy-2,2,6,6-tetramethylhexahydropyridyl) sebacate; bis(1-octyloxy-2) succinate 2,6,6-tetramethylhexahydropyridinyl); 8-ethylindenyl-3-dodecyl-7,7,9,9-tetramethyl-1,3,8-triaza Spiro[4.5]decane-2,4-dione; 3-dodecyl-1-(2,2,6,6-tetramethylhexahydropyridin-4-yl)pyrrolidine-2,5- Diketone; 3-dodecyl-1-(1-ethylindenyl-2,2,6,6-tetramethylhexahydropyridin-4-yl)pyrrolidine-2,5-dione; 3- Dodecyl-1-(1,2,2,6,6-pentamethylhexahydropyridin-4-yl)pyrrolidine-2,5-dione; 4-hexadecyloxy-2,2 a mixture of 6,6-tetramethylhexahydropyridine and 4-stearylnonyloxy-2,2,6,6-tetramethylhexahydropyridine; 2-undecyl-7,7,9 , 9-tetramethyl-1-oxa-3,8-diaza-4-oxooxyspiro[4.5]decane; 1,5-dioxaspiro{5,5}undecane-3 ,3-dicarboxylic acid bis(2,2,6,6-tetramethyl-4-hexahydropyridyl) and 1,5-dioxaspiro{5,5}undecane-3,3-di acid bis (1,2,2,6,6-pentamethyl-4-piperidinyl) ester; N 1 - (β- hydroxyethyl) 3,3-pentamethylene-5,5 Methyl hexahydro-2-one; N 1 - third - octyl -3,3,5,5-tetramethyl - dinitrogen Boom 2-one; N 1 - third - octyl - 3 ,3-pentamethylene-5,5-hexamethylene-diazepin-2-one; N 1 -tris-octyl-3,3-pentamethylene-5,5-dimethyl Hexahydropyrazin-2-one; trans-1,2-cyclohexane-bis-(N 1 -5,5-dimethyl-3,3-pentamethylene-2-hexahydropyrazinone Trans-1,2-cyclohexane-bis-(N 1 -3,3,5,5-dispiropentamethylene-2-hexahydropyrazinone); N 1 -isopropyl- 1,4-diaza-spiro-(3,3,5,5)pentamethylene-2-hexahydropyrazinone; N 1 -isopropyl-1,4-diazaspiro-3 ,3-pentamethylene-5,5-tetramethylene-2-hexahydropyrazinone; N 1 -isopropyl-5,5-dimethyl-3,3-pentamethylene-2 - hexahydropyrazinone; trans-1,2-cyclohexane-bis-N 1 -(dimethyl-3,3-pentamethylene-2-hexahydropyrazinone); N 1 -octyl 5-,5-dimethyl-3,3-pentamethylene-1,4-diazepin-2-one; and N 1 -octyl-1,4-diazabi-spiro-(3 , 3, 5, 5) pentamethylene-1,5-diazepin-2-one. Other sterically hindered amines suitable for use with the present invention include, for example, any of those disclosed in EP 1 308 084.

受阻胺組份可基於欲安定有機材料之總重量以0.01重量%至10重量%之量存在。較佳地,基於欲安定有機材料之總重量,受阻胺之量可為0.05%至5%、且更佳0.1重量%至3重量%。 The hindered amine component may be present in an amount of from 0.01% by weight to 10% by weight based on the total weight of the organic material to be stabilized. Preferably, the amount of hindered amine may range from 0.05% to 5%, and more preferably from 0.1% to 3% by weight, based on the total weight of the organic material to be stabilized.

適宜與本發明一起使用之其他光安定劑包括以下中之一或多者:2-(2'-羥基苯基)苯并三唑,例如2-(2'-羥基-5'-甲基苯基)-苯并三唑;2-(3',5'-二-第三-丁基-2'-羥基苯基)苯并三唑;2-(5'-第三-丁基-2'-羥基苯基)苯并三唑;2-(2'-羥基-5'-(1,1,3,3-四甲基丁基)苯基)苯并三唑;2-(3',5'-二-第三-丁基-2'-羥基苯基)-5-氯-苯并三唑;2-(3'-第三-丁基-2'-羥基-5'-甲基苯基)-5-氯-苯并三唑;2-(3'-第二-丁基-5'-第三-丁基-2'-羥基苯基)苯并三唑;2-(2'-羥基-4'-辛氧基苯基)苯并三唑;2-(3',5'-二-第三-戊基-2'-羥基苯基)苯并三唑;2-(3',5'-雙-(α,α-二甲基苄基)-2'-羥基苯基)苯并三唑;2-(3'-第三-丁基-2'-羥基-5'-(2-辛氧基羰基乙基)苯基)-5-氯-苯并三唑;2-(3'-第三-丁基-5'-[2-(2-乙基己氧基)-羰基乙基]-2'-羥基苯基)-5-氯-苯并三唑;2-(3'-第三-丁基-2'-羥基-5'-(2-甲氧基羰基乙基)苯基)-5-氯-苯并三唑;2-(3'-第三-丁基-2'-羥基-5'-(2-甲氧基羰基乙基)苯基)苯并三唑;2- (3'-第三-丁基-2'-羥基-5'-(2-辛氧基羰基乙基)苯基)苯并三唑;2-(3'-第三-丁基-5'-[2-(2-乙基己氧基)羰基]-2'-羥基苯基)苯并三唑;2-(3'-十二烷基-2'-羥基-5'-甲基苯基)苯并三唑;2-(3'-第三-丁基-2'-羥基-5'-(2-異辛氧基羰基乙基)苯基苯并三唑;2,2'-亞甲基-雙[4-(1,1,3,3-四甲基丁基)-6-苯并三唑-2-基酚];2-[3'-第三-丁基-5'-(2-甲氧基羰基乙基)-2'-羥基苯基]-2H-苯并三唑與聚乙二醇300之轉酯化產物;[R-CH2CH2-COO-CH2CH2]2,其中R=3'-第三-丁基-4'-羥基-5'-2H-苯并三唑-2-基苯基;2-[2'-羥基-3'-(α,α-二甲基苄基)-5'-(1,1,3,3-四甲基丁基)-苯基]苯并三唑;2-[2'-羥基-3'-(1,1,3,3-四甲基丁基)-5'-(α,α-二甲基苄基)-苯基]苯并三唑;2-羥基二苯甲酮,例如4-羥基、4-甲氧基、4-辛氧基、4-癸氧基、4-十二烷氧基、4-苄氧基、4,2',4'-三羥基及2'-羥基-4,4'-二甲氧基衍生物;經取代及未經取代苯甲酸之酯,例如水楊酸4-第三丁基苯基酯、水楊酸苯基酯、水楊酸辛基苯基酯、二苯甲醯基間苯二酚、雙(4-第三丁基苯甲醯基)間苯二酚、苯甲醯基間苯二酚、3,5-二-第三丁基-4-羥基苯甲酸2,4-二-第三丁基苯基酯、3,5-二-第三丁基-4-羥基苯甲酸十六烷基酯、3,5-二-第三丁基-4-羥基苯甲酸十八烷基酯、3,5-二-第三丁基-4-羥基苯甲酸2-甲基-4,6-二-第三丁基苯基酯。 Other photostabilizers suitable for use with the present invention include one or more of the following: 2-(2'-hydroxyphenyl)benzotriazole, such as 2-(2'-hydroxy-5'-methylbenzene Benzo-benzotriazole; 2-(3',5'-di-t-butyl-butyl-2'-hydroxyphenyl)benzotriazole;2-(5'-tris-butyl-2'-Hydroxyphenyl)benzotriazole;2-(2'-hydroxy-5'-(1,1,3,3-tetramethylbutyl)phenyl)benzotriazole;2-(3' , 5'-di-t-butyl-2'-hydroxyphenyl)-5-chloro-benzotriazole;2-(3'-tris-butyl-2'-hydroxy-5'-APhenyl)-5-chloro-benzotriazole;2-(3'-second-butyl-5'-tris-butyl-2'-hydroxyphenyl)benzotriazole; 2-( 2'-hydroxy-4'-octyloxyphenyl)benzotriazole;2-(3',5'-di-tris-pentyl-2'-hydroxyphenyl)benzotriazole; 2- (3',5'-bis-(α,α-dimethylbenzyl)-2'-hydroxyphenyl)benzotriazole;2-(3'-tris-butyl-2'-hydroxy-5'-(2-octyloxycarbonylethyl)phenyl)-5-chloro-benzotriazole;2-(3'-tris-butyl-5'-[2-(2-ethylhexyl)Oxy)-carbonylethyl]-2'-hydroxyphenyl)-5-chloro-benzotriazole;2-(3'-tris-butyl-2'-hydroxy-5'-(2-AOxycarbonylethyl)phenyl)-5-chloro-benzotriazole;2-(3'-third-Butyl-2'-hydroxy-5'-(2-methoxycarbonylethyl)phenyl)benzotriazole;2-(3'-tris-butyl-2'-hydroxy-5'-(2-octyloxycarbonylethyl)phenyl)benzotriazole;2-(3'-tris-butyl-5'-[2-(2-ethylhexyloxy)carbonyl]-2'-Hydroxyphenyl)benzotriazole;2-(3'-dodecyl-2'-hydroxy-5'-methylphenyl)benzotriazole;2-(3'-tris-butyl-2'-hydroxy-5'-(2-isooctyloxycarbonylethyl)phenylbenzotriazole;2,2'-methylene-bis[4-(1,1,3,3-tetramethyl)Benzyl)-6-benzotriazol-2-ylphenol];2-[3'-tris-butyl-5'-(2-methoxycarbonylethyl)-2'-hydroxyphenyl a transesterification product of -2H-benzotriazole with polyethylene glycol 300; [R-CH 2 CH 2 -COO-CH 2 CH 2 ] 2 wherein R = 3'-tertiary-butyl-4 '-Hydroxy-5'-2H-benzotriazol-2-ylphenyl;2-[2'-hydroxy-3'-(α,α-dimethylbenzyl)-5'-(1,1,3,3-tetramethylbutyl)-phenyl]benzotriazole;2-[2'-hydroxy-3'-(1,1,3,3-tetramethylbutyl)-5'-(α,α-dimethylbenzyl)-phenyl]benzotriazole; 2-hydroxybenzophenone, for example 4-hydroxy, 4-methoxy, 4-octyloxy, 4-decyloxy 4-dodecyloxy, 4-benzyloxy, 4,2',4'-trihydroxy and 2'-hydroxy-4 , 4'-dimethoxy derivative; ester of substituted and unsubstituted benzoic acid, such as 4-tert-butylphenyl salicylate, phenyl salicylate, octylphenyl salicylate , benzoyl resorcinol, bis(4-t-butylbenzylidene) resorcinol, benzhydryl resorcinol, 3,5-di-t-butyl-4 2,4-di-t-butylphenyl hydroxybenzoate, cetyl 3,5-di-tert-butyl-4-hydroxybenzoate, 3,5-di-t-butyl Octadecyl 4-hydroxybenzoate, 2-methyl-4,6-di-tert-butylphenyl 3,5-di-tert-butyl-4-hydroxybenzoate.

鎳化合物,例如含或不含諸如正丁基胺、三乙醇胺或N-環己基二乙醇胺等其他配體之2,2'-硫基-雙-[4-(1,1,3,3-四 甲基丁基)苯酚]之鎳錯合物(例如1:1或1:2錯合物)、二丁基二硫基胺基甲酸鎳、單烷基酯(例如4-羥基-3,5-二-第三丁基苄基膦酸之甲酯或乙酯)之鎳鹽、酮肟(例如2-羥基-4-甲基苯基十一烷基酮肟)之鎳錯合物、含或不含其他配體之1-苯基-4-月桂醯基-5-羥基吡唑之鎳錯合物。 Nickel compounds, such as 2,2'-thio-bis-[4-(1,1,3,3-) with or without other ligands such as n-butylamine, triethanolamine or N-cyclohexyldiethanolamine four a nickel complex of methyl butyl phenol] (eg 1:1 or 1:2 complex), nickel dibutyldithiocarbamate, monoalkyl ester (eg 4-hydroxy-3,5) Nickel salt of -di-tert-butylbenzylphosphonic acid methyl ester or ethyl ester), nickel complex of ketone oxime (for example 2-hydroxy-4-methylphenylundecyl ketone oxime), Or a nickel complex of 1-phenyl-4-lauryl-5-hydroxypyrazole which is free of other ligands.

式(VII)之2-(2'-羥基苯基)-1,3,5-三嗪化合物: 其中R34及R35中之每一者獨立地選自視情況經取代之C6-C10芳基、C1-C10烴基取代之胺基、C1-C10醯基及C1-C10烷氧基;且其中R36係在式VII之苯氧基部分之0個至4個位置處相同或不同之取代基且係獨立地選自羥基、C1-C12烴基、C1-C12烷氧基、C1-C12烷氧基酯及C1-C12醯基。該等2-(2-羥基苯基)-1,3,5-三嗪包括(但不限於):4,6-雙-(2,4-二甲基苯基)-2-(2-羥基-4-辛氧基苯基)-對稱-三嗪(CYASORB® 1164,自Cytec Industries有限公司購得);4,6-雙-(2,4-二甲基苯基)-2-(2,4-二羥基苯基)-對稱-三嗪;2,4-雙(2,4-二羥基苯基)-6-(4-氯苯基)-對稱-三嗪;2,4-雙[2-羥基-4-(2-羥 基-乙氧基)苯基]-6-(4-氯苯基)-對稱-三嗪;2,4-雙[2-羥基-4-(2-羥基-4-(2-羥基-乙氧基)苯基]-6-(2,4-二甲基苯基)-對稱-三嗪;2,4-雙[2-羥基-4-(2-羥基乙氧基)苯基]-6-(4-溴苯基)-對稱-三嗪;2,4-雙[2-羥基-4-(2-乙醯氧基乙氧基)苯基]-6-(4-氯苯基)-對稱-三嗪;2,4-雙(2,4-二羥基苯基)-6-(2,4-二甲基苯基)-對稱-三嗪;2,4-雙(4-聯苯基)-6-[2-羥基-4-[(辛氧基羰基)亞乙基氧基]苯基]-對稱-三嗪;2,4-雙(4-聯苯基)-6-[2-羥基-4-(2-乙基己氧基)苯基]-對稱-三嗪;2-苯基-4-[2-羥基-4-(3-第二-丁氧基-2-羥基丙氧基)苯基]-6-[2-羥基-4-(3-第二-戊氧基-2-羥基丙氧基)苯基]-對稱-三嗪;2,4-雙(2,4-二甲基苯基)-6-[2-羥基-4(3-苄氧基-2-羥基丙氧基)苯基]-對稱-三嗪;2,4-雙(2-羥基-4-正-丁氧基苯基)-6-(2,4-二-正-丁氧基苯基)-對稱-三嗪;2,4-雙(2,4-二甲基苯基)-6-[2-羥基-4-(3-壬氧基-2-羥基丙氧基)-5-α-異丙苯基苯基]-對稱-三嗪;亞甲基雙-{2,4-雙(2,4-二甲基苯基)-6-[2-羥基-4-(3-丁氧基-2-羥基丙氧基)苯基]-對稱-三嗪};在3:5'、5:5'及3:3'位處以5:4:1吡率橋連之亞甲基橋連二聚體混合物;2,4,6-叁(2-羥基-4-異辛氧基羰基異亞丙基氧基-苯基)-對稱-三嗪;2,4-雙(2,4-二甲基苯基)-6-(2-羥基-4-己氧基-5-α-異丙苯基苯基)-對稱-三嗪;2-(2,4,6-三甲基苯基)-4,6-雙[2-羥基-4-(3-丁氧基-2-羥基丙氧基)苯基]-對稱-三嗪;2,4,6-叁[2-羥基-4-(3-第二-丁氧基-2-羥基丙氧基)-苯基]-對稱-三嗪;4,6-雙-(2,4-二甲基苯基)-2-(2-羥基-4-(3-十二烷氧基-2-羥基丙氧基)苯基)-對稱-三嗪與4,6-雙- (2,4-二甲基苯基)-2-(2-羥基-4-(3-十三烷氧基-2-羥基丙氧基)苯基)-對稱-三嗪之混合物(TINUVIN® 400,自BASF公司購得);4,6-雙-(2,4-二甲基苯基)-2-(2-羥基-4(3-(2-乙基己氧基)-2-羥基丙氧基)-苯基)-對稱-三嗪;4,6-二苯基-2-(4-己氧基-2-羥基苯基)-對稱-三嗪;2-(4,6-二苯基-1,3,5-三嗪-2-基)-5-[2-(2-乙基己醯基氧基)乙氧基]苯酚(ADK STAB® LA-46,自Adeka Palmarole,Saint-Louis,France購得);2,4,6-叁(2-羥基-4-辛氧基苯基)-1,3,5-三嗪;丙酸2,2',2"-[1,3,5-三嗪-2,4,6-三基叁[(3-羥基-4,1-伸苯基)氧基]]叁-1,1',1"-三辛基酯(TINUVIN® 477,自BASF公司購得);丙酸2-[4-[4,6-雙([1,1'-聯苯基]-4-基)-1,3,5-三嗪-2基]-3-羥基苯氧基]-異辛基酯(TINUVIN® 479,自BASF公司購得);及其組合。適宜與本發明一起使用之其他三嗪化合物包括彼等在EP 1 308 084(例如式IId)及美國專利申請案第13/144861號(公開案第2011/0272648號)中所述者。 2-(2'-hydroxyphenyl)-1,3,5-triazine compound of formula (VII): Wherein each of R 34 and R 35 is independently selected from optionally substituted C 6 -C 10 aryl, C 1 -C 10 hydrocarbyl substituted amine, C 1 -C 10 decyl and C 1 - C 10 alkoxy; and wherein R 36 is the same or different substituent at the 0 to 4 positions of the phenoxy moiety of formula VII and is independently selected from hydroxy, C 1 -C 12 hydrocarbyl, C 1 -C 12 alkoxy, C 1 -C 12 alkoxy ester and C 1 -C 12 fluorenyl. The 2-(2-hydroxyphenyl)-1,3,5-triazines include, but are not limited to, 4,6-bis-(2,4-dimethylphenyl)-2-(2- Hydroxy-4-octyloxyphenyl)-symmetric-triazine (CYASORB® 1164, available from Cytec Industries, Inc.); 4,6-bis-(2,4-dimethylphenyl)-2-( 2,4-dihydroxyphenyl)-symmetric-triazine; 2,4-bis(2,4-dihydroxyphenyl)-6-(4-chlorophenyl)-symmetric-triazine; 2,4- Bis[2-hydroxy-4-(2-hydroxy-ethoxy)phenyl]-6-(4-chlorophenyl)-symmetric-triazine; 2,4-bis[2-hydroxy-4-(2) -hydroxy-4-(2-hydroxy-ethoxy)phenyl]-6-(2,4-dimethylphenyl)-symmetric-triazine; 2,4-bis[2-hydroxy-4-( 2-hydroxyethoxy)phenyl]-6-(4-bromophenyl)-symmetric-triazine; 2,4-bis[2-hydroxy-4-(2-ethyloxyethoxy)benzene 6-(4-chlorophenyl)-symmetric-triazine; 2,4-bis(2,4-dihydroxyphenyl)-6-(2,4-dimethylphenyl)-symmetric- Triazine; 2,4-bis(4-biphenylyl)-6-[2-hydroxy-4-[(octyloxycarbonyl)ethyleneoxy]phenyl]-symmetric-triazine; 2,4 - bis(4-biphenyl)-6-[2-hydroxy-4-(2-ethylhexyloxy)phenyl]-symmetric-triazine; 2-phenyl-4-[2-hydroxy-4 -(3-second-butoxy-2-hydroxypropoxy)phenyl]-6-[2-hydroxy-4-(3-second-pentyl) Oxy-2-hydroxypropoxy)phenyl]-symmetric-triazine; 2,4-bis(2,4-dimethylphenyl)-6-[2-hydroxy-4(3-benzyloxy) 2-hydroxypropoxy)phenyl]-symmetric-triazine; 2,4-bis(2-hydroxy-4-n-butoxyphenyl)-6-(2,4-di-n-butyl Oxyphenyl)-symmetric-triazine; 2,4-bis(2,4-dimethylphenyl)-6-[2-hydroxy-4-(3-decyloxy-2-hydroxypropoxy) -5-α-isopropylphenylphenyl]-symmetric-triazine; methylene bis-{2,4-bis(2,4-dimethylphenyl)-6-[2-hydroxy-4 -(3-Butoxy-2-hydroxypropoxy)phenyl]-symmetric-triazine}; 5:4:1 pyridinium bridge at 3:5', 5:5' and 3:3' positions a mixture of methylene bridged dimers; 2,4,6-anthracene (2-hydroxy-4-isooctyloxycarbonylisopropyleneoxy-phenyl)-symmetric-triazine; 2,4 - bis(2,4-dimethylphenyl)-6-(2-hydroxy-4-hexyloxy-5-α-isopropylphenylphenyl)-symmetric-triazine; 2-(2,4 ,6-trimethylphenyl)-4,6-bis[2-hydroxy-4-(3-butoxy-2-hydroxypropoxy)phenyl]-symmetric-triazine; 2,4,6 -叁[2-hydroxy-4-(3-second-butoxy-2-hydroxypropoxy)-phenyl]-symmetric-triazine; 4,6-bis-(2,4-dimethyl Phenyl)-2-(2-hydroxy-4-(3-dodecyloxy-2-hydroxypropoxy) Phenyl)-symmetric-triazine with 4,6-bis-(2,4-dimethylphenyl)-2-(2-hydroxy-4-(3-tridecyloxy-2-hydroxypropoxy) a mixture of phenyl)-symmetric-triazine (TINUVIN® 400, available from BASF Corporation); 4,6-bis-(2,4-dimethylphenyl)-2-(2-hydroxy-4) (3-(2-ethylhexyloxy)-2-hydroxypropoxy)-phenyl)-symmetric-triazine; 4,6-diphenyl-2-(4-hexyloxy-2-hydroxyl) Phenyl)-symmetric-triazine; 2-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-[2-(2-ethylhexyloxy) Ethoxy]phenol (ADK STAB® LA-46, available from Adeka Palmarole, Saint-Louis, France); 2,4,6-anthracene (2-hydroxy-4-octyloxyphenyl)-1,3 ,5-triazine; propionic acid 2,2',2"-[1,3,5-triazine-2,4,6-triylindole[(3-hydroxy-4,1-phenylene)oxy Base]]叁-1,1',1"-trioctyl ester (TINUVIN® 477, available from BASF); propionate 2-[4-[4,6-double ([1,1'-linked) Phenyl]-4-yl)-1,3,5-triazin-2-yl]-3-hydroxyphenoxy]-isooctyl ester (TINUVIN® 479, available from BASF Corporation); and combinations thereof. Other triazine compounds which are suitable for use with the present invention include those described in EP 1 308 084 (e.g., Formula IId) and U.S. Patent Application Serial No. 13/144,861 (issued No. 2011/0272648).

在某些實施例中,本發明之安定劑組合物包括至少一種受阻胺光安定劑與至少一種紫外光吸收劑之摻合物。 In certain embodiments, the stabilizer composition of the present invention comprises a blend of at least one hindered amine light stabilizer and at least one ultraviolet light absorber.

適宜與本發明安定劑組合物一起使用之抗氧化劑包括彼等業內所習知抗氧化劑中之任一者。尤其適宜之抗氧化劑包括彼等在美國專利第6,444,733中所列示者中之任一者。在某些實施例中,本發明之安定劑組合物可進一步包括生育酚化合物(例如α-生育酚、β-生育酚、γ-生育酚、δ-生育酚、其異構體及其混合物)及/或生育三烯酚化合物(例如 α、β、γ、δ-生育三烯酚、其異構體及其混合物)。 Antioxidants suitable for use with the stabilizer compositions of the present invention include any of those conventionally known in the art. Particularly suitable antioxidants include any of those listed in U.S. Patent No. 6,444,733. In certain embodiments, the stabilizer composition of the present invention may further comprise a tocopherol compound (eg, alpha-tocopherol, beta-tocopherol, gamma-tocopherol, delta-tocopherol, isomers thereof, and mixtures thereof) And/or tocotrienol compounds (eg α, β, γ, δ-tocotrienol, isomers thereof, and mixtures thereof).

本發明之安定劑組合物之其他實施例包括至少一種選自以下之化合物:式VIII之羥基胺化合物: 其中T1係選自C1-C36烴基、C5-C12環烷基及C7-C9芳烷基,視情況經取代;且T2係選自氫或T1;及式IX之三級胺氧化物化合物: 其中W1及W2係各自獨立地選自C6-C36烴基,該C6-C36烴基選自直鏈或具支鏈C6-C36烷基、C6-C12芳基、C7-C36芳烷基、C7-C36烷芳基、C5-C36環烷基、C6-C36烷基環烷基;及C6-C36環烷基烷基;W3係選自C1-C36烴基,該C1-C36烴基選自直鏈或具支鏈C1-C36烷基、C6-C12芳基、C7-C36芳烷基、C7-C36烷芳基、C5-C36環烷基、C6-C36烷基環烷基;及C6-C36環烷基烷基; 限制條件係W1、W2及W3中之至少一者含有β碳-氫鍵;且其中該等烷基、芳烷基、烷芳基、環烷基、烷基環烷基及環烷基烷基可雜有1個至16個-O-、-S-、-SO-、-SO2-、-COO-、-OCO-、-CO-、-NW4-、-CONW4-及-NW4CO-基團,或其中該等烷基、芳烷基、烷芳基、環烷基、烷基環烷基及環烷基烷基可經1個至16個選自以下之基團取代:-OW4、-SW4、-COOW4、-OCOW4、-COW4、-N(W4)2、-CON(W4)2、-NW4COW4及含有-C(CH3)(CH2Rx)NL(CH2Rx)(CH3)C-基團之5-及6-員環,或其中該等烷基、芳烷基、烷芳基、環烷基、烷基環烷基及環烷基烷基雜有上文所提及基團並經其取代;且其中W4係選自氫或C1-C8烷基;Rx係選自氫或甲基;且L係選自C1-C30烷基、-C(O)R部分,其中R係C1-C30直鏈或具支鏈烷基或-OR部分,其中R係C1-C30直鏈或具支鏈烷基;且其中該等芳基可經1個至3個鹵素、C1-C8烷基、C1-C8烷氧基或其組合取代。 Other examples of stabilizer compositions of the present invention include at least one compound selected from the group consisting of hydroxylamine compounds of formula VIII: Wherein T 1 is selected from the group consisting of C 1 -C 36 hydrocarbyl, C 5 -C 12 cycloalkyl and C 7 -C 9 aralkyl, optionally substituted; and T 2 is selected from hydrogen or T 1 ; Tertiary amine oxide compound: Wherein W 1 and W 2 are each independently selected line C 6 -C 36 hydrocarbon group, the C 6 -C 36 hydrocarbon group selected from linear or branched C 6 -C 36 alkyl, C 6 -C 12 aryl group, a C 7 -C 36 aralkyl group, a C 7 -C 36 alkaryl group, a C 5 -C 36 cycloalkyl group, a C 6 -C 36 alkylcycloalkyl group; and a C 6 -C 36 cycloalkylalkyl group; W 3 is selected from C 1 -C 36 hydrocarbyl C 1 -C 36 hydrocarbon group selected from linear or branched C 1 -C 36 alkyl, C 6 -C 12 aryl, C 7 -C 36 aralkyl a C 7 -C 36 alkaryl group, a C 5 -C 36 cycloalkyl group, a C 6 -C 36 alkylcycloalkyl group; and a C 6 -C 36 cycloalkylalkyl group; the constraint is W 1 , W At least one of 2 and W 3 contains a beta carbon-hydrogen bond; and wherein the alkyl, aralkyl, alkaryl, cycloalkyl, alkylcycloalkyl and cycloalkylalkyl groups are miscellaneous to 16 -O -, - S -, - SO -, - SO 2 -, - COO -, - OCO -, - CO -, - NW 4 -, - CONW 4 - -NW 4 CO- group and Or wherein the alkyl, aralkyl, alkaryl, cycloalkyl, alkylcycloalkyl and cycloalkylalkyl groups may be substituted with from 1 to 16 groups selected from: -OW 4 , -SW 4, -COOW 4, -OCOW 4 , -COW 4, -N (W 4) 2, -CON (W 4) 2, -NW 4 COW 4 and containing -C (CH 3) (CH 2 R x) NL (CH 2 R x) (CH 3) 5- C- group and the 6-membered ring, or wherein such alkyl, aralkyl, alkaryl a cycloalkyl group, an alkylcycloalkyl group, and a cycloalkylalkyl group having and substituted with a group as mentioned above; and wherein W 4 is selected from hydrogen or C 1 -C 8 alkyl; R x Selected from hydrogen or methyl; and L is selected from the group consisting of C 1 -C 30 alkyl, -C(O)R, wherein R is a C 1 -C 30 straight or branched alkyl or -OR moiety, wherein R is a C 1 -C 30 linear or branched alkyl group; and wherein the aryl groups may be through 1 to 3 halogens, C 1 -C 8 alkyl groups, C 1 -C 8 alkoxy groups or combinations thereof Replace.

在特定實施例中,較佳者係式VIII之N,N-二烴基羥基胺化合物,其中T1及T2係獨立地選自苄基、乙基、辛基、月桂基、十二烷基、十四烷基、十六烷基、十七烷基及十八烷基;或其中T1及T各自係氫化牛脂胺中所發現之烷基混 合物。 In a particular embodiment, those preferred formula VIII Department of N, N- dihydrocarbyl hydroxyl amine compound, wherein T 1 and T 2 are independently selected benzyl, ethyl, octyl, lauryl, dodecyl , tetradecyl, hexadecyl, heptadecyl and octadecyl; or wherein each of T 1 and T is a mixture of alkyl groups found in hydrogenated tallow amines.

在某些實施例中,式VIII之羥基胺化合物係選自:N,N-二苄基羥基胺;N,N-二乙基羥基胺;N,N-二辛基羥基胺;N,N-二月桂基羥基胺;N,N-二-十二烷基羥基胺;N,N-二-十四烷基羥基胺;N,N-二-十六烷基羥基胺;N,N-二-十八烷基羥基胺;N-十六烷基-N-十四烷基羥基胺;N-十六烷基-N-十七烷基羥基胺;N-十六烷基-N-十八烷基羥基胺;N-十七烷基-N-十八烷基羥基胺;N,N-二(氫化牛脂)羥基胺;及藉由N,N-二(氫化牛脂)胺之直接氧化產生之N,N-二(烷基)羥基胺。 In certain embodiments, the hydroxylamine compound of Formula VIII is selected from the group consisting of: N,N-dibenzylhydroxylamine; N,N-diethylhydroxylamine; N,N-dioctylhydroxylamine; N,N - dilauryl hydroxylamine; N,N-di-dodecylhydroxylamine; N,N-di-tetradecylhydroxylamine; N,N-di-hexadecylhydroxylamine; N,N- Di-octadecylhydroxylamine; N-hexadecyl-N-tetradecylhydroxylamine; N-hexadecyl-N-heptadecylhydroxylamine; N-hexadecyl-N- Octadecylhydroxylamine; N-heptadecyl-N-octadecylhydroxylamine; N,N-di(hydrogenated tallow)hydroxylamine; and direct by N,N-di(hydrogenated tallow)amine N,N-di(alkyl)hydroxylamine produced by oxidation.

在某些實施例中,較佳者係彼等式IX結構,其中W1及W2獨立地係苄基或經取代之苄基。W1、W2及W3中之每一者亦可係相同殘基。在其他實施例中,W1及W2可係8個至26個碳原子之烷基、更佳10個至26個碳原子之烷基。W3可係1個至22個碳原子之烷基、更佳甲基或經取代之甲基。其他較佳胺氧化物包括彼等其中W1、W2及W3係6個至36個碳原子之相同烷基者。較佳地,W1、W2及W3之所有上述殘基係飽和烴殘基或含有上述-O-、-S-、-SO-、-CO2-、-CO-或-CON-部分中之至少一者之飽和烴殘基。熟習此項技術者將能夠為W1、W2及W3中之每一者預想其他有用殘基,而不背離本發明。 In certain embodiments, preferred are those of the formula IX wherein W 1 and W 2 are independently benzyl or substituted benzyl. Each of W 1 , W 2 and W 3 may also be the same residue. In other embodiments, W 1 and W 2 may be an alkyl group of 8 to 26 carbon atoms, more preferably an alkyl group of 10 to 26 carbon atoms. W 3 may be an alkyl group of 1 to 22 carbon atoms, more preferably a methyl group or a substituted methyl group. Other preferred amine oxides include those in which W 1 , W 2 and W 3 are the same alkyl groups of 6 to 36 carbon atoms. Preferably, all of the above residues of W 1 , W 2 and W 3 are saturated hydrocarbon residues or contain the above -O-, -S-, -SO-, -CO 2 -, -CO- or -CON- moiety A saturated hydrocarbon residue of at least one of the foregoing. Those skilled in the art will be able to W 1, W 2 and W 3 are each residues of other useful envisioned without departing from the present invention.

飽和胺氧化物亦可包括聚(胺氧化物)。聚(胺氧化物)意 指每分子含有至少兩個三級胺氧化物之三級胺氧化物。說明性聚(胺氧化物)(亦稱「聚(三級胺氧化物)」)包括(但不限於):脂肪族及脂環族二胺之三級胺氧化物類似物,例如,1,4-二胺基丁烷;1,6-二胺基己烷;1,10-二胺基癸烷;及1,4-二胺基環己烷,及基於芳香族之二胺,例如,二胺基蒽醌及二胺基苯甲醚。 The saturated amine oxide may also include a poly(amine oxide). Poly(amine oxide) Refers to a tertiary amine oxide containing at least two tertiary amine oxides per molecule. Illustrative poly(amine oxides) (also known as "poly(tribasic amine oxides)") include, but are not limited to, tertiary amine oxide analogs of aliphatic and cycloaliphatic diamines, for example, 1, 4-diaminobutane; 1,6-diaminohexane; 1,10-diaminodecane; and 1,4-diaminocyclohexane, and an aromatic diamine, for example, Diaminoguanidine and diaminoanisole.

與本發明一起使用之適宜胺氧化物亦包括衍生自上述二胺之寡聚物及聚合物之三級胺氧化物。有用胺氧化物亦包括附接至以下聚合物之胺氧化物:例如,聚烯烴、聚丙烯酸酯、聚酯、聚醯胺、聚苯乙烯及諸如此類。當胺氧化物附接至聚合物時,每聚合物之胺氧化物平均數量可廣泛變化,此乃因並非所有聚合物鏈均需含有胺氧化物。所有上述胺氧化物可視情況含有至少一個-O-、-S-、-SO-、-CO2-、-CO-或-CONW4-部分。在較佳實施例中,聚合三級胺氧化物之每一三級胺氧化物含有C1殘基。 Suitable amine oxides for use with the present invention also include tertiary amine oxides derived from oligomers and polymers of the above diamines. Useful amine oxides also include amine oxides attached to the following polymers: for example, polyolefins, polyacrylates, polyesters, polyamines, polystyrene, and the like. When an amine oxide is attached to a polymer, the average number of amine oxides per polymer can vary widely, as not all polymer chains need to contain an amine oxide. All of the above amine oxides may optionally contain at least one -O-, -S-, -SO-, -CO 2 -, -CO- or -CONW 4 - moiety. In the preferred embodiment, each of the polymeric tertiary amine oxide of the tertiary amine oxides containing a C 1 residue.

式IX之基團W1、W2及W3可附接至含有受阻胺之分子。受阻胺為業內所已知,且本發明之胺氧化物可以任一方式且在受阻胺之任一結構位置處附接至受阻胺。有用受阻胺當為胺氧化物化合物之一部分時包括彼等具有通式X及XI者: 其中L及Rx係如上文所述來定義。 The groups W 1 , W 2 and W 3 of formula IX can be attached to a molecule containing a hindered amine. Hindered amines are known in the art, and the amine oxides of the present invention can be attached to the hindered amine in any manner and at any structural position of the hindered amine. Useful hindered amines include those having the general formulas X and XI when they are part of an amine oxide compound: Wherein L and R x are as defined above.

亦包括每分子含有一個以上受阻胺及一個以上飽和胺氧化物之胺氧化物。受阻胺可附接至聚(三級胺氧化物)或附接至聚合基質,如上文所論述。 Also included are amine oxides containing more than one hindered amine and more than one saturated amine oxide per molecule. The hindered amine can be attached to the poly(tri-amine oxide) or attached to the polymeric matrix, as discussed above.

羥基胺衍生物及/或胺氧化物衍生物可基於欲安定有機材料之重量以約0.0005%至約5%、特定而言約0.001%至約2%、通常約0.01重量%至約2重量%之總量使用。 The hydroxylamine derivative and/or amine oxide derivative may be from about 0.0005% to about 5%, specifically from about 0.001% to about 2%, typically from about 0.01% to about 2% by weight, based on the weight of the organic material to be stabilized. The total amount used.

在其他實施例中,安定劑組合物包括其他可選添加劑,其可包括至少一種選自共添加劑;成核劑;填充劑;強化劑;及其組合之化合物。 In other embodiments, the stabilizer composition includes other optional additives, which may include at least one compound selected from the group consisting of co-additives; nucleating agents; fillers; reinforcing agents;

該等添加劑之實例包括(但不限於):鹼性共添加劑,例如三聚氰胺、聚乙烯基吡咯啶酮、二氰二胺、異氰尿酸三烯丙酯、脲衍生物、肼衍生物、胺、 聚醯胺、聚胺基甲酸酯、高脂肪酸之鹼金屬鹽及鹼土金屬鹽,例如硬脂酸鈣、硬脂酸鋅、二十二酸鎂、硬脂酸鎂、蓖麻酸鈉及棕櫚酸鉀、羥基苯酚銻(antimony pyrocatecholate)或羥基苯酚鋅(zinc pyrocatecholate)。 Examples of such additives include, but are not limited to, alkaline co-additives such as melamine, polyvinylpyrrolidone, dicyandiamide, triallyl isocyanurate, urea derivatives, anthraquinone derivatives, amines, Polyamines, polyurethanes, alkali metal salts of high fatty acids and alkaline earth metal salts, such as calcium stearate, zinc stearate, magnesium dodecate, magnesium stearate, sodium ricinate and palm Potassium acid, antimony pyrocatecholate or zinc pyrocatecholate.

成核劑,例如無機物質,例如滑石、金屬氧化物(例如二氧化鈦或氧化鎂)、較佳鹼土金屬之磷酸鹽、碳酸鹽或硫酸鹽;有機化合物,例如單-或多羧酸及其鹽,例如4-第三-丁基苯甲酸、己二酸、二苯基乙酸、琥珀酸鈉或苯甲酸鈉;聚合化合物,例如離子型共聚物(離聚物)。 a nucleating agent, such as an inorganic substance such as talc, a metal oxide such as titanium dioxide or magnesium oxide, preferably a phosphate, carbonate or sulfate of an alkaline earth metal; an organic compound such as a mono- or polycarboxylic acid and a salt thereof, For example, 4-tert-butylbenzoic acid, adipic acid, diphenylacetic acid, sodium succinate or sodium benzoate; polymeric compounds such as ionic copolymers (ionomers).

填充劑及強化劑,例如碳酸鈣、矽酸鹽、玻璃纖維、玻璃球、石棉、滑石、高嶺土(kaolin)、雲母、硫酸鋇、金屬氧化物及氫氧化物(例如氫氧化鋁或氫氧化鎂)、碳黑、石墨、木粉及其他天然產物之粉末或纖維、合成纖維;耐衝擊改良劑。 Fillers and enhancers such as calcium carbonate, strontium silicate, glass fiber, glass spheres, asbestos, talc, kaolin, mica, barium sulfate, metal oxides and hydroxides (eg aluminum hydroxide or magnesium hydroxide) ), carbon black, graphite, wood powder and other natural products of powder or fiber, synthetic fiber; impact modifier.

苯并呋喃酮及吲哚啉酮,例如彼等在美國專利第4,325,863號;第4,338,244號;第5,175,312號;第5,216,052號;第5,252,643號;第5,369,159號;第5,488,117號;第5,356,966號;第5,367,008號;第5,428,162號;第5,428,177號;第5,516,920號;DE-A-4316611號;DE-A-4316622;DE-A-4316876;EP-A-0589839或EP-A-0591102中所揭示者或3-[4-(2-乙醯氧基乙氧基)苯基]-5,7-二-第三-丁基-苯并呋喃-2-酮、5,7-二-第三-丁基-3-[4-(2-硬脂醯基氧基乙氧基)苯基]苯并呋喃-2-酮、3,3'-雙[5,7-二-第三-丁基-3-(4-[2-羥基乙氧基]苯基)苯并呋喃-2-酮]、5,7-二-第 三-丁基-3-(4-乙氧基苯基)苯并呋喃-2-酮、3-(4-乙醯氧基-3,5-二甲基苯基)-5,7-二-第三-丁基-苯并呋喃-2-酮、3-(3,5-二甲基-4-三甲基乙醯基氧基苯基)-5,7-二-第三-丁基-苯并呋喃-2-酮、3-(3,4-二甲基苯基)-5,7-二-第三-丁基-苯并呋喃-2-酮、3-(2,3-二甲基苯基)-5,7-二-第三-丁基-苯并呋喃-2-酮;金屬去活化劑,例如N,N'-二苯基草醯胺、N-柳醛-N'-柳醯基肼、N,N'-雙(柳醯基)肼、N,N'-雙(3,5-二-第三-丁基-4-羥基苯基丙醯基)肼、3-柳醯基胺基-1,2,4-三唑、雙(亞苄基)草醯二醯肼、草醯苯胺、間苯二甲醯二醯肼、癸二醯雙苯基醯肼、N,N'-二乙醯基已二醯基二醯肼、N,N'-雙(柳醯基)草醯二醯肼、N,N'-雙(柳醯基)硫基丙醯基二醯肼。 Benzofuranones and porphyrins, for example, in U.S. Patent Nos. 4,325,863; 4,338,244; 5,175,312; 5,216,052; 5,252,643; 5,369,159; 5,488,117; 5,356,966; 5,367,008 No. 5,428,162; 5,428,177; 5,516,920; DE-A-4316611; DE-A-4316622; DE-A-4316876; EP-A-0589839 or EP-A-0591102 or 3 -[4-(2-Ethyloxyethoxy)phenyl]-5,7-di-t-butyl-benzofuran-2-one, 5,7-di-t-butyl -3-[4-(2- stearyl ethoxyethoxy)phenyl]benzofuran-2-one, 3,3'-bis[5,7-di-t-butyl-3 -(4-[2-hydroxyethoxy]phenyl)benzofuran-2-one], 5,7-di- Tri-butyl-3-(4-ethoxyphenyl)benzofuran-2-one, 3-(4-acetoxy-3,5-dimethylphenyl)-5,7-di -Third-butyl-benzofuran-2-one, 3-(3,5-dimethyl-4-trimethylethenyloxyphenyl)-5,7-di-third-butyl -Benzofuran-2-one, 3-(3,4-dimethylphenyl)-5,7-di-t-butyl-benzofuran-2-one, 3-(2,3 -Dimethylphenyl)-5,7-di-t-butyl-benzofuran-2-one; metal deactivator, such as N,N'-diphenyl oxazamide, N- sulphonaldehyde -N'-柳醯基肼, N,N'-bis(柳醯)肼, N,N'-bis(3,5-di-t-butyl-4-hydroxyphenylpropanyl)anthracene, 3- Salicylamino-1,2,4-triazole, bis(benzylidene)oxadiazepine, oxalic acid aniline, m-xylylene dioxime, anthraquinone bisphenylhydrazine, N,N '-Diethyl fluorenyl di- fluorenyl dihydrazide, N, N'- bis (liusyl) grass 醯 醯肼, N, N'- bis (cannonyl) thio propyl fluorenyl dioxime.

硝酮,例如,N-苄基-α-苯基-硝酮、N-乙基-α-甲基-硝酮、N-辛基-α-庚基-硝酮、N-月桂基-α-十一烷基-硝酮、N-十四烷基-α-十三烷基-硝酮、N-十六烷基-α-十五烷基-硝酮、N-十八烷基-α-十七烷基-硝酮、N-十六烷基-α-十七烷基-硝酮、N-十八烷基-α-十五烷基-硝酮、N-十七烷基-α-十七烷基-硝酮、N-十八烷基-α-十六烷基-硝酮、衍生自N,N-二(氫化牛脂)羥基胺之硝酮;硫基增效劑,例如硫基二丙酸二月桂基酯或硫基二丙酸二硬脂醯基酯;過氧化物捕獲劑,例如β-硫基二丙酸之酯,例如,月桂基、硬脂醯基或十三烷基酯、巰基苯并咪唑或2-巰基苯并 咪唑之鋅鹽、二丁基二硫基胺基甲酸鋅、二-十八烷基二硫化物、四(β-十二烷基巰基)丙酸新戊四醇酯。 Nitrones, for example, N-benzyl-α-phenyl-nitrone, N-ethyl-α-methyl-nitrone, N-octyl-α-heptyl-nitrone, N-lauryl-α -undecyl-nitrone, N-tetradecyl-α-tridecyl-nitrone, N-hexadecyl-α-pentadecyl-nitrone, N-octadecyl- --heptadecyl-nitrone, N-hexadecyl-α-heptadecyl-nitrone, N-octadecyl-α-pentadecyl-nitrone, N-heptadecyl -α-heptadecyl-nitrone, N-octadecyl-α-hexadecyl-nitrone, nitrone derived from N,N-di(hydrogenated tallow) hydroxylamine; sulfur-based synergist For example, dilauryl thiodipropionate or distearyl thiodipropionate; a peroxide scavenger such as an ester of β-thiodipropionic acid, for example, lauryl or stearyl Or tridecyl ester, mercaptobenzimidazole or 2-mercaptobenzoene A zinc salt of imidazole, zinc dibutyldithiocarbamate, di-octadecyl disulfide, and neopentyl glycol tetra(β-dodecylmercapto)propionate.

適宜與本發明一起使用之不會明顯損害欲安定有機材料之性質的其他添加劑為熟習此項技術者所已知,且可包括(例如)塑化劑、潤滑劑、乳化劑、顏料、流變學添加劑、觸媒、流動控制劑、螢光增白劑、防焰劑、抗靜電劑、澄清劑及發泡劑。 Other additives suitable for use with the present invention which do not significantly impair the properties of the organic material to be stabilized are known to those skilled in the art and may include, for example, plasticizers, lubricants, emulsifiers, pigments, rheological agents. Additives, catalysts, flow control agents, fluorescent whitening agents, flame retardants, antistatic agents, clarifying agents and foaming agents.

在某些實施例中,基於欲安定有機材料組合物之總重量且基於所添加安定添加劑之數量及類型及/或欲安定材料之特性,安定劑組合物係以0.001重量%至65.0重量%存在。在一些實施例中,安定劑組合物係以有機材料之總重量之0.01重量%至50重量%、且較佳總量之0.05重量%至25重量%或總量之0.1重量%至10重量%存在。熟習此項技術者將能夠基於所已知或文獻中所述製劑或僅藉助常規實驗即容易地確定所應添加之安定添加劑之量及類型。 In certain embodiments, the stabilizer composition is present in an amount from 0.001% to 65.0% by weight, based on the total weight of the composition of the organic material to be stabilized and based on the amount and type of stabilizer added, and/or the properties of the material to be stabilized. . In some embodiments, the stabilizer composition is from 0.01% to 50% by weight, and preferably from 0.05% to 25% by weight or from 0.1% to 10% by weight based on the total weight of the organic material. presence. Those skilled in the art will be able to readily determine the amount and type of stabilizer added to be added based on the formulation known or described in the literature or by routine experimentation.

可藉由熟習此項技術者所已知的任一適宜方法容易地將本發明之安定劑組合物與欲安定有機材料摻和。在某些實施例中,藉由至少一種選自擠出、製粒、研磨及模製之技術將安定劑組合物之組份與欲安定材料混合。在其他實施例中,可藉由熔融、溶解於溶劑中、直接混合及乾燥混合中之至少一者實施混合。 The stabilizer composition of the present invention can be readily blended with the solid material to be stabilized by any suitable method known to those skilled in the art. In certain embodiments, the components of the stabilizer composition are mixed with the material to be stabilized by at least one technique selected from the group consisting of extrusion, granulation, milling, and molding. In other embodiments, the mixing can be carried out by at least one of melting, dissolving in a solvent, direct mixing, and dry mixing.

在(例如)模製之前或之後藉由熟習此項技術者所已知的任一適宜方法將安定劑組合物之組份及可選其他添加劑納入欲安定有機材料中,或亦藉由將溶解或分散之安定劑混 合物施加至欲安定有機材料中並進行或不進行溶劑之後續蒸發來實施此納入。安定劑組份及可選其他添加劑亦可以母料之形式添加至欲安定有機材料中。 The components of the stabilizer composition and optional other additives are incorporated into the desired organic material, or also by dissolution, by any suitable method known to those skilled in the art, for example, before or after molding. Or dispersed stabilizer This incorporation is carried out by applying the composition to the desired organic material with or without subsequent evaporation of the solvent. The stabilizer component and optional other additives may also be added to the desired organic material in the form of a masterbatch.

安定劑組合物之組份及可選其他添加劑亦可在(例如)聚合之前或期間或在交聯之前添加。其亦可以純形式納入欲安定有機材料中(即純淨且直接納入該樹脂)或囊封於蠟、油或聚合物中。各種添加劑亦可經預摻和(即混合在一起)以簡單添加至欲安定有機材料中。安定劑組合物之組份及可選其他添加劑亦可噴射至欲安定有機材料上。其能夠稀釋其他添加劑(例如上文所示習用添加劑)或其熔體,以便其亦可與該等添加劑一起噴射至欲安定材料上。例如,在球面聚合之聚合物之情形中,藉由噴射視情況與其他添加劑一起施加安定劑組合物之組份可係有利的。 The components of the stabilizer composition and optional other additives may also be added, for example, before or during polymerization or prior to crosslinking. It may also be incorporated in pure form into the organic material to be stabilized (ie, purely and directly incorporated into the resin) or encapsulated in waxes, oils or polymers. The various additives may also be pre-blended (ie, mixed together) for simple addition to the desired organic material. The components of the stabilizer composition and optional other additives may also be sprayed onto the desired organic material. It is capable of diluting other additives, such as the conventional additives shown above, or their melts, so that they can also be sprayed with the additives onto the material to be stabilized. For example, in the case of a spherically polymerized polymer, it may be advantageous to apply a component of the stabilizer composition together with other additives by spraying.

已提及使用本發明之安定劑組合物來使有機材料安定。因此,本發明之另一態樣提供:(i)用於使由於光、氧及/或熱之效應而經受降解及/或變色之有機材料安定的製程;(ii)用於加強有機材料之處理穩定性之製程;及(iii)用於減少或防止有機材料變色之製程。該等製程各自係藉由在處理之前、期間或之後將安定量之本說明書及申請專利範圍通篇所述之本發明安定劑組合物添加至欲安定有機材料中來達成。在某些實施例中,將含有本發明之安定劑組合物之母料組合物添加至欲安定有機材料中。 It has been mentioned that the stabilizer composition of the present invention is used to stabilize the organic material. Accordingly, another aspect of the present invention provides: (i) a process for stabilizing an organic material that undergoes degradation and/or discoloration due to the effects of light, oxygen, and/or heat; (ii) for reinforcing an organic material. a process for treating stability; and (iii) a process for reducing or preventing discoloration of organic materials. Each of these processes is accomplished by adding an amount of the stabilizer composition of the present invention as described throughout the specification and the scope of the patent application to the desired organic material before, during or after the treatment. In certain embodiments, a masterbatch composition containing a stabilizer composition of the present invention is added to the organic material to be stabilized.

適於安定之各種非生命有機材料包括(但不限於):聚烯烴、聚酯、聚醚、聚酮、聚醯胺、天然及合成橡膠、聚胺 基甲酸酯、聚苯乙烯、高耐衝擊聚苯乙烯、聚丙烯酸酯、聚甲基丙烯酸酯、聚縮醛、聚丙烯腈、聚丁二烯、聚苯乙烯、丙烯腈-丁二烯-苯乙烯、苯乙烯丙烯腈、丙烯酸酯苯乙烯丙烯腈、乙酸丁酸纖維素、纖維素聚合物、聚醯亞胺、聚醯胺醯亞胺、聚醚醯亞胺、聚苯硫醚、聚二氧苯聚碸、聚醚碸、聚氯乙烯、聚碳酸酯、聚酮、脂肪族聚酮、熱塑性烯烴、胺基樹脂交聯之聚丙烯酸酯及聚酯、聚異氰酸酯交聯之聚酯及聚丙烯酸酯、苯酚/甲醛、脲/甲醛及三聚氰胺/甲醛樹脂、乾性及非乾性醇酸樹脂、醇酸樹脂、聚酯樹脂、與三聚氰胺樹脂交聯之丙烯酸酯樹脂、脲樹脂、異氰酸酯、異氰尿酸酯、胺基甲酸酯、環氧樹脂、衍生自脂肪族、環脂肪族、雜環及芳香族縮水甘油基化合物之與酸酐或胺交聯之交聯環氧樹脂、聚矽氧烷、邁克爾加成聚合物(Michael addition polymer)、胺、具有活化不飽和亞甲基化合物之封端之胺、具有活化不飽和亞甲基化合物之酮亞胺、與不飽和丙烯酸聚乙醯乙酸酯樹脂組合之聚酮亞胺、與不飽和丙烯酸樹脂組合之聚酮亞胺、輻射可固化組合物、環氧三聚氰胺樹脂、有機染料、化妝品、基於纖維素之紙調配物、照相膠片紙、纖維、蠟及油墨。 Various non-living organic materials suitable for stability include (but are not limited to): polyolefins, polyesters, polyethers, polyketones, polyamides, natural and synthetic rubbers, polyamines Carbamate, polystyrene, high impact polystyrene, polyacrylate, polymethacrylate, polyacetal, polyacrylonitrile, polybutadiene, polystyrene, acrylonitrile-butadiene - Styrene, styrene acrylonitrile, acrylate styrene acrylonitrile, cellulose acetate butyrate, cellulose polymer, polyimine, polyamidimide, polyether phthalimide, polyphenylene sulfide, poly Dioxin, polyether oxime, polyvinyl chloride, polycarbonate, polyketone, aliphatic polyketone, thermoplastic olefin, amino resin crosslinked polyacrylate and polyester, polyisocyanate crosslinked polyester and Polyacrylate, phenol/formaldehyde, urea/formaldehyde and melamine/formaldehyde resin, dry and non-dry alkyd resin, alkyd resin, polyester resin, acrylate resin crosslinked with melamine resin, urea resin, isocyanate, isocyanide a urethane, a urethane, an epoxy resin, a crosslinked epoxy resin or a polyoxyalkylene which is derived from an aliphatic or cycloaliphatic, heterocyclic and aromatic glycidyl compound and crosslinked with an acid anhydride or an amine. Michael addition polym Er), an amine, a blocked amine having an activated unsaturated methylene compound, a ketimine having an activated unsaturated methylene compound, a polyketimine in combination with an unsaturated acrylic polyethylene acetate resin, Polyketimines, radiation curable compositions, epoxy melamine resins, organic dyes, cosmetics, cellulose-based paper formulations, photographic film paper, fibers, waxes, and inks in combination with unsaturated acrylic resins.

在某些實施例中,欲安定之非生命有機材料係聚烯烴。適宜與本發明之安定劑組合物一起如此使用之聚烯烴之實例至少包括以下:(A)單烯烴之聚合物,例如聚丙烯、聚異丁烯、聚丁-1-烯及聚-4-甲基戊-1-烯;二烯烴之聚合物,例如聚異戊 二烯或聚丁二烯;以及環烯烴之聚合物,例如環戊烯或降冰片烯之聚合物;聚乙烯(其視情況可交聯),例如高密度聚乙烯(HDPE)、高密度及高分子量聚乙烯(HDPE-HMW)、高密度及超高分子量聚乙烯(HDPE-UHMW)、中等密度聚乙烯(MDPE)、低密度聚乙烯(LDPE)、直鏈低密度聚乙烯(LLDPE)、(VLDPE)及(ULDPE);(B)聚烯烴,即(A)中所例示之單烯烴之聚合物,較佳聚乙烯及聚丙烯,其可藉由不同方法且尤其藉由以下方法來製備:i)自由基聚合(通常在高壓及高溫下進行);或ii)催化聚合,其使用通常含有一種或一種以上元素週期表第IVb族、第Vb族、第VIb族或第VIII族之金屬之觸媒。 該等金屬通常具有一個或一個以上配體(通常為氧化物、鹵化物、醇化物、酯、醚、胺、烷基、烯基及/或芳基),其可為p-或s-配位。該等金屬錯合物可呈游離形式或固定於基質上,通常固定於活化氯化鎂、氯化鈦(III)、氧化鋁或氧化矽上。該等觸媒可溶於或不溶於聚合介質中。在聚合反應中可使用該等觸媒自身或可使用其他活化劑,通常為金屬烷基化物、金屬氫化物、金屬烷基鹵化物、金屬烷基氧化物或金屬烷基氧烷(metal alkyloxane),該等金屬係元素週期表之第Ia族、第IIa族及/或第IIIa族之元素。該等活化劑可方便地經其他酯、醚、胺或甲矽烷基醚基團修飾。該等觸媒系統通常稱為Phillips、Standard Oil(Indiana)、Ziegler-Natta、TNZ(DuPont)、茂金屬或單位 點觸媒(SSC);(C)(A)下所提及之聚合物之混合物,例如,聚丙烯與聚異丁烯之混合物、聚丙烯與聚乙烯之混合物(例如,PP/HDPE、PP/LDPE)及不同類型之聚乙烯之混合物(例如,LDPE/HDPE);及(D)單烯烴與二烯烴彼此間之共聚物或與其他乙烯基單體之共聚物,例如乙烯/丙烯共聚物、直鏈低密度聚乙烯(LLDPE)及其與低密度聚乙烯(LDPE)之混合物、丙烯/丁-1-烯共聚物、丙烯/異丁烯共聚物、乙烯/丁-1-烯共聚物、乙烯/己烯共聚物、乙烯/甲基戊烯共聚物、乙烯/庚烯共聚物、乙烯/辛烯共聚物、丙烯/丁二烯共聚物、異丁烯/異戊二烯共聚物、乙烯/丙烯酸烷基酯共聚物、乙烯/甲基丙烯酸烷基酯共聚物、乙烯/乙酸乙烯酯共聚物及其與一氧化碳之共聚物或乙烯/丙烯酸共聚物及其鹽(離聚物)以及乙烯與丙烯及二烯(例如己二烯、二環戊二烯或亞乙基-降冰片烯)之三元共聚物;及該等共聚物彼此間之混合物及與上文(A)中所提及聚合物之聚合物,例如聚丙烯/乙烯-丙烯共聚物、LDPE/乙烯-乙酸乙烯酯共聚物(EVA)、LDPE/乙烯-丙烯酸共聚物(EAA)、LLDPE/EVA、LLDPE/EAA及交替或隨機聚伸烷基/一氧化碳共聚物及其與其他聚合物(例如聚醯胺)之混合物。 In certain embodiments, the non-living organic material to be stabilized is a polyolefin. Examples of polyolefins suitable for use with the stabilizer compositions of the present invention include at least the following: (A) polymers of monoolefins such as polypropylene, polyisobutylene, polybutene-1-ene and poly-4-methyl Pent-1-ene; a polymer of a diene such as polyisoprene a diene or polybutadiene; and a polymer of a cyclic olefin such as a polymer of cyclopentene or norbornene; a polyethylene (which may be crosslinked as appropriate), such as high density polyethylene (HDPE), high density and High molecular weight polyethylene (HDPE-HMW), high density and ultra high molecular weight polyethylene (HDPE-UHMW), medium density polyethylene (MDPE), low density polyethylene (LDPE), linear low density polyethylene (LLDPE), (VLDPE) and (ULDPE); (B) a polyolefin, that is, a polymer of a monoolefin exemplified in (A), preferably polyethylene and polypropylene, which can be prepared by various methods and especially by the following method : i) free radical polymerization (usually carried out at elevated pressures and temperatures); or ii) catalytic polymerization, which typically comprises one or more metals of Group IVb, Group Vb, Group VIb or Group VIII of the Periodic Table of the Elements Catalyst. The metals typically have one or more ligands (usually oxides, halides, alcoholates, esters, ethers, amines, alkyls, alkenyls and/or aryls) which may be p- or s-compounds Bit. The metal complexes may be in free form or immobilized on a substrate, typically on activated magnesium chloride, titanium (III) chloride, alumina or cerium oxide. The catalysts are soluble or insoluble in the polymerization medium. The catalyst may be used in the polymerization itself or other activators may be used, typically metal alkylates, metal hydrides, metal alkyl halides, metal alkyl oxides or metal alkyloxanes. The elements of Group Ia, Group IIa and/or Group IIIa of the periodic table of the metals. These activators are conveniently modified with other ester, ether, amine or formamidine ether groups. These catalyst systems are commonly referred to as Phillips, Standard Oil (Indiana), Ziegler-Natta, TNZ (DuPont), metallocene or units. Point catalyst (SSC); a mixture of polymers mentioned under (C) (A), for example, a mixture of polypropylene and polyisobutylene, a mixture of polypropylene and polyethylene (for example, PP/HDPE, PP/LDPE) And mixtures of different types of polyethylene (eg, LDPE/HDPE); and (D) copolymers of monoolefins and diolefins with each other or with other vinyl monomers, such as ethylene/propylene copolymers, straight Chain low density polyethylene (LLDPE) and its mixture with low density polyethylene (LDPE), propylene/but-1-ene copolymer, propylene/isobutylene copolymer, ethylene/but-1-ene copolymer, ethylene/hexene Ene copolymer, ethylene/methylpentene copolymer, ethylene/heptene copolymer, ethylene/octene copolymer, propylene/butadiene copolymer, isobutylene/isoprene copolymer, ethylene/alkyl acrylate Copolymers, ethylene/alkyl methacrylate copolymers, ethylene/vinyl acetate copolymers and copolymers thereof with carbon monoxide or ethylene/acrylic acid copolymers and salts thereof (ionomers) and ethylene with propylene and dienes ( Terpolymers such as hexadiene, dicyclopentadiene or ethylidene-norbornene; and such a mixture of polymers with each other and with a polymer of the polymer mentioned in (A) above, such as a polypropylene/ethylene-propylene copolymer, LDPE/ethylene-vinyl acetate copolymer (EVA), LDPE/ethylene- Acrylic copolymer (EAA), LLDPE/EVA, LLDPE/EAA, and alternating or random polyalkylene/carbon monoxide copolymers and mixtures thereof with other polymers such as polyamine.

本發明之安定劑組合物亦預期用於各種工業模製製程中以產生經安定模製物件。因此,在另一態樣中,本發明提供用於藉由以下方式來產生模製物件之製程:將聚合有機 材料及聚合物安定量之本文所闡述且主張之本發明安定劑組合物添加至工業模製裝置或器件中,或以其他方式添加於工業模製製程中,並藉助該裝置/器件且因此該模製製程使經安定聚合材料循環。 The stabilizer compositions of the present invention are also contemplated for use in a variety of industrial molding processes to produce stabilized molded articles. Thus, in another aspect, the present invention provides a process for producing a molded article by: polymerizing organic Materials and Polymer Amperages The stabilizer compositions of the present invention as set forth and claimed herein are added to an industrial molding apparatus or device, or otherwise added to an industrial molding process, and by means of the apparatus/device and thus The molding process circulates the stabilized polymeric material.

熟悉此項技術者應瞭解,組合物及製程適宜與包括(但不限於)以下之任一工業模製製程一起使用且容易適合於該任一工業模製製程:射出模製、旋轉模製、吹塑模製、捲對捲模製、金屬射出模製、壓縮模製、轉移模製、浸漬模製、氣體輔助模製、嵌入射出模製、微模製、反應射出模製、雙料射出模製,以及任何變化形式或其組合。 Those skilled in the art will appreciate that the compositions and processes are suitable for use with, but not limited to, any of the following industrial molding processes and are readily adaptable to any of the industrial molding processes: injection molding, rotational molding, Blow molding, roll-to-roll molding, metal injection molding, compression molding, transfer molding, dip molding, gas-assisted molding, embedded injection molding, micro molding, reactive injection molding, double injection molding System, and any variations or combinations thereof.

在本文所述製程之某些實施例中,安定劑組合物係以欲安定有機材料之總重量之0.001重量%至65.0重量%;較佳以0.01%至25%;且更佳以欲安定有機材料之總重量之0.01重量%至10重量%存在。 In certain embodiments of the processes described herein, the stabilizer composition is from 0.001% to 65.0% by weight, based on the total weight of the organic material to be stabilized; preferably from 0.01% to 25%; and more preferably to be organic From 0.01% to 10% by weight of the total weight of the material is present.

亦預期,本文所述之安定劑組合物之組份及/或欲安定有機材料可含於套組內。該套組可包括至少一種本發明安定劑組合物之單一或多重組份、至少一種欲安定材料(例如,諸如聚烯烴等聚合物組合物)及至少一種其他可選添加劑,每一者個別地經包裝或調配,或至少一種本發明安定劑組合物之單一或多重組份、至少一種欲安定材料及至少一種其他可選添加劑經組合包裝或調配。因此,安定劑組合物之一或多個組份可存在於第一容器中,且該套組可視情況在第二或另一容器中包括安定劑組合物之一或多個組份及/或欲安定材料。將容器置於包裝內,且該包裝可 視情況包括投與或混合說明書,其呈包裝上之標籤或網站地址之形式,或呈套組包裝中所包括之插頁之形式。套組可包括其他組份或用於投與或混合該等組份以及溶劑之其他方法或用於調配之其他方法。 It is also contemplated that the components of the stabilizer composition described herein and/or the organic material to be stabilized may be contained within the kit. The kit may comprise at least one single or multiple reconstituted parts of the stabilizer composition of the present invention, at least one material to be stabilized (for example, a polymer composition such as a polyolefin), and at least one other optional additive, each individually The packaged or formulated, or at least one single or multiple reconstituted parts of the stabilizer composition of the present invention, at least one material to be stabilized, and at least one other optional additive are packaged or formulated in combination. Thus, one or more components of the stabilizer composition may be present in the first container, and the kit may optionally include one or more components of the stabilizer composition and/or in the second or another container. Want to stabilize the material. Put the container in the package and the package can Included in the case of a copy or mix of instructions, in the form of a label or website address on the package, or in the form of an insert included in the package. The kit may include other components or other methods for administering or mixing the components and solvents or other methods for formulation.

其他實施例Other embodiments

1.一種安定劑組合物,其包含安定量之基於唍之式(V)化合物: 其中R21係選自COR28或Si(R29)3,其中R28係選自H或C1-C20烴基;且R29係選自C1-C12烴基或烷氧基;R22係在式V之芳香族部分之n=0個至3個位置處可相同或不同之取代基,且係獨立地選自H或C1-C12烴基;R23係選自H或C1-C12烴基;R24係選自H或C1-C20烴基;且R25至R27中之每一者係獨立地選自選自由H;C1-C12烴基;及OR30組成之群之成員,其中R30係選自H或C1-C12烴基;且R27係H或與R26一起形成=O之鍵。 A stabilizer composition comprising an amount based on an amount of Compound of formula (V): Wherein R 21 is selected from the group consisting of COR 28 or Si(R 29 ) 3 , wherein R 28 is selected from H or C 1 -C 20 hydrocarbyl; and R 29 is selected from C 1 -C 12 hydrocarbyl or alkoxy; R 22 a substituent which may be the same or different at n=0 to 3 positions of the aromatic moiety of formula V, and is independently selected from H or a C 1 -C 12 hydrocarbon group; and R 23 is selected from H or C 1 a -C 12 hydrocarbyl group; R 24 is selected from H or a C 1 -C 20 hydrocarbyl group; and each of R 25 to R 27 is independently selected from the group consisting of H; C 1 -C 12 hydrocarbyl; and OR 30 A member of the group wherein R 30 is selected from H or a C 1 -C 12 hydrocarbyl group; and R 27 is H or together with R 26 forms a bond of =0.

2.根據實施例1之安定劑組合物,其進一步包含至少一 種選自有機亞磷酸酯或膦酸酯之群之化合物。 2. The stabilizer composition of embodiment 1, further comprising at least one A compound selected from the group of organophosphites or phosphonates.

3.根據實施例2之安定劑組合物,其中該至少一種有機亞磷酸酯或膦酸酯係選自式1至7之化合物: 其中下標為整數且n係2、3或4;p係1或2;q係2或3;r係4至12;y係1、2或3;且z係1至6;若n係2,則A1係C2-C18伸烷基;雜有氧、硫或-NR4-之C2-C12伸烷基;下式之基團 或伸苯基;若n係3,則A1係式-CrH2r-1-之基團;若n係4,則A1 若n係2,則A2係如針對A1所定義;B係直接鍵、-CH2-、-CHR4-、-CR1R4-、硫、C5-C7亞環烷基或在3、4及/或5位處經1個至4個C1-C4烷基取代之亞環己基;若p係1,則D1係C1-C4烷基,且若p係2,則D1 係-CH2OCH2-;若p係1,則D2係C1-C4烷基;若y係1,則E係C1-C18烷基、-OR1或鹵素;若y係2,則E係-O-A2-O-,若y係3,則E係式R4C(CH2O-)3或N(CH2CH2O-)3之基團;Q係至少z價醇或酚之基團,此基團經由氧原子附接至磷原子;R1、R2及R3彼此獨立地係未經取代或經鹵素、-COOR4、-CN或-CONR4R4取代之C1-C18烷基;雜有氧、硫或-NR4-之C2-C18烷基;C7-C9苯基烷基;C5-C12環烷基、苯基或萘基;經鹵素、1個至3個具有總共1個至18個碳原子之烷基或烷氧基或經C7-C9苯基烷基取代之萘基或苯基;或下式之基團 其中m係在3至6之範圍內之整數;R4係氫、C1-C8烷基、C5-C12環烷基或C7-C9苯基烷基,R5及R6彼此獨立地係氫、C1-C8烷基或C5-C6環烷基,若q係2,則R7及R8彼此獨立地係C1-C4烷基或一起為2,3-去氫五亞甲基;且若q係3,則R7及R8係甲基; R14係氫、C1-C9烷基或環己基,R15係氫或甲基,且若存在兩種或更多個基團R14及R15,則該等基團相同或不同,X及Y各自係直接鍵或氧,Z係直接鍵、亞甲基、-C(R16)2-或硫,且R16係C1-C8烷基;式8之亞磷酸叁芳基酯: 其中R17係在式8之芳香族部分之0個至5個位置處相同或不同之取代基,且係獨立地選自選自由C1-C20烷基、C3-C20環烷基、C4-C20烷基環烷基、C6-C10芳基及C7-C20烷基芳基組成之群之成員;及其組合。 3. The stabilizer composition of embodiment 2, wherein the at least one organophosphite or phosphonate is selected from the group consisting of compounds of formulas 1 to 7: Wherein subscript is an integer and n is 2, 3 or 4; p is 1 or 2; q is 2 or 3; r is 4 to 12; y is 1, 2 or 3; and z is 1 to 6; 2, then A 1 is a C 2 -C 18 alkylene group; a heteroatomous aerobic, sulfur or -NR 4 -C 2 -C 12 alkyl group; a group of the formula Or phenyl; if n is 3, the A 1 is a group of -C r H 2r-1 -; if n is 4, the A 1 is If n is 2, A 2 is as defined for A 1 ; B is a direct bond, -CH 2 -, -CHR 4 -, -CR 1 R 4 -, sulfur, C 5 -C 7 cycloalkylene or a cyclohexylene group substituted with 1 to 4 C 1 -C 4 alkyl groups at the 3, 4 and/or 5 positions; if the p system is 1, the D 1 is a C 1 -C 4 alkyl group, and if the p system is 2, then D 1 is -CH 2 OCH 2 -; if p is 1, D 2 is C 1 -C 4 alkyl; if y is 1, E is C 1 -C 18 alkyl, -OR 1 or Halogen; if y is 2, E is -OA 2 -O-, and if y is 3, E is a group of R 4 C(CH 2 O-) 3 or N(CH 2 CH 2 O-) 3 Q is a group of at least a z-valent alcohol or phenol which is attached to the phosphorus atom via an oxygen atom; R 1 , R 2 and R 3 are independently unsubstituted or halogen-, -COOR 4 , -CN Or -CONR 4 R 4 substituted C 1 -C 18 alkyl; heteroatomoxy, sulfur or -NR 4 -C 2 -C 18 alkyl; C 7 -C 9 phenylalkyl; C 5 -C 12 a cycloalkyl, phenyl or naphthyl group; a naphthyl group substituted by halogen, one to three alkyl or alkoxy groups having a total of from 1 to 18 carbon atoms or substituted with a C 7 -C 9 phenylalkyl group or a phenyl group; or a group of the formula Wherein m is an integer in the range of from 3 to 6; R 4 is hydrogen, C 1 -C 8 alkyl, C 5 -C 12 cycloalkyl or C 7 -C 9 phenylalkyl, R 5 and R 6 Independently from each other, hydrogen, C 1 -C 8 alkyl or C 5 -C 6 cycloalkyl, if q is 2, then R 7 and R 8 are independently C 1 -C 4 alkyl or 2 together. 3-dehydropentamethylene; and if q is 3, then R 7 and R 8 are methyl; R 14 is hydrogen, C 1 -C 9 alkyl or cyclohexyl, R 15 is hydrogen or methyl, and If two or more groups R 14 and R 15 are present , the groups are the same or different, X and Y are each a direct bond or oxygen, Z is a direct bond, a methylene group, -C(R 16 ) 2- or sulphur, and R 16 is C 1 -C 8 alkyl; arylene phosphite of formula 8: Wherein R 17 is the same or different substituent at 0 to 5 positions of the aromatic moiety of formula 8, and is independently selected from the group consisting of C 1 -C 20 alkyl, C 3 -C 20 cycloalkyl, a member of the group consisting of C 4 -C 20 alkylcycloalkyl, C 6 -C 10 aryl and C 7 -C 20 alkylaryl; and combinations thereof.

4.根據實施例3之安定劑組合物,其中該有機亞磷酸酯或膦酸酯係選自:亞磷酸三苯酯;亞磷酸二苯基烷基酯;亞磷酸苯基二烷基酯;亞磷酸三月桂基酯;亞磷酸三-十八烷基酯;二硬脂醯基新戊四醇亞磷酸酯;亞磷酸叁(2,4-二-第三-丁基苯基)酯;亞磷酸叁(壬基苯基)酯;式(A)、(B)、(C)、(D)、(E)、(F)、(G)、(H)、(J)、(K)及(L)之化合物: 2-丁基-2-乙基-1,3-丙二醇2,4,6-三-第三-丁基苯酚亞磷酸酯、雙-(2,6-二-第三-丁基-4-甲基苯基)新戊四醇二亞磷酸酯、2-丁基-2-乙基-1,3-丙二醇2,4-二-異丙苯基苯酚亞磷酸酯、2-丁基-2-乙基-1,3-丙二醇4-甲基-2,6-二-第三-丁基苯酚亞磷酸酯及雙-(2,4,6-三-第三-丁基-苯基)新戊四醇二亞磷酸酯。 4. The stabilizer composition of embodiment 3, wherein the organophosphite or phosphonate is selected from the group consisting of: triphenyl phosphite; diphenylalkyl phosphite; phenyl dialkyl phosphite; Trilauryl phosphite; tri-octadecyl phosphite; distearyl decyl neopentyl phosphite; bismuth phosphite (2,4-di-tert-butylphenyl) ester; Lanthanum phosphite (nonylphenyl) ester; formula (A), (B), (C), (D), (E), (F), (G), (H), (J), (K And (L) compounds: 2-butyl-2-ethyl-1,3-propanediol 2,4,6-tri-tert-butylphenol phosphite, bis-(2,6-di-t-butyl-4- Methylphenyl) pentaerythritol diphosphite, 2-butyl-2-ethyl-1,3-propanediol 2,4-di-cumylphenol phosphite, 2-butyl-2 -ethyl-1,3-propanediol 4-methyl-2,6-di-tertiary-butylphenol phosphite and bis-(2,4,6-tri-tert-butyl-phenyl) Neopentyl alcohol diphosphite.

5.根據實施例3至4中任一實施例之安定劑組合物,其中該至少一種有機亞磷酸酯或膦酸酯係選自亞磷酸叁(2,4-二-第三-丁基苯基)酯(IRGAFOS® 168);雙(2,4-二異丙苯基苯基)新戊四醇二亞磷酸酯(DOVERPHOS® S9228);及4,4'-伸聯苯基-二膦酸四(2,4-二-第三-丁基苯基)酯(IRGAFOS® P-EPQ)。 The stabilizer composition according to any one of embodiments 3 to 4, wherein the at least one organic phosphite or phosphonate is selected from the group consisting of bismuth phosphite (2,4-di-tert-butylbenzene) Ester (IRGAFOS® 168); bis(2,4-diisopropylphenylphenyl)neopentanediol diphosphite (DOVERPHOS® S9228); and 4,4'-extended biphenyl-diphosphine Tetrakis(2,4-di-t-butylphenyl) acid (IRGAFOS® P-EPQ).

6.根據前述實施例中任一實施例之安定劑組合物,其進一步包含至少一種受阻酚化合物。 6. The stabilizer composition of any of the preceding embodiments, further comprising at least one hindered phenol compound.

7.根據實施例6之安定劑組合物,其中該至少一種受阻酚化合物包含式(IVa)、(IVb)或(IVc)中之一或多者之分子片段: 其中R18係選自H或C1-4烴基;R19及R20中之每一者係獨立地選自氫或C1-C20烴基;且R37係選自C1-C12烴基。 7. The stabilizer composition of embodiment 6, wherein the at least one hindered phenol compound comprises a molecular fragment of one or more of formula (IVa), (IVb) or (IVc): Wherein R 18 is selected from H or C 1-4 hydrocarbyl; each of R 19 and R 20 is independently selected from hydrogen or C 1 -C 20 hydrocarbyl; and R 37 is selected from C 1 -C 12 hydrocarbyl .

8.根據實施例7之安定劑組合物,其中R18及R37中之每一者係獨立地選自甲基或第三-丁基。 8. The stabilizer composition of embodiment 7, wherein each of R 18 and R 37 is independently selected from methyl or tert-butyl.

9.根據實施例6至8中任一實施例之安定劑組合物,其中該至少一種受阻酚化合物係選自選自由以下組成之群之成員:(1,3,5-叁(4-第三-丁基-3-羥基-2,6-二甲基苄基)-1,3,5-三嗪-2,4,6-(1H,3H,5H)-三酮;1,1,3-叁(2'-甲基-4'-羥基-5'-第三-丁基苯基)丁烷;三乙二醇雙[3-(3-第三-丁基-4-羥基-5-甲基苯基)丙酸酯];4,4'-硫基雙(2-第三-丁基-5-甲基苯酚);2,2'-硫基二伸乙基雙[3-(3-第三-丁基-4-羥基-5-甲基苯基)丙酸酯];3-(3'-第三-丁基-4'-羥基-5'-甲基苯基)丙酸十八烷基酯;四亞甲基(3-第三-丁基-4-羥基-5-甲基氫化桂皮酸酯)甲烷;N,N'-六亞甲基雙[3-(3-第三-丁基-4-羥基-5-甲基苯基)丙醯胺];硫基二丙酸二(4-第三丁基-3-羥基-2,6-二甲基苄基)酯;及3,5-二-(第三)-丁基-4-羥基氫化桂皮酸十八烷基酯。 The stabilizer composition according to any one of embodiments 6 to 8, wherein the at least one hindered phenol compound is selected from the group consisting of: (1,3,5-叁(4-third) -butyl-3-hydroxy-2,6-dimethylbenzyl)-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione; 1,1,3 -叁(2'-methyl-4'-hydroxy-5'-tris-butylphenyl)butane; triethylene glycol bis[3-(3-tri-butyl-4-hydroxy-5) -Methylphenyl)propionate]; 4,4'-thiobis(2-tris-butyl-5-methylphenol); 2,2'-thiodiethylidene double [3- (3-tert-butyl-4-hydroxy-5-methylphenyl)propionate]; 3-(3'-tris-butyl-4'-hydroxy-5'-methylphenyl) Octadecyl propionate; tetramethylene (3-tert-butyl-4-hydroxy-5-methylhydrocinnamate) methane; N,N'-hexamethylene double [3-( 3-tert-butyl-4-hydroxy-5-methylphenyl)propanamide]; thiodipropionic acid bis(4-tert-butyl-3-hydroxy-2,6-dimethylbenzyl And octadecyl 3,5-di-(tri)-butyl-4-hydroxyhydrocinnamate.

10.根據前述實施例中任一實施例之安定劑組合物,其中R22在至少一種情況下存在且係甲基。 According to any one of the preceding embodiments, the embodiment of the stabilizer composition, and wherein R 22 is present in at least one system where methyl.

11.根據前述實施例中任一實施例之安定劑組合物,其中R24係C1-C18烴基。 The stabilizer composition according to any of the preceding embodiments, wherein R 24 is a C 1 -C 18 hydrocarbyl group.

12.根據前述實施例中任一實施例之安定劑組合物,其中該基於唍之化合物係式(Va)之維生素E乙酸酯 或其異構體及/或混合物。 The stabilizer composition according to any of the preceding embodiments, wherein the stabilizer composition Vitamin E acetate of formula (Va) Or isomers and/or mixtures thereof.

13.根據前述實施例中任一實施例之安定劑組合物,其中該基於唍之化合物係包含基於唍之式V化合物與另一基於唍之化合物之化合物摻合物。 13. The stabilizer composition of any of the preceding embodiments, wherein the 唍 compounds are based on Compound of formula V and another based A compound blend of a compound of hydrazine.

14.根據前述實施例中任一實施例之安定劑組合物,其中該基於唍之化合物係以安定劑組合物之總重量之0.001重量%至5.0重量%存在。 14. The stabilizer composition of any of the preceding embodiments, wherein the stabilizer composition The bismuth compound is present from 0.001% to 5.0% by weight based on the total weight of the stabilizer composition.

15.根據實施例14之安定劑組合物,其中該基於唍之化合物係以安定劑組合物之總重量之0.01重量%至1.0重量%存在。 15. The stabilizer composition of embodiment 14 wherein the based The bismuth compound is present from 0.01% to 1.0% by weight based on the total weight of the stabilizer composition.

16.根據前述實施例中任一實施例之安定劑組合物,其進一步包含有效量之選自選自由以下組成之群之成員的光安定劑:受阻胺光安定劑、受阻羥基苯甲酸酯、酚鎳、紫外光安定劑及其組合。 16. The stabilizer composition of any of the preceding embodiments, further comprising an effective amount of a light stabilizer selected from the group consisting of: a hindered amine light stabilizer, a hindered hydroxybenzoate, Phenol nickel, UV stabilizer, and combinations thereof.

17.根據實施例16之安定劑組合物,其中該光安定劑係受阻胺光安定劑化合物,其包含式(VI)之分子片段: 其中R62係選自選自由以下組成之群之成員:氫;OH;C1-C20烴基;-CH2CN;C1-C12醯基;及C1-C18烷氧基;R65係選自選自由氫;及C1-C8烴基組成之群之成員;且R60、R61、R63及R64中之每一者係獨立地選自C1-C20烴基,或R60及R61及/或R63及R64與其所附接之碳一起形成C5-C10環烷基;或式(VIa)之分子片段 其中m係1至2之整數;R39係選自選自由以下組成之群之成員:氫;OH;C1-C20烴基;-CH2CN;C1-C12醯基;及C1-C18烷氧基;且 G1至G4中之每一者係獨立地選自C1-C20烴基。 17. The stabilizer composition of embodiment 16, wherein the light stabilizer is a hindered amine light stabilizer compound comprising a molecular fragment of formula (VI): Wherein R 62 is selected from the group consisting of: hydrogen; OH; C 1 -C 20 hydrocarbyl; -CH 2 CN; C 1 -C 12 mercapto; and C 1 -C 18 alkoxy; R 65 And is selected from the group consisting of hydrogen; and a C 1 -C 8 hydrocarbon group; and each of R 60 , R 61 , R 63 and R 64 is independently selected from a C 1 -C 20 hydrocarbon group, or R 60 and R 61 and/or R 63 and R 64 together with the carbon to which they are attached form a C 5 -C 10 cycloalkyl group; or a molecular fragment of formula (VIa) Wherein m is an integer from 1 to 2; R 39 is selected from members selected from the group consisting of hydrogen; OH; C 1 -C 20 hydrocarbyl; -CH 2 CN; C 1 -C 12 mercapto; and C 1 - C 18 alkoxy; and each of G 1 to G 4 is independently selected from a C 1 -C 20 hydrocarbyl group.

18.根據實施例16或17之安定劑組合物,其中該受阻胺光安定劑係選自選自由以下組成之群之成員:癸二酸雙(2,2,6,6-四甲基六氫吡啶-4-基)酯;琥珀酸雙(2,2,6,6-四甲基六氫吡啶-4-基)酯;癸二酸雙(1,2,2,6,6-五甲基六氫吡啶-4-基)酯;癸二酸雙(1-辛氧基-2,2,6,6-四甲基六氫吡啶-4-基)酯;正-丁基3,5-二-第三-丁基-4-羥基苄基丙二酸雙(1,2,2,6,6-五甲基六氫吡啶-4-基)酯;1-(2-羥基乙基)-2,2,6,6-四甲基-4-羥基六氫吡啶與琥珀酸之縮合物;硬脂酸2,2,6,6-四甲基六氫吡啶-4-基酯;十二烷酸2,2,6,6-四甲基六氫吡啶-4-基酯;硬脂酸1,2,2,6,6-五甲基六氫吡啶-4-基酯;十二烷酸1,2,2,6,6-五甲基六氫吡啶-4-基酯;N,N'-雙(2,2,6,6-四甲基六氫吡啶-4-基)六亞甲基二胺與4-第三-辛基胺基-2,6-二氯-1,3,5-三嗪之縮合物;氮基三乙酸叁(2,2,6,6-四甲基六氫吡啶-4-基)酯;1,2,3,4-丁烷四甲酸四(2,2,6,6-四甲基六氫吡啶-4-基)酯;4-苯甲醯-2,2,6,6-四甲基六氫吡啶;4-硬脂醯基氧基-2,2,6,6-四甲基六氫吡啶;2-正-丁基-2-(2-羥基-3,5-二-第三-丁基苄基)丙二酸雙(1,2,2,6,6-五甲基六氫吡啶基)酯;3-正-辛基-7,7,9,9-四甲基-1,3,8-三氮雜螺[4.5]癸烷-2,4-二酮;癸二酸雙(1-辛氧基-2,2,6,6-四甲基六氫吡啶基)酯;琥珀酸雙(1-辛氧基-2,2,6,6-四甲基六氫吡啶基)酯;N,N'-雙(2,2,6,6-四甲基六氫吡啶-4-基)六亞甲基二胺與4-嗎啉基-2,6-二氯-1,3,5-三嗪之縮合物;2-氯-4,6-雙(4-正-丁基胺基-2,2,6,6-四甲基 六氫吡啶基)-1,3,5-三嗪與1,2-雙(3-胺基丙基胺基)乙烷之縮合物;2-氯-4,6-雙(4-正-丁基胺基-1,2,2,6,6-五甲基六氫吡啶基)-1,3,5-三嗪與1,2-雙-(3-胺基丙基胺基)乙烷之縮合物;8-乙醯基-3-十二烷基-7,7,9,9-四甲基-1,3,8-三氮雜螺[4.5]癸烷-2,4-二酮;3-十二烷基-1-(2,2,6,6-四甲基六氫吡啶-4-基)吡咯啶-2,5-二酮;3-十二烷基-1-(1-乙醯基-2,2,6,6-四甲基六氫吡啶-4-基)吡咯啶-2,5-二酮;3-十二烷基-1-(1,2,2,6,6-五甲基六氫吡啶-4-基)吡咯啶-2,5-二酮;4-十六烷氧基-2,2,6,6-四甲基六氫吡啶與4-硬脂醯基氧基-2,2,6,6-四甲基六氫吡啶之混合物;N,N'-雙(2,2,6,6-四甲基六氫吡啶-4-基)六亞甲基二胺與4-環己基胺基-2,6-二氯-1,3,5-三嗪之縮合物;1,2-雙(3-胺基丙基胺基)乙烷、2,4,6-三氯-1,3,5-三嗪與4-丁基胺基-2,2,6,6-四甲基六氫吡啶之縮合物;2-十一烷基-7,7,9,9-四甲基-1-氧雜-3,8-二氮雜-4-側氧基螺[4.5]癸烷;側氧基-六氫吡嗪基-三嗪;7,7,9,9-四甲基-2-環十一烷基-1-氧雜-3,8-二氮雜-4-側氧基螺[4.5]癸烷與環氧氯丙烷之反應產物;丁烷-1,2,3,4-四甲酸四(2,2,6,6-四甲基-4-六氫吡啶基)酯;1,2,3,4-丁烷四甲酸四(1,2,2,6,6-五甲基-4-六氫吡啶基)酯;1,2,3,4-丁烷四甲酸1,2,2,6,6-五甲基-4-六氫吡啶基十三烷基酯;1,2,3,4-丁烷四甲酸2,2,6,6-四甲基-4-六氫吡啶基十三烷基酯;1,2,3,4-丁烷四甲酸、2,2,6,6-四甲基-2,4,8,10-四氧雜螺[5.5]-十一烷-3,9-二乙醇與1,2,2,6,6-五甲基-4-六氫吡啶基酯之聚合物;1,2,3,4-丁烷四甲酸、2,2,6,6-四甲 基-2,4,8,10-四氧雜螺[5.5]-十一烷-3,9-二乙醇與2,2,6,6-四甲基-4-六氫吡啶基酯之聚合物;碳酸雙(1-十一烷氧基-2,2,6,6-四甲基六氫吡啶-4-基)酯;1-(2-羥基-2-甲基丙氧基)-2,2,6,6-四甲基-4-六氫吡啶醇;1-(2-羥基-2-甲基丙氧基)-4-十八醯基氧基-2,2,6,6-四甲基六氫吡啶;1-(4-十八醯基氧基-2,2,6,6-四甲基六氫吡啶-1-基氧基)-2-十八醯基氧基-2-甲基丙烷;1-(2-羥基乙基)-2,2,6,6-四甲基-4-六氫吡啶醇;1-(2-羥基乙基)-2,2,6,6-四甲基-4-六氫吡啶醇與琥珀酸二甲酯之反應產物;2,2,4,4-四甲基-7-氧雜-3,20-二氮雜二螺[5.1.11.2]二十一烷-21-酮;2,2,6,6-四甲基-4-六氫吡啶醇與高脂肪酸之酯;3-十二烷基-1-(2,2,6,6-四甲基-4-六氫吡啶基)吡咯啶-2,5-二酮;1-十八烷基-1H-吡咯-2,5-二酮與(1-甲基乙烯基)苯及1-(2,2,6,6-四甲基-4-六氫吡啶基)-1H-吡咯-2,5-二酮之聚合物;1,1',1"-[1,3,5-三嗪-2,4,6-三基叁[(環己基亞胺基)-2,1-乙烷二基]]叁[3,3,5,5-四甲基-六氫吡嗪酮];1,1',1"-[1,3,5-三嗪-2,4,6-三基叁[(環己基亞胺基)-2,1-乙烷二基]]叁[3,3,4,5,5-五甲基-六氫吡嗪酮];7,7,9,9-四甲基-2-環十一烷基-1-氧雜-3,8-二氮雜-4-側氧基螺[4.5]癸烷與環氧氯丙烷之反應產物;N,N'-雙(2,2,6,6-四甲基六氫吡啶-4-基)六亞甲基二胺與4-環己基胺基-2,6-二氯-1,3,5-三嗪之縮合物;1,2-雙(3-胺基丙基胺基)乙烷、2,4,6-三氯-1,3,5-三嗪及4-丁基胺基-2,2,6,6-四甲基六氫吡啶之縮合物;N,N'-雙(2,2,6,6-四甲基六氫吡啶-4-基)六亞甲基二胺與4-嗎啉基-2,6-二 氯-1,3,5-三嗪之縮合物;2-氯-4,6-雙(4-正-丁基胺基-2,2,6,6-四甲基六氫吡啶基)-1,3,5-三嗪與1,2-雙(3-胺基丙基胺基)乙烷之縮合物;2-氯-4,6-雙(4-正-丁基胺基-1,2,2,6,6-五甲基六氫吡啶基)-1,3,5-三嗪與1,2-雙-(3-胺基丙基胺基)乙烷之縮合物;2-[(2-羥基乙基)胺基]-4,6-雙[N-(1-環己氧基-2,2,6,6-四甲基六氫吡啶-4-基)丁基胺基-1,3,5-三嗪;丙二酸[(4-甲氧基苯基)-亞甲基]-雙-(1,2,2,6,6-五甲基-4-六氫吡啶基)酯;1,2,3,4-丁烷四甲酸四(2,2,6,6-四甲基六氫吡啶-4-基)酯;3,5-雙(1,1-二甲基乙基)-4-羥基-苯丙酸1-[2-[3-[3,5-雙(1,1-二甲基乙基)-4-羥基苯基]-1-側氧基丙氧基]乙基]-2,2,6,6-四甲基-4-六氫吡啶基酯;N-(1-辛氧基-2,2,6,6-四甲基六氫吡啶-4-基)-N'-十二烷基草醯胺;氮基三乙酸叁(2,2,6,6-四甲基六氫吡啶-4-基)酯;1,5-二氧雜螺{5,5}十一烷-3,3-二甲酸雙(1,2,2,6,6-五甲基-4-六氫吡啶基)酯:1,5-二氧雜螺{5,5}十一烷-3,3-二甲酸雙(2,2,6,6-四甲基-4-六氫吡啶基)酯;1-(2-羥基乙基)-2,2,6,6-四甲基-4-羥基六氫吡啶與琥珀酸之縮合物;N,N'-雙(2,2,6,6-四甲基六氫吡啶-4-基)六亞甲基二胺與4-第三-辛基胺基-2,6-二氯-1,3,5-三嗪之縮合物;1,2,3,4-丁烷四甲酸1,2,2,6,6-五甲基-4-六氫吡啶基十三烷基酯;1,2,3,4-丁烷四甲酸四(2,2,6,6-四甲基六氫吡啶-4-基)酯;1,2,3,4-丁烷四甲酸2,2,6,6-四甲基-4-六氫吡啶基十三烷基酯;1,2,3,4-丁烷四甲酸四(1,2,2,6,6-五甲基六氫吡啶-4-基)酯;2,2,4,4-四甲基-21-側氧基-7-氧雜-3.20-二氮雜螺 (5.1.11.2)-二十一烷-20-丙酸-十二烷基酯與2,2,4,4-四甲基-21-側氧基-7-氧雜-3.20-二氮雜螺(5.1.11.2)-二十一烷-20-丙酸-十四烷基酯之混合物;六氫-2,6-雙(2,2,6,6-四甲基-4-六氫吡啶基)-1H,4H,5H,8H-2,3a,4a,6,7a,8a-六氮雜環戊并[def]茀-4,8-二酮;聚甲基[丙基-3-氧基(2',2',6',6'-四甲基-4,4'-六氫吡啶基)]矽氧烷;聚甲基[丙基-3-氧基(1',2',2',6',6'-五甲基-4,4'-六氫吡啶基)]矽氧烷;甲基丙烯酸甲酯與丙烯酸乙酯及丙烯酸2,2,6,6-四甲基六氫吡啶-4-基酯之共聚物;C20至C24混合α-烯烴與(2,2,6,6-四甲基六氫吡啶-4-基)琥珀醯亞胺之共聚物;1,2,3,4-丁烷四甲酸、β,β,β',β'-四甲基-2,4,8,10-四氧雜螺[5.5]十一烷-3,9-二乙醇與1,2,2,6,6-五甲基-4-六氫吡啶基酯之聚合物;1,2,3,4-丁烷四甲酸、β,β,β',β'-四甲基-2,4,8,10-四氧雜螺[5.5]十一烷-3,9-二乙醇與2,2,6,6-四甲基-4-六氫吡啶基酯共聚物之聚合物;N,N'-雙(2,2,6,6-四甲基-4-六氫吡啶基)1,3-苯二甲醯胺;1,1'-(1,10-二側氧基-1,10-癸烷二基)-雙(六氫-2,2,4,4,6-五甲基嘧啶);N-(1-乙醯基-2,2,6,6-四甲基六氫吡啶基)-N'-十二烷基乙烷二醯胺;N,N'-1,6-己烷二基雙[N-(2,2,6,6-四甲基-4-六氫吡啶基)甲醯胺;1,3:2,4-雙-O-(2,2,6,6-四甲基-4-亞六氫吡啶基)-D-葡萄糖醇;2,2,4,4-四甲基-7-氧雜-3,20-二氮雜-21-側氧基-二螺[5.1.11.2]二十一烷;2-甲基-N-(2,2,6,6-四甲基-4-六氫吡啶基)-2-[(2,2,6,6-四甲基-4-六氫吡啶基)胺基]-丙醯胺;2,2,4,4-四甲基-21-側氧基-7-氧雜-3,20-二氮雜二螺[5.1.11.2]二十一烷-20-丙 酸十二烷基酯;N-(2,2,6,6-四甲基六氫吡啶-4-基)-β-胺基丙酸十二烷基酯;N-(2,2,6,6-四甲基六氫吡啶-4-基)-N'-胺基草醯胺;N-(2,2,6,6-四甲基-4-六氫吡啶基)-3-[(2,2,6,6-四甲基-4-六氫吡啶基)胺基]-丙醯胺;4-十六烷氧基-2,2,6,6-四甲基六氫吡啶與4-硬脂醯基氧基-2,2,6,6-四甲基六氫吡啶之混合物;3-十二烷基-1-(1,2,2,6,6-五甲基六氫吡啶-4-基)吡咯啶-2,5-二酮;3-十二烷基-1-(1-乙醯基-2,2,6,6-五甲基六氫吡啶-4-基)吡咯啶-2,5-二酮;琥珀酸雙(2,2,6,6-四甲基六氫吡啶-4-基)酯;正-丁基3,5-二-第三-丁基-4-羥基苄基丙二酸雙(1,2,2,6,6-五甲基六氫吡啶-4-基)酯;氮基三乙酸叁(2,2,6,6-四甲基六氫吡啶-4-基)酯;1,1'-(1,2-乙烷二基)雙(3,3,5,5-四甲基六氫吡嗪酮);4-苯甲醯-2,2,6,6-四甲基六氫吡啶;4-硬脂醯基氧基-2,2,6,6-四甲基六氫吡啶;2-正-丁基-2-(2-羥基-3,5-二-第三-丁基苄基)丙二酸雙(1,2,2,6,6-五甲基六氫吡啶基)酯;3-正-辛基-7,7,9,9-四甲基-1,3,8-三氮雜螺[4.5]癸烷-2,4-二酮;癸二酸雙(1-辛氧基-2,2,6,6-四甲基六氫吡啶基)酯;琥珀酸雙(1-辛氧基-2,2,6,6-四甲基六氫吡啶基)酯;8-乙醯基-3-十二烷基-7,7,9,9-四甲基-1,3,8-三氮雜螺[4.5]癸烷-2,4-二酮;3-十二烷基-1-(2,2,6,6-四甲基六氫吡啶-4-基)吡咯啶-2,5-二酮;3-十二烷基-1-(1-乙醯基-2,2,6,6-四甲基六氫吡啶-4-基)吡咯啶-2,5-二酮;3-十二烷基-1-(1,2,2,6,6-五甲基六氫吡啶-4-基)吡咯啶-2,5-二酮;4-十六烷氧基-2,2,6,6-四甲基六氫吡啶與4-硬脂醯基氧基-2,2,6,6-四甲基六氫吡啶 之混合物;2-十一烷基-7,7,9,9-四甲基-1-氧雜-3,8-二氮雜-4-側氧基螺[4.5]癸烷;1,5-二氧雜螺{5,5}十一烷-3,3-二甲酸雙(2,2,6,6-四甲基-4-六氫吡啶基)酯及1,5-二氧雜螺{5,5}十一烷-3,3-二甲酸雙(1,2,2,6,6-五甲基-4-六氫吡啶基)酯;N1-(β-羥基乙基)3,3-五亞甲基-5,5-二甲基六氫吡嗪-2-酮;N1-第三-辛基-3,3,5,5-四甲基-二氮呯-2-酮;N1-第三-辛基-3,3-五亞甲基-5,5-六亞甲基-二氮呯-2-酮;N1-第三-辛基-3,3-五亞甲基-5,5-二甲基六氫吡嗪-2-酮;反式-1,2-環己烷-雙-(N1-5,5-二甲基-3,3-五亞甲基-2-六氫吡嗪酮);反式-1,2-環己烷-雙-(N1-3,3,5,5-二螺五亞甲基-2-六氫吡嗪酮);N1-異丙基-1,4-二氮雜二螺-(3,3,5,5)五亞甲基-2-六氫吡嗪酮;N1-異丙基-1,4-二氮雜二螺-3,3-五亞甲基-5,5-四亞甲基-2-六氫吡嗪酮;N1-異丙基-5,5-二甲基-3,3-五亞甲基-2-六氫吡嗪酮;反式-1,2-環己烷-雙-N1-(二甲基-3,3-五亞甲基-2-六氫吡嗪酮);N1-辛基-5,5-二甲基-3,3-五亞甲基-1,4-二氮呯-2-酮;及N1-辛基-1,4-二氮雜二螺-(3,3,5,5)五亞甲基-1,5-二氮呯-2-酮。 18. The stabilizer composition of embodiment 16 or 17, wherein the hindered amine light stabilizer is selected from the group consisting of: azelaic acid bis(2,2,6,6-tetramethylhexahydro Pyridin-4-yl) ester; bis(2,2,6,6-tetramethylhexahydropyridin-4-yl) succinate; bis(1,2,2,6,6-penta-azelaic acid) Hexahydropyridin-4-yl) ester; bis(1-octyloxy-2,2,6,6-tetramethylhexahydropyridin-4-yl) sebacate; n-butyl 3,5 -di-t-butyl-4-hydroxybenzylmalonate bis(1,2,2,6,6-pentamethylhexahydropyridin-4-yl) ester; 1-(2-hydroxyethyl a condensate of -2,2,6,6-tetramethyl-4-hydroxyhexahydropyridine and succinic acid; 2,2,6,6-tetramethylhexahydropyridin-4-yl stearate; 2,2,6,6-tetramethylhexahydropyridin-4-yl dodecanoate; 1,2,2,6,6-pentamethylhexahydropyridin-4-yl stearate; 1,2,2,6,6-pentamethylhexahydropyridin-4-yl dialkylate; N,N'-bis(2,2,6,6-tetramethylhexahydropyridin-4-yl a condensate of hexamethylenediamine with 4-tris-octylamino-2,6-dichloro-1,3,5-triazine; bismuth triacetate (2,2,6,6) -tetramethylhexahydropyridin-4-yl)ester; 1,2,3,4-butanetetracarboxylic acid tetrakis(2,2,6,6-tetramethylhexahydropyridinium 4-yl)ester; 4-benzylidene-2,2,6,6-tetramethylhexahydropyridine; 4-stearylpurinyl-2,2,6,6-tetramethylhexahydro Pyridine; 2-n-butyl-2-(2-hydroxy-3,5-di-tris-butylbenzyl)malonic acid bis(1,2,2,6,6-pentamethylhexahydro Pyridyl)ester; 3-n-octyl-7,7,9,9-tetramethyl-1,3,8-triazaspiro[4.5]decane-2,4-dione; sebacic acid Bis(1-octyloxy-2,2,6,6-tetramethylhexahydropyridyl) ester; bis(1-octyloxy-2,2,6,6-tetramethylhexahydropyridine) succinate Esteryl ester; N,N'-bis(2,2,6,6-tetramethylhexahydropyridin-4-yl)hexamethylenediamine and 4-morpholinyl-2,6-dichloro- a condensate of 1,3,5-triazine; 2-chloro-4,6-bis(4-n-butylamino-2,2,6,6-tetramethylhexahydropyridinyl)-1, a condensate of 3,5-triazine with 1,2-bis(3-aminopropylamino)ethane; 2-chloro-4,6-bis(4-n-butylamino-1,2 , 2,6,6-pentamethylhexahydropyridyl)-1,3,5-triazine and 1,2-bis-(3-aminopropylamino)ethane condensate; 8-B Mercapto-3-dodecyl-7,7,9,9-tetramethyl-1,3,8-triazaspiro[4.5]decane-2,4-dione; 3-dodecane 1-(2,2,6,6-tetramethylhexahydropyridin-4-yl)pyrrolidine-2,5-dione; 3-dodecyl-1-(1-ethenyl- 2, 2,6,6-tetramethylhexahydropyridin-4-yl)pyrrolidine-2,5-dione; 3-dodecyl-1-(1,2,2,6,6-pentamethyl Hexahydropyridin-4-yl)pyrrolidine-2,5-dione; 4-hexadecyloxy-2,2,6,6-tetramethylhexahydropyridine and 4-stearylpurinyloxy- a mixture of 2,2,6,6-tetramethylhexahydropyridine; N,N'-bis(2,2,6,6-tetramethylhexahydropyridin-4-yl)hexamethylenediamine and a condensate of 4-cyclohexylamino-2,6-dichloro-1,3,5-triazine; 1,2-bis(3-aminopropylamino)ethane, 2,4,6- a condensate of trichloro-1,3,5-triazine with 4-butylamino-2,2,6,6-tetramethylhexahydropyridine; 2-undecyl-7,7,9, 9-tetramethyl-1-oxa-3,8-diaza-4-oxooxyspiro[4.5]decane; pendant oxy-hexahydropyrazinyl-triazine; 7,7,9, Reaction product of 9-tetramethyl-2-cycloundecyl-1-oxa-3,8-diaza-4-oxooxyspiro[4.5]decane with epichlorohydrin; butane- 1,2,3,4-tetracarboxylic acid tetrakis(2,2,6,6-tetramethyl-4-hexahydropyridyl) ester; 1,2,3,4-butanetetracarboxylic acid tetrakis (1,2 , 2,6,6-pentamethyl-4-hexahydropyridinyl) 1,2,3,4-butanetetracarboxylic acid 1,2,2,6,6-pentamethyl-4-hexahydro Pyridyltridecyl ester; 1,2,3,4-butanetetracarboxylic acid 2,2,6,6-tetramethyl-4- Hydropyridyltridecyl ester; 1,2,3,4-butanetetracarboxylic acid, 2,2,6,6-tetramethyl-2,4,8,10-tetraoxaspiro[5.5]- a polymer of undecane-3,9-diethanol and 1,2,2,6,6-pentamethyl-4-hexahydropyridyl ester; 1,2,3,4-butanetetracarboxylic acid, 2 ,2,6,6-tetramethyl-2,4,8,10-tetraoxaspiro[5.5]-undecane-3,9-diethanol and 2,2,6,6-tetramethyl- a polymer of 4-hexahydropyridyl ester; bis(1-undecyloxy-2,2,6,6-tetramethylhexahydropyridin-4-yl) carbonate; 1-(2-hydroxy- 2-methylpropoxy)-2,2,6,6-tetramethyl-4-hexahydropyridinol; 1-(2-hydroxy-2-methylpropoxy)-4-octadecyl Oxy-2,2,6,6-tetramethylhexahydropyridine; 1-(4-octadecyloxy-2,2,6,6-tetramethylhexahydropyridin-1-yloxy )-2-octadecyloxy-2-methylpropane; 1-(2-hydroxyethyl)-2,2,6,6-tetramethyl-4-hexahydropyridinol; 1-(2 -hydroxyethyl)-2,2,6,6-tetramethyl-4-hexahydropyridinol and reaction product of dimethyl succinate; 2,2,4,4-tetramethyl-7-oxa -3,20-diazabispiro[5.1.11.2] eicosane-21-one; ester of 2,2,6,6-tetramethyl-4-hexahydropyridinol with high fatty acids; 3- Dodecyl-1-(2,2,6,6-tetramethyl-4-hexahydropyridine Pyrrolidine-2,5-dione; 1-octadecyl-1H-pyrrole-2,5-dione with (1-methylvinyl)benzene and 1-(2,2,6,6 -Tetramethyl-4-hexahydropyridyl)-1H-pyrrole-2,5-dione polymer; 1,1',1"-[1,3,5-triazine-2,4,6 -Triyl hydrazine [(cyclohexylimylidene)-2,1-ethanediyl]]indole [3,3,5,5-tetramethyl-hexahydropyrazinone]; 1,1',1 "-[1,3,5-Triazine-2,4,6-triyloxime [(cyclohexylimylidene)-2,1-ethanediyl]]indole [3,3,4,5, 5-pentamethyl-hexahydropyrazinone; 7,7,9,9-tetramethyl-2-cycloundecyl-1-oxa-3,8-diaza-4-lateral oxygen Reaction product of snail [4.5] decane with epichlorohydrin; N,N'-bis(2,2,6,6-tetramethylhexahydropyridin-4-yl)hexamethylenediamine and 4 a condensate of cyclohexylamino-2,6-dichloro-1,3,5-triazine; 1,2-bis(3-aminopropylamino)ethane, 2,4,6-three Condensate of chloro-1,3,5-triazine and 4-butylamino-2,2,6,6-tetramethylhexahydropyridine; N,N'-bis(2,2,6,6 a condensate of tetrakis(hexahydropyridin-4-yl)hexamethylenediamine and 4-morpholinyl-2,6-dichloro-1,3,5-triazine; 2-chloro-4, 6-bis(4-n-butylamino-2,2,6,6-tetramethylhexahydropyridyl)-1,3,5-triazine with 1,2-bis(3-aminopropyl Amino group) Alkane condensate; 2-chloro-4,6-bis(4-n-butylamino-1,2,2,6,6-pentamethylhexahydropyridyl)-1,3,5-three Condensate of azine with 1,2-bis-(3-aminopropylamino)ethane; 2-[(2-hydroxyethyl)amino]-4,6-bis[N-(1-ring) Hexyloxy-2,2,6,6-tetramethylhexahydropyridin-4-yl)butylamino-1,3,5-triazine; malonic acid [(4-methoxyphenyl) -methylene]-bis-(1,2,2,6,6-pentamethyl-4-hexahydropyridyl) ester; 1,2,3,4-butanetetracarboxylic acid tetrakis (2,2, 6,6-tetramethylhexahydropyridin-4-yl)ester; 3,5-bis(1,1-dimethylethyl)-4-hydroxy-phenylpropionic acid 1-[2-[3-[ 3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-1-oxopropoxy]ethyl]-2,2,6,6-tetramethyl-4 - hexahydropyridyl ester; N-(1-octyloxy-2,2,6,6-tetramethylhexahydropyridin-4-yl)-N'-dodecyl oxalidamide; nitrogen-based Bismuth (2,2,6,6-tetramethylhexahydropyridin-4-yl) acetate; 1,5-dioxaspiro{5,5}undecane-3,3-dicarboxylic acid bis (1) ,2,2,6,6-pentamethyl-4-hexahydropyridinyl): 1,5-dioxaspiro{5,5}undecane-3,3-dicarboxylic acid bis (2,2 ,6,6-tetramethyl-4-hexahydropyridinyl); 1-(2-hydroxyethyl)-2,2,6,6-tetramethyl-4-hydroxyhexahydropyridine and succinic acid condensation N,N'-bis(2,2,6,6-tetramethylhexahydropyridin-4-yl)hexamethylenediamine and 4-tris-octylamino-2,6-di a condensate of chloro-1,3,5-triazine; 1,2,3,4-butanetetracarboxylic acid 1,2,2,6,6-pentamethyl-4-hexahydropyridyltridecyl Ester; 1,2,3,4-butanetetracarboxylic acid tetrakis(2,2,6,6-tetramethylhexahydropyridin-4-yl) ester; 1,2,3,4-butanetetracarboxylic acid 2 , 2,6,6-tetramethyl-4-hexahydropyridyltridecyl ester; 1,2,3,4-butanetetracarboxylic acid tetrakis(1,2,2,6,6-pentamethyl Hexahydropyridin-4-yl)ester; 2,2,4,4-tetramethyl-21-oxooxy-7-oxa-3.20-diazaspiro (5.1.11.2)-icosane- 20-propionic acid-dodecyl ester and 2,2,4,4-tetramethyl-21-oxo-7-oxa-3.20-diazaspiro (5.1.11.2)-eicosane a mixture of -20-propionic acid-tetradecyl ester; hexahydro-2,6-bis(2,2,6,6-tetramethyl-4-hexahydropyridyl)-1H, 4H, 5H, 8H -2,3a,4a,6,7a,8a-hexazacyclo[def]indole-4,8-dione; polymethyl[propyl-3-oxy(2',2',6 ',6'-Tetramethyl-4,4'-hexahydropyridinyl)]oxane; polymethyl [propyl-3-oxy (1', 2', 2', 6', 6' - pentamethyl-4,4'-hexahydropyridinyl)]oxane; methyl methacrylate with ethyl acrylate and acrylic acid 2, 2, 6, Copolymer of 6-tetramethylhexahydropyridin-4-yl ester; C 20 to C 24 mixed α-olefin and (2,2,6,6-tetramethylhexahydropyridin-4-yl) amber Copolymer of amine; 1,2,3,4-butanetetracarboxylic acid, β,β,β',β'-tetramethyl-2,4,8,10-tetraoxaspiro[5.5]undecane a polymer of -3,9-diethanol and 1,2,2,6,6-pentamethyl-4-hexahydropyridyl ester; 1,2,3,4-butanetetracarboxylic acid, β,β, '',β'-Tetramethyl-2,4,8,10-tetraoxaspiro[5.5]undecane-3,9-diethanol and 2,2,6,6-tetramethyl-4- a polymer of a hexahydropyridyl ester copolymer; N,N'-bis(2,2,6,6-tetramethyl-4-hexahydropyridyl)1,3-benzenedimethylamine; 1,1 '-(1,10-di-oxy-1,10-decanediyl)-bis(hexahydro-2,2,4,4,6-pentamethylpyrimidine); N-(1-acetamidine) -2,2,6,6-tetramethylhexahydropyridyl)-N'-dodecylethanediamine;N,N'-1,6-hexanediyl bis[N-( 2,2,6,6-tetramethyl-4-hexahydropyridinyl)carbenamide; 1,3:2,4-bis-O-(2,2,6,6-tetramethyl-4- Hexahydropyridyl)-D-glucitol; 2,2,4,4-tetramethyl-7-oxa-3,20-diaza-21-sideoxy-two snail [5.1.11.2] Dioxane; 2-methyl-N-(2,2,6,6-tetramethyl-4-hexahydropyridinyl)-2-[(2,2,6,6-tetramethyl) -4-hexahydropyridyl)amino]-propionamide; 2,2,4,4-tetramethyl-21-oxyl-7-oxa-3,20-diazabispiro[5.1 .11.2] Behenyl-20-propionic acid lauryl ester; N-(2,2,6,6-tetramethylhexahydropyridin-4-yl)-β-aminopropionic acid dodecane Base ester; N-(2,2,6,6-tetramethylhexahydropyridin-4-yl)-N'-aminoglyoxime; N-(2,2,6,6-tetramethyl- 4-hexahydropyridyl)-3-[(2,2,6,6-tetramethyl-4-hexahydropyridinyl)amino]-propanamine; 4-hexadecyloxy-2,2 a mixture of 6,6-tetramethylhexahydropyridine and 4-stearylnonyloxy-2,2,6,6-tetramethylhexahydropyridine; 3-dodecyl-1-(1, 2,2,6,6-pentamethylhexahydropyridin-4-yl)pyrrolidine-2,5-dione; 3-dodecyl-1-(1-ethenyl-2,2,6 ,6-pentamethylhexahydropyridin-4-yl)pyrrolidine-2,5-dione; bis(2,2,6,6-tetramethylhexahydropyridin-4-yl) succinate; -butyl 3,5-di-tertiary-butyl-4-hydroxybenzylmalonate bis(1,2,2,6,6-pentamethylhexahydropyridin-4-yl) ester; nitrogen group Bismuth triacetate (2,2,6,6-tetramethylhexahydropyridin-4-yl) ester; 1,1'-(1,2-ethanediyl) bis (3,3,5,5- Tetramethylhexahydropyrazinone; 4-benzylidene-2,2,6,6-tetramethylhexahydropyridine; 4-hard Mercaptooxy-2,2,6,6-tetramethylhexahydropyridine; 2-n-butyl-2-(2-hydroxy-3,5-di-tris-butylbenzyl)propane Bis(1,2,2,6,6-pentamethylhexahydropyridyl) acid; 3-n-octyl-7,7,9,9-tetramethyl-1,3,8-triazole Heterospiro[4.5]decane-2,4-dione; bis(1-octyloxy-2,2,6,6-tetramethylhexahydropyridyl) sebacate; bisuccinate Octyloxy-2,2,6,6-tetramethylhexahydropyridyl); 8-ethylindolyl-3-dodecyl-7,7,9,9-tetramethyl-1,3 , 8-triazaspiro[4.5]decane-2,4-dione; 3-dodecyl-1-(2,2,6,6-tetramethylhexahydropyridin-4-yl)pyrrole Pyridin-2,5-dione; 3-dodecyl-1-(1-ethylindenyl-2,2,6,6-tetramethylhexahydropyridin-4-yl)pyrrolidine-2,5 -dione; 3-dodecyl-1-(1,2,2,6,6-pentamethylhexahydropyridin-4-yl)pyrrolidine-2,5-dione; 4-hexadecane a mixture of oxy-2,2,6,6-tetramethylhexahydropyridine and 4-stearylnonyloxy-2,2,6,6-tetramethylhexahydropyridine; 2-undecyl -7,7,9,9-tetramethyl-1-oxa-3,8-diaza-4-oxooxyspiro[4.5]decane; 1,5-dioxaspiro {5,5 }Dodecane-3,3-dicarboxylic acid bis(2,2,6,6-tetramethyl-4-hexahydropyridinyl) and 1,5-dioxaspiro {5,5} An alkoxy-3,3-dicarboxylic acid bis (1,2,2,6,6-pentamethyl-4-piperidinyl) ester; N 1 - (β- hydroxyethyl) 3,3-pentamethylene Methyl-5,5-dimethylhexahydropyrazin-2-one; N 1 -tris-octyl-3,3,5,5-tetramethyl-diazepin-2-one; N 1 -Third-octyl-3,3-pentamethylene-5,5-hexamethylene-diazepin-2-one; N 1 -tris-octyl-3,3-pentamethylene -5,5-dimethylhexahydropyrazin-2-one; trans-1,2-cyclohexane-bis-(N 1 -5,5-dimethyl-3,3-pentamethylene -2- hexahydropyrazinone; trans-1,2-cyclohexane-bis-(N 1 -3,3,5,5-dispiro-pentamethylene-2-hexahydropyrazinone) ;N 1 -isopropyl-1,4-diazabispiro-(3,3,5,5) pentamethylene-2-hexahydropyrazinone; N 1 -isopropyl-1,4 -diazabispiro-3,3-pentamethylene-5,5-tetramethylene-2-hexahydropyrazinone; N 1 -isopropyl-5,5-dimethyl-3, 3-pentamethylene-2-hexahydropyrazinone; trans-1,2-cyclohexane-bis-N 1 -(dimethyl-3,3-pentamethylene-2-hexahydropyridyl Nazinone); N 1 -octyl-5,5-dimethyl-3,3-pentamethylene-1,4-diazepin-2-one; and N 1 -octyl-1,4- Diazabis-(3,3,5,5)pentamethylene-1,5-diazepin-2-one.

19.根據實施例16之安定劑組合物,其中該光安定劑係選自選自由2-羥基二苯甲酮化合物、2-(2'-羥基苯基)苯并三唑化合物、2-(2'-羥基苯基)-1,3,5-三嗪化合物及其組合組成之群之成員的紫外光吸收劑。 19. The stabilizer composition of embodiment 16, wherein the light stabilizer is selected from the group consisting of a 2-hydroxybenzophenone compound, a 2-(2'-hydroxyphenyl)benzotriazole compound, 2-(2) An ultraviolet light absorber of a member of the group consisting of '-hydroxyphenyl)-1,3,5-triazine compounds and combinations thereof.

20.根據實施例19之安定劑組合物,其中該紫外光吸收劑係式(VII)之2-(2'-羥基苯基)-1,3,5-三嗪化合物: 其中R34及R35中之每一者係獨立地選自選自由視情況經取代之C6-C10芳基、C1-C10烴基取代之胺基、C1-C10醯基及C1-C10烷氧基組成之群之成員;且R36係在式VII之苯氧基部分之0個至4個位置處相同或不同之取代基,且在每一情況下係獨立地選自選自由羥基、C1-C12烴基、C1-C12烷氧基、C1-C12烷氧基酯及C1-C12醯基組成之群之成員。 20. The stabilizer composition of embodiment 19, wherein the ultraviolet light absorber is a 2-(2'-hydroxyphenyl)-1,3,5-triazine compound of formula (VII): Wherein each of R 34 and R 35 is independently selected from the group consisting of an optionally substituted C 6 -C 10 aryl group, a C 1 -C 10 hydrocarbon group substituted amino group, a C 1 -C 10 fluorenyl group, and a C group. a member of the group consisting of 1 -C 10 alkoxy groups; and R 36 is the same or different substituent at the 0 to 4 positions of the phenoxy moiety of formula VII, and is independently selected in each case From a member selected from the group consisting of a hydroxyl group, a C 1 -C 12 hydrocarbon group, a C 1 -C 12 alkoxy group, a C 1 -C 12 alkoxy ester, and a C 1 -C 12 fluorenyl group.

21.根據實施例19或實施例20中任一實施例之安定劑組合物,其中該2-(2'-羥基苯基)-1,3,5-三嗪化合物係選自選自由以下組成之群之成員:4,6-雙-(2,4-二甲基苯基)-2-(2-羥基-4-辛氧基苯基)-對稱-三嗪(Cyasorb® 1164,自Cytec Industries有限公司購得);4,6-雙-(2,4-二甲基苯基)-2-(2,4-二羥基苯基)-對稱-三嗪;2,4-雙(2,4-二羥基苯基)-6-(4-氯苯基)-對稱-三嗪;2,4-雙[2-羥基-4-(2-羥基-乙氧基)苯基]-6-(4-氯苯基)-對稱-三嗪;2,4-雙[2-羥基-4-(2-羥基-4-(2-羥基-乙氧基)苯基]-6-(2,4-二甲基苯基)-對稱-三 嗪;2,4-雙[2-羥基-4-(2-羥基乙氧基)苯基]-6-(4-溴苯基)-對稱-三嗪;2,4-雙[2-羥基-4-(2-乙醯氧基乙氧基)苯基]-6-(4-氯苯基)-對稱-三嗪;2,4-雙(2,4-二羥基苯基)-6-(2,4-二甲基苯基)-對稱-三嗪;2,4-雙(4-聯苯基)-6-[2-羥基-4-[(辛氧基羰基)亞乙基氧基]苯基]-對稱-三嗪;2,4-雙(4-聯苯基)-6-[2-羥基-4-(2-乙基己氧基)苯基]-對稱-三嗪;2-苯基-4-[2-羥基-4-(3-第二-丁氧基-2-羥基丙氧基)苯基]-6-[2-羥基-4-(3-第二-戊氧基-2-羥基丙氧基)苯基]-對稱-三嗪;2,4-雙(2,4-二甲基苯基)-6-[2-羥基-4(3-苄氧基-2-羥基丙氧基)苯基]-對稱-三嗪;2,4-雙(2-羥基-4-正-丁氧基苯基)-6-(2,4-二-正-丁氧基苯基)-對稱-三嗪;2,4-雙(2,4-二甲基苯基)-6-[2-羥基-4-(3-壬氧基-2-羥基丙氧基)-5-α-異丙苯基苯基]-對稱-三嗪;亞甲基雙-{2,4-雙(2,4-二甲基苯基)-6-[2-羥基-4-(3-丁氧基-2-羥基丙氧基)苯基]-對稱-三嗪};在3:5'、5:5'及3:3'位處以5:4:1比率橋連之亞甲基橋連二聚體混合物;2,4,6-叁(2-羥基-4-異辛氧基羰基異亞丙基氧基-苯基)-對稱-三嗪;2,4-雙(2,4-二甲基苯基)-6-(2-羥基-4-己氧基-5-α-異丙苯基苯基)-對稱-三嗪;2-(2,4,6-三甲基苯基)-4,6-雙[2-羥基-4-(3-丁氧基-2-羥基丙氧基)苯基]-對稱-三嗪;2,4,6-叁[2-羥基-4-(3-第二-丁氧基-2-羥基丙氧基)-苯基]-對稱-三嗪;4,6-雙-(2,4-二甲基苯基)-2-(2-羥基-4-(3-十二烷氧基-2-羥基丙氧基)苯基)-對稱-三嗪與4,6-雙-(2,4-二甲基苯基)-2-(2-羥基-4-(3-十三烷氧基-2-羥基丙氧基)苯基)-對稱-三嗪之混合物(Tinuvin® 400,自Ciba Specialty Chemicals公司購得);4,6-雙-(2,4-二甲基苯基)-2-(2-羥基-4(3-(2-乙基己氧基)-2-羥基丙氧基)-苯基)-對稱-三嗪;4,6-二苯基-2-(4-己氧基-2-羥基苯基)-對稱-三嗪;及其組合。 The stabilizer composition according to any one of the embodiments 19 or 20, wherein the 2-(2'-hydroxyphenyl)-1,3,5-triazine compound is selected from the group consisting of the following Member of the group: 4,6-bis-(2,4-dimethylphenyl)-2-(2-hydroxy-4-octyloxyphenyl)-symmetric-triazine (Cyasorb® 1164, from Cytec Industries Ltd.); 4,6-bis-(2,4-dimethylphenyl)-2-(2,4-dihydroxyphenyl)-symmetric-triazine; 2,4-bis(2, 4-dihydroxyphenyl)-6-(4-chlorophenyl)-symmetric-triazine; 2,4-bis[2-hydroxy-4-(2-hydroxy-ethoxy)phenyl]-6- (4-chlorophenyl)-symmetric-triazine; 2,4-bis[2-hydroxy-4-(2-hydroxy-4-(2-hydroxy-ethoxy)phenyl]-6-(2, 4-dimethylphenyl)-symmetric-three Bis; 2,4-bis[2-hydroxy-4-(2-hydroxyethoxy)phenyl]-6-(4-bromophenyl)-symmetric-triazine; 2,4-bis[2-hydroxyl 4-(2-acetoxyethoxy)phenyl]-6-(4-chlorophenyl)-symmetric-triazine; 2,4-bis(2,4-dihydroxyphenyl)-6 -(2,4-dimethylphenyl)-symmetric-triazine; 2,4-bis(4-biphenylyl)-6-[2-hydroxy-4-[(octyloxycarbonyl)ethylene Oxy]phenyl]-symmetric-triazine; 2,4-bis(4-biphenyl)-6-[2-hydroxy-4-(2-ethylhexyloxy)phenyl]-symmetric-three 2-phenyl-4-[2-hydroxy-4-(3-second-butoxy-2-hydroxypropoxy)phenyl]-6-[2-hydroxy-4-(3- Di-pentyloxy-2-hydroxypropoxy)phenyl]-symmetric-triazine; 2,4-bis(2,4-dimethylphenyl)-6-[2-hydroxy-4(3- Benzyloxy-2-hydroxypropoxy)phenyl]-symmetric-triazine; 2,4-bis(2-hydroxy-4-n-butoxyphenyl)-6-(2,4-di- n-Butoxyphenyl)-symmetric-triazine; 2,4-bis(2,4-dimethylphenyl)-6-[2-hydroxy-4-(3-indolyloxy-2-hydroxyl) Propoxy)-5-α-isopropylphenylphenyl]-symmetric-triazine; methylenebis-{2,4-bis(2,4-dimethylphenyl)-6-[2- Hydroxy-4-(3-butoxy-2-hydroxypropoxy)phenyl]-symmetric-triazine}; at 3:5', 5:5' and 3:3' positions a methylene bridged dimer mixture bridged at a ratio of 5:4:1; 2,4,6-indole (2-hydroxy-4-isooctyloxycarbonylisopropylideneoxy-phenyl)- Symmetrical-triazine; 2,4-bis(2,4-dimethylphenyl)-6-(2-hydroxy-4-hexyloxy-5-α-isopropylphenylphenyl)-symmetric-three 2-(2,4,6-trimethylphenyl)-4,6-bis[2-hydroxy-4-(3-butoxy-2-hydroxypropoxy)phenyl]-symmetric- Triazine; 2,4,6-indole[2-hydroxy-4-(3-second-butoxy-2-hydroxypropoxy)-phenyl]-symmetric-triazine; 4,6-double- (2,4-Dimethylphenyl)-2-(2-hydroxy-4-(3-dodecyloxy-2-hydroxypropoxy)phenyl)-symmetric-triazine with 4,6- a mixture of bis-(2,4-dimethylphenyl)-2-(2-hydroxy-4-(3-tridecyloxy-2-hydroxypropoxy)phenyl)-symmetric-triazine ( Tinuvin® 400, from Ciba Specialty Chemicals company purchased; 4,6-bis-(2,4-dimethylphenyl)-2-(2-hydroxy-4(3-(2-ethylhexyloxy)-2-hydroxypropoxyl) ()phenyl)-symmetric-triazine; 4,6-diphenyl-2-(4-hexyloxy-2-hydroxyphenyl)-symmetric-triazine; and combinations thereof.

22.根據實施例16之安定劑組合物,其中該光安定劑係根據實施例17或實施例18之受阻胺光安定劑及根據實施例20或實施例21之紫外光吸收劑。 22. The stabilizer composition of embodiment 16 wherein the light stabilizer is a hindered amine light stabilizer according to embodiment 17 or embodiment 18 and an ultraviolet light absorber according to embodiment 20 or embodiment 21.

23.根據前述實施例中任一實施例之安定劑組合物,其進一步包含至少一種選自選自由以下組成之群之成員的化合物:式(VIII)之羥基胺化合物: 其中T1係選自選自由視情況經取代之C1-C36烴基、視情況經取代之C5-C12環烷基及視情況經取代之C7-C9芳烷基組成之群之成員;且T2係選自氫或T1;及式(IX)之三級胺氧化物化合物: 其中W1及W2中之每一者係獨立地選自C6-C36烴基,該C6-C36烴基選自選自由以下組成之群之成員:直鏈或具支鏈C6-C36烷基、C6-C12芳基、C7-C36芳烷基、C7-C36烷芳基、C5-C36環烷基、C6-C36烷基環烷基;及C6-C36環烷基烷基;W3係選自C1-C36烴基,該C1-C36烴基選自選自由以下組成之群之成員:直鏈或具支鏈C1-C36烷基、C6-C12芳基、C7-C36芳烷基、C7-C36烷芳基、C5-C36環烷基、C6-C36烷基環烷基;及C6-C36環烷基烷基;限制條件係W1、W2及W3中之至少一者含有β碳-氫鍵;且其中該等烷基、芳烷基、烷芳基、環烷基、烷基環烷基及環烷基烷基可雜有1個至16個選自選自由以下組成之群之成員的基團:-O-、-S-、-SO-、-SO2-、-COO-、-OCO-、-CO-、-NW4-、-CONW4-及-NW4CO-,或其中該等烷基、芳烷基、烷芳基、環烷基、烷基環烷基及環烷基烷基可經1個至16個選自選自由以下組成之群之成員的基團取代:-OW4、-SW4、-COOW4、-OCOW4、-COW4、-N(W4)2、-CON(W4)2、-NW4COW4及含有基團-C(CH3)(CH2Rx)NL(CH2Rx)(CH3)C-之5-及6-員環,或其中該等烷基、芳烷基、烷芳基、環烷基、烷基環烷基及環烷基烷基雜有上文所提及基團並經其取代;且其中W4係選自氫或C1-C8烷基; Rx係選自氫或甲基;且L係選自C1-C30烷基;-C(O)R部分或-OR部分,其中R係C1-C30直鏈或具支鏈烷基;且其中該等芳基可經選自由1個至3個鹵素基團、C1-C8烷基、C1-C8烷氧基及其組合組成之群之成員取代。 23. The stabilizer composition according to any of the preceding embodiments, further comprising at least one compound selected from the group consisting of: a hydroxylamine compound of formula (VIII): Wherein T 1 is selected from the group consisting of a C 1 -C 36 hydrocarbon group optionally substituted, a C 5 -C 12 cycloalkyl group optionally substituted, and optionally a C 7 -C 9 aralkyl group. a member; and T 2 is selected from hydrogen or T 1 ; and a tertiary amine oxide compound of formula (IX): Wherein each of W 1 and W 2 are independently selected in the C 6 -C 36 hydrocarbon, C 6 -C 36 hydrocarbon group which is selected from the group of optional members of the group consisting of: linear or branched C 6 -C 36 alkyl, C 6 -C 12 aryl, C 7 -C 36 aralkyl, C 7 -C 36 alkaryl, C 5 -C 36 cycloalkyl, C 6 -C 36 alkylcycloalkyl; and C 6 -C 36 cycloalkylalkyl; W 3 is selected from C 1 -C 36 hydrocarbyl C 1 -C 36 hydrocarbon selected from the group consisting of the group members managed consisting of: linear or branched C 1 - C 36 alkyl, C 6 -C 12 aryl, C 7 -C 36 aralkyl, C 7 -C 36 alkaryl, C 5 -C 36 cycloalkyl, C 6 -C 36 alkylcycloalkyl And a C 6 -C 36 cycloalkylalkyl group; the constraint is that at least one of W 1 , W 2 and W 3 contains a β carbon-hydrogen bond; and wherein the alkyl group, the aralkyl group, the alkaryl group And a cycloalkyl group, an alkylcycloalkyl group, and a cycloalkylalkyl group may have 1 to 16 groups selected from members selected from the group consisting of -O-, -S-, -SO-, - SO 2 -, - COO -, - OCO -, - CO -, - NW 4 -, - CONW 4 - and -NW 4 CO-, or wherein such alkyl, aralkyl, alkaryl, cycloalkyl, , alkylcycloalkyl and cycloalkylalkyl groups can be passed through 1 to 16 are substituted with a group selected from members selected from the group consisting of -OW 4 , -SW 4 , -COOW 4 , -OCOW 4 , -COW 4 , -N(W 4 ) 2 , -CON(W 4 ) 2 , -NW 4 COW 4 and a 5- and 6-membered ring containing a group -C(CH 3 )(CH 2 R x )NL(CH 2 R x )(CH 3 )C-, or wherein the alkane a aryl group, an arylalkyl group, an alkylaryl group, a cycloalkyl group, an alkylcycloalkyl group, and a cycloalkylalkyl group having the above-mentioned groups and substituted therewith; and wherein the W 4 group is selected from hydrogen or C 1 -C 8 alkyl; R x is selected from hydrogen or methyl; and L is selected from C 1 -C 30 alkyl; -C(O)R moiety or -OR moiety, wherein R is C 1 -C 30 straight a chain or a branched alkyl group; and wherein the aryl group may be selected from the group consisting of 1 to 3 halogen groups, C 1 -C 8 alkyl groups, C 1 -C 8 alkoxy groups, and combinations thereof Member replaced.

24.根據實施例23之安定劑組合物,其中式(VIII)化合物係N,N-二烴基羥基胺,其中T1及T2中之每一者係獨立地選自選自由以下組成之群之成員:苄基、乙基、辛基、月桂基、十二烷基、十四烷基、十六烷基、十七烷基及十八烷基;或其中T1及T2中之每一者係氫化牛脂胺中所發現之烷基混合物。 24. The stabilizer composition of Example 23, compound is N, N- dihydrocarbyl hydroxyl amine of formula (VIII), wherein T 1 and 2 T of each of the lines managed independently selected from the group consisting of Member: benzyl, ethyl, octyl, lauryl, dodecyl, tetradecyl, hexadecyl, heptadecyl and octadecyl; or wherein each of T 1 and T 2 The alkyl mixture found in hydrogenated tallow amine.

25.根據實施例23或實施例24之安定劑組合物,其中式(VIII)化合物係選自選自由以下組成之群之成員的N,N-二烴基羥基胺:N,N-二苄基羥基胺;N,N-二乙基羥基胺;N,N-二辛基羥基胺;N,N-二月桂基羥基胺;N,N-二-十二烷基羥基胺;N,N-二-十四烷基羥基胺;N,N-二-十六烷基羥基胺;N,N-二-十八烷基羥基胺;N-十六烷基-N-十四烷基羥基胺;N-十六烷基-N-十七烷基羥基胺;N-十六烷基-N-十八烷基羥基胺;N-十七烷基-N-十八烷基羥基胺;及N,N-二(氫化牛脂)羥基胺。 25. The stabilizer composition of embodiment 23 or embodiment 24, wherein the compound of formula (VIII) is selected from the group consisting of N,N-dihydrocarbylhydroxylamines selected from the group consisting of N,N-dibenzylhydroxyl Amine; N,N-diethylhydroxylamine; N,N-dioctylhydroxylamine; N,N-dilauroylhydroxylamine; N,N-di-dodecylhydroxylamine; N,N-di -tetradecylhydroxylamine; N,N-di-hexadecylhydroxylamine; N,N-di-octadecylhydroxylamine; N-hexadecyl-N-tetradecylhydroxylamine; N-hexadecyl-N-heptadecylhydroxylamine; N-hexadecyl-N-octadecylhydroxylamine; N-heptadecyl-N-octadecylhydroxylamine; , N-di (hydrogenated tallow) hydroxylamine.

26.根據前述實施例中任一實施例之安定劑組合物,其進一步包含至少一種選自選自由以下組成之群之成員的化合物:共添加劑;生育酚化合物;成核劑;填充劑;強化劑;聚合物添加劑;及其組合。 The stabilizer composition according to any of the preceding embodiments, further comprising at least one compound selected from the group consisting of: a co-additive; a tocopherol compound; a nucleating agent; a filler; a fortifier ; polymer additives; and combinations thereof.

27.根據實施例26之安定劑組合物,其中該生育酚化合物係選自選自由以下組成之群之成員:α-生育酚、β-生育酚、γ-生育酚、δ-生育酚、其異構體、相關生育三烯酚及其混合物。 27. The stabilizer composition of embodiment 26, wherein the tocopherol compound is selected from the group consisting of: alpha-tocopherol, beta-tocopherol, gamma-tocopherol, delta-tocopherol, Constructs, related tocotrienols, and mixtures thereof.

28.一種母料組合物,其包含如在實施例1至27中任一實施例中所定義之安定劑組合物及與欲安定有機材料相同或相容之有機材料。 28. A masterbatch composition comprising a stabilizer composition as defined in any of embodiments 1 to 27 and an organic material which is the same or compatible with the organic material to be stabilized.

29.一種用於使由於光、氧或熱之效應而經受降解及/或變色之有機材料安定之製程,該製程包含:添加安定量之如實施例1至27中任一實施例中所定義之安定劑組合物或如實施例28中所定義之母料組合物。 29. A process for the stabilization of an organic material which undergoes degradation and/or discoloration due to the effects of light, oxygen or heat, the process comprising: adding an amount of an amount as defined in any of embodiments 1 to 27. The stabilizer composition or the masterbatch composition as defined in Example 28.

30.一種用於加強有機材料之處理穩定性之製程,該製程包含在處理之前或期間添加安定量之如實施例1至27中任一實施例中所定義之安定劑組合物或如實施例28中所定義之母料組合物。 30. A process for enhancing the processing stability of an organic material, the process comprising adding an amount of a stabilizer composition as defined in any one of embodiments 1 to 27 before or during the treatment or as in the embodiment Masterbatch composition as defined in 28.

30.一種用於減少或防止有機材料變色之製程,該製程包含在處理之前或期間添加安定量之如實施例1至27中任一實施例中所定義之安定劑組合物或如實施例28中所定義之母料組合物。 30. A process for reducing or preventing discoloration of an organic material, the process comprising adding an amount of a stabilizer composition as defined in any of embodiments 1 to 27 prior to or during processing or as in Example 28 A masterbatch composition as defined in the above.

31.一種用於產生模製物件之製程,該製程包含將聚合有機材料及聚合物安定量之如實施例1至27中任一實施例中所定義之安定劑組合物或如實施例28中所定義之母料組合物添加至用於實施工業模製之器件或製程中;及藉助該工業模製製程使該經安定聚合有機材料循環。 31. A process for producing a molded article, the process comprising quantifying a polymeric composition and a polymer as defined in any of embodiments 1 through 27, or as in Example 28 The defined masterbatch composition is added to a device or process for performing industrial molding; and the stabilized polymeric organic material is recycled by the industrial molding process.

32.根據實施例31之製程,其中該工業模製製程或器件係選自射出模製、旋轉模製、吹塑模製、捲對捲模製、金屬射出模製、壓縮模製、轉移模製、浸漬模製、氣體輔助模製、嵌入射出模製、微模製、反應射出模製及雙料射出模製。 32. The process of embodiment 31, wherein the industrial molding process or device is selected from the group consisting of injection molding, rotational molding, blow molding, roll-to-roll molding, metal injection molding, compression molding, transfer molding. Preparation, impregnation molding, gas-assisted molding, embedded injection molding, micro-molding, reactive injection molding, and two-shot molding.

33.根據實施例29至32中任一實施例之製程,其中該安定劑組合物係以該欲安定有機材料之總重量之0.001重量%至65.0重量%存在。 The process according to any one of embodiments 29 to 32, wherein the stabilizer composition is present in an amount of from 0.001% to 65.0% by weight based on the total weight of the organic material to be stabilized.

34.根據實施例33之製程,其中該安定劑組合物係以該欲安定有機材料之總重量之0.01重量%至25重量%存在。 34. The process of embodiment 33, wherein the stabilizer composition is present in an amount from 0.01% to 25% by weight based on the total weight of the organic material to be stabilized.

35.根據實施例34之製程,其中該安定劑組合物係以該欲安定有機材料之總重量之0.01重量%至10重量%存在。 35. The process of embodiment 34 wherein the stabilizer composition is present in an amount from 0.01% to 10% by weight based on the total weight of the organic material to be stabilized.

36.根據實施例29至35中任一實施例之製程,其中該欲安定有機材料係選自選自由以下組成之群之成員:聚烯烴、聚酯、聚醚、聚酮、聚醯胺、天然及合成橡膠、聚胺基甲酸酯、聚苯乙烯、高耐衝擊聚苯乙烯、聚丙烯酸酯、聚甲基丙烯酸酯、聚縮醛、聚丙烯腈、聚丁二烯、聚苯乙烯、丙烯腈-丁二烯-苯乙烯、苯乙烯丙烯腈、丙烯酸酯苯乙烯丙烯腈、乙酸丁酸纖維素、纖維素聚合物、聚醯亞胺、聚醯胺醯亞胺、聚醚醯亞胺、聚苯硫醚、聚二氧苯聚碸、聚醚碸、聚氯乙烯、聚碳酸酯、聚酮、脂肪族聚酮、熱塑性烯烴、胺基樹脂交聯之聚丙烯酸酯及聚酯、聚異氰 酸酯交聯之聚酯及聚丙烯酸酯、酚/甲醛、脲/甲醛及三聚氰胺/甲醛樹脂、乾性及非乾性醇酸樹脂、醇酸樹脂、聚酯樹脂、與三聚氰胺樹脂交聯之丙烯酸酯樹脂、脲樹脂、異氰酸酯、異氰尿酸酯、胺基甲酸酯、環氧樹脂、衍生自脂肪族、環脂肪族、雜環及芳香族縮水甘油基化合物之與酸酐或胺交聯之交聯環氧樹脂、聚矽氧烷、邁克爾加成聚合物、胺、具有活化不飽和亞甲基化合物之封端之胺、具有活化不飽和亞甲基化合物之酮亞胺、與不飽和丙烯酸聚乙醯乙酸酯樹脂組合之聚酮亞胺、與不飽和丙烯酸樹脂組合之聚酮亞胺、輻射可固化組合物、環氧三聚氰胺樹脂、有機染料、化妝品、基於纖維素之紙調配物、照相膠片紙、纖維、蠟及油墨。 36. The process of any one of embodiments 29 to 35, wherein the material to be stabilized is selected from the group consisting of: polyolefins, polyesters, polyethers, polyketones, polyamines, natural And synthetic rubber, polyurethane, polystyrene, high impact polystyrene, polyacrylate, polymethacrylate, polyacetal, polyacrylonitrile, polybutadiene, polystyrene, propylene Nitrile-butadiene-styrene, styrene acrylonitrile, acrylate styrene acrylonitrile, cellulose acetate butyrate, cellulose polymer, polyimine, polyamidimide, polyetherimide, Polyphenylene sulfide, polydioxybenzene polyfluorene, polyether oxime, polyvinyl chloride, polycarbonate, polyketone, aliphatic polyketone, thermoplastic olefin, amine resin crosslinked polyacrylate and polyester, polyiso Cyanide Acid-crosslinked polyester and polyacrylate, phenol/formaldehyde, urea/formaldehyde and melamine/formaldehyde resin, dry and non-dry alkyd resin, alkyd resin, polyester resin, acrylate resin crosslinked with melamine resin , urea resin, isocyanate, isocyanurate, urethane, epoxy resin, cross-linking with anhydride or amine derived from aliphatic, cycloaliphatic, heterocyclic and aromatic glycidyl compounds Epoxy resin, polyoxyalkylene oxide, Michael addition polymer, amine, blocked amine with activated unsaturated methylene compound, ketimine with activated unsaturated methylene compound, and unsaturated acrylic polyethylene Polyketimine in combination with acetal acetate resin, polyketimine in combination with unsaturated acrylic resin, radiation curable composition, epoxy melamine resin, organic dye, cosmetic, cellulose-based paper preparation, photographic film Paper, fiber, wax and ink.

37.根據實施例36之製程,其中該欲安定有機材料係選自選自由以下組成之群之成員的聚烯烴聚合物:i)單烯烴之聚合物,其選自聚丙烯、聚異丁烯、聚丁-1-烯及聚-4-甲基戊-1-烯;ii)二烯烴之聚合物,其選自聚異戊二烯或聚丁二烯;iii)環烯烴之聚合物,其選自環戊烯及降冰片烯;iv)聚乙烯,其選自視情況交聯之聚乙烯、高密度聚乙烯(HDPE)、高密度及高分子量聚乙烯(HDPE-HMW)、高密度及超高分子量聚乙烯(HDPE-UHMW)、中等密度聚乙烯(MDPE)、低密度聚乙烯(LDPE)、直鏈低密度聚乙烯(LLDPE)、極低密度聚乙烯(VLDPE)及超低密度聚乙烯(ULDPE);v)其共聚物;及vi)其混合物。 37. The process of embodiment 36, wherein the desirabilizing organic material is selected from the group consisting of polyolefin polymers selected from the group consisting of i) a monoolefin polymer selected from the group consisting of polypropylene, polyisobutylene, and polybutylene. a 1-olefin and a poly-4-methylpent-1-ene; ii) a polymer of a diene selected from the group consisting of polyisoprene or polybutadiene; iii) a polymer of a cyclic olefin selected from the group consisting of Cyclopentene and norbornene; iv) polyethylene selected from the group consisting of cross-linked polyethylene, high density polyethylene (HDPE), high density and high molecular weight polyethylene (HDPE-HMW), high density and ultra high Molecular weight polyethylene (HDPE-UHMW), medium density polyethylene (MDPE), low density polyethylene (LDPE), linear low density polyethylene (LLDPE), very low density polyethylene (VLDPE) and ultra low density polyethylene ( ULDPE); v) its copolymer; and vi) a mixture thereof.

38.一種用於使有機材料安定之套組,其在一或多個 容器中包含安定量之如實施例1至27中任一實施例中所定義之安定劑組合物。 38. A kit for stabilizing an organic material, one or more The container contains an amount of a stabilizer composition as defined in any of embodiments 1 to 27.

39.根據實施例38之套組,其進一步在同一或另一容器中包含共添加劑。 39. The kit of embodiment 38, further comprising a co-additive in the same or another container.

40.一種模製物件:a)包含如實施例1至27中任一實施例中所定義之安定劑組合物或如實施例28中所定義之母料組合物;或b)藉由根據實施例31至37中任一實施例之製程產生。 40. A molded article: a) a stabilizer composition as defined in any of embodiments 1 to 27 or a masterbatch composition as defined in Example 28; or b) by implementation The process of any of Examples 31 to 37 was produced.

實例Instance

提供以下實例來幫助熟習此項技術者進一步理解本發明之某些實施例。該等實例意欲用於闡釋目的且不應理解為限制本發明之各種實施例之範圍。 The following examples are provided to assist those skilled in the art to further understand certain embodiments of the invention. The examples are intended to be illustrative and not to limit the scope of the various embodiments of the invention.

作為流動性標度,熔融指數(下文中亦稱為MI)在工業上主要係用於預期有機聚合物材料之可處理性或用於指示標準及品質控制。當藉由施加某一負荷自具有標準長度及直徑之圓形模具擠出在給定溫度下熔融之高分子量聚合物時,MI顯示10 min內之重量流率(單位:g),且用作熔融黏度指數。在高分子量聚合物中,具有較低MI值之聚丙烯在處理期間具有較好穩定性,且具有較大MI值之聚丙烯在處理期間具有較差穩定性。在重複量測MI後各值顯示較小變化之聚合物視為具有較大MI保持效應且在處理期間之穩定性方面具有優越性。 As a fluidity scale, the melt index (hereinafter also referred to as MI) is mainly used industrially for the treatability of an intended organic polymer material or for indicating standard and quality control. When a high molecular weight polymer melted at a given temperature is extruded from a circular die of standard length and diameter by applying a load, MI shows the weight flow rate (unit: g) within 10 min and is used as Melt viscosity index. Among the high molecular weight polymers, polypropylene having a lower MI value has better stability during processing, and polypropylene having a larger MI value has poor stability during processing. Polymers whose values show a small change after repeated measurement of MI are considered to have a large MI retention effect and are superior in stability during processing.

當將添加劑捏合至有機聚合物材料中(例如藉由多道次擠出)時,黃化指數(下文中亦稱為YI)亦廣泛地用作用於評 價聚合物材料變色之標度。藉由比色計來量測黃化指數(YI),其中較大值意指在處理期間變色或顯色較大,且較小值意指在處理期間著色較少且因此具有優越性。 When the additive is kneaded into an organic polymer material (for example, by multiple passes), the yellowing index (hereinafter also referred to as YI) is also widely used for evaluation. The scale of discoloration of valence polymer materials. The yellowing index (YI) is measured by a colorimeter, where a larger value means discoloration or color development during processing, and a smaller value means less coloration during processing and thus superiority.

現藉由結合圖式閱讀以下實例來揭示本發明之安定劑組合物及製程提供之優越優勢及意外性質。 The advantages and unexpected properties of the stabilizer compositions and processes provided by the present invention are now disclosed by reading the following examples in conjunction with the drawings.

實例1Example 1

藉由多道次擠出來測試經本發明安定劑組合物安定之有機聚合物組合物之流變性質。 The rheological properties of the stabilized organic polymer composition of the stabilizer composition of the present invention were tested by multiple passes.

圖1A:將呈與硬脂酸鋅(0.05%)一起之維生素E乙酸酯(0.15%)形式之本發明安定劑組合物與Profax 6301聚丙烯均聚物(自LyondellBasell Industries購得)乾摻和(B),並與不含任一安定劑添加劑組合物之聚丙烯(A)相比。將Killion單螺桿擠出機設定為60目網篩、280℃熔融溫度及100 RPM之螺桿速度。將摻合物擠出5次(擠出並再重新擠出4次)。在每一道次之後收集樣品並測定熔融指數。收集每一道次之樣品,並根據ASTM D1238-10在Dynisco熔融指數測定儀上測試熔融流動指數。 Figure 1A: The stabilizer composition of the present invention in the form of vitamin E acetate (0.15%) together with zinc stearate (0.05%) is dry blended with Profax 6301 polypropylene homopolymer (available from LyondellBasell Industries). And (B), and compared to polypropylene (A) which does not contain any stabilizer additive composition. The Killion single screw extruder was set to a 60 mesh screen, a 280 ° C melting temperature and a screw speed of 100 RPM. The blend was extruded 5 times (extrusion and re-extruding 4 times). Samples were collected after each pass and the melt index was determined. Samples of each pass were collected and tested for melt flow index on a Dynisco melt indexer according to ASTM D1238-10.

如相應圖1A所指示,結果顯示不含有安定劑組合物(A)之聚丙烯樣品可僅處理兩次,而將與0.15%維生素E乙酸酯摻和之聚丙烯材料擠出4次。 As indicated by corresponding Fig. 1A, the results show that the polypropylene sample containing no stabilizer composition (A) can be treated only twice, while the polypropylene material blended with 0.15% vitamin E acetate is extruded 4 times.

圖1B:如上文所述製備聚丙烯樣品並多道次擠出。(A):無安定添加劑;(B):0.15%維生素E乙酸酯;(C):0.15%維生素E;(D):0.075%維生素E及0.075%維生素E乙酸酯。亦將所有含有安定添加劑之樣品與0.05%硬脂酸鋅 摻和。如圖1B所指示,樣品D顯示之性能好於基於比較樣品A、B或C之預期性能。 Figure IB: A polypropylene sample was prepared as described above and extruded in multiple passes. (A): no stabilizer additive; (B): 0.15% vitamin E acetate; (C): 0.15% vitamin E; (D): 0.075% vitamin E and 0.075% vitamin E acetate. Also sample all with stability additives and 0.05% zinc stearate Blending. As indicated in Figure 1B, Sample D showed better performance than expected based on Comparative Samples A, B or C.

實例2Example 2

量測有機材料之機械性質(如藉由斷裂伸長率%所測定)以檢查有機材料如何受處理影響。如實例1乾摻和並複合兩種調配物,其不含安定劑添加劑(B)或具有0.15%之維生素E乙酸酯以及0.05%硬脂酸鋅(C)。將經複合材料擠出且然後收集且壓縮模製成1/16"厚薄片。亦將未經處理聚丙烯之樣品(A)壓縮模製成1/16"薄片。使用衝壓機將拉伸樣品切割成類型5(ASTM D638)之狗骨形試樣。在MTS拉伸測試機上以2"/min十字頭速度測試樣品。所有分析均使用五個樣品之中位數值。使用未經處理聚丙烯作為基線對照,計算含及不含本發明安定劑組合物之聚丙烯樣品之伸長保持%。 The mechanical properties of the organic material (as determined by % elongation at break) were measured to check how the organic material was affected by the treatment. As in Example 1, dry blending and combining the two formulations contained no stabilizer additive (B) or 0.15% vitamin E acetate and 0.05% zinc stearate (C). The composite was extruded and then collected and compression molded into 1/16" thick flakes. Sample (A) of untreated polypropylene was also compression molded into 1/16" flakes. The tensile sample was cut into a dog bone sample of type 5 (ASTM D638) using a punch. Samples were tested on a MTS tensile tester at a crosshead speed of 2"/min. All analyses used a median of five samples. Using untreated polypropylene as a baseline control, the combination with and without the stabilizer of the present invention was calculated. The elongation of the polypropylene sample of the material was kept at %.

如相應圖2所指示,與未經處理聚丙烯樹脂(A)相比,樣品(C)相比於樣品(B)顯示伸長保持顯著改良。 As indicated in the corresponding Fig. 2, the sample (C) showed a significant improvement in elongation compared to the sample (B) as compared with the untreated polypropylene resin (A).

實例3Example 3

量測含或不含安定劑組合物之有機聚合物組合物之黃化指數用於評價變色。藉由將先前技術之安定添加劑或彼等根據本發明者以相等濃度與低密度聚乙烯乾摻和來製備樣品。使用設定為60目網篩、250℃熔融溫度及100 RPM之螺桿速度之Killion單螺桿擠出機實施複合。再將樣品重新擠出4次(總共5次)。收集每一道次之經複合材料之樣品。使用Greta Macbeth Color i7分光光度計來測定黃化指數 (ASTM E313)。(A):無安定添加劑;(B):0.1% IRGANOX® 1010酚系抗氧化劑(自BASF購得);(C):0.1% CYANOX® 1790酚系抗氧化劑(自Cytec Industries有限公司購得);(D):0.1%維生素E乙酸酯。所有含有安定添加劑之樣品亦含有0.05%硬脂酸鋅。 The yellowing index of the organic polymer composition with or without the stabilizer composition was measured for evaluation of discoloration. Samples were prepared by dry blending prior art stabilizers or they were dry blended with low density polyethylene at equal concentrations according to the inventors. The compounding was carried out using a Killion single screw extruder set to a 60 mesh screen, a 250 ° C melting temperature and a screw speed of 100 RPM. The sample was re-extruded 4 times (5 times in total). Samples of the composite material for each pass were collected. Determination of yellowing index using the Greta Macbeth Color i7 spectrophotometer (ASTM E313). (A): no stabilizer additive; (B): 0.1% IRGANOX® 1010 phenolic antioxidant (available from BASF); (C): 0.1% CYANOX® 1790 phenolic antioxidant (available from Cytec Industries, Inc.) (D): 0.1% vitamin E acetate. All samples containing stabilizers also contained 0.05% zinc stearate.

如相應圖3所指示,黃化指數顯示樣品(B)及(C)比(D)更黃(即賦予聚乙烯顏色更多),且樣品(B)及(C)之數據在第3道次及第5道次顯著升高。對照樣品(A)(無安定添加劑)之黃化指數保持較低,此乃因沒有賦予顏色之安定添加劑。熟習此項技術者可進一步瞭解並預期僅經維生素E安定之聚乙烯樣品之黃化指數將甚至大於樣品(B)及(C),此乃因業內已知維生素E使聚合物基質嚴重變色且諸如IRGANOX® 1010及CYANOX® 1790等酚系抗氧化劑減少使用維生素E作為安定添加劑所導致之不期望變色。 As indicated in Figure 3, the yellowing index shows that samples (B) and (C) are more yellow than (D) (ie give more color to polyethylene), and the data for samples (B) and (C) are in lane 3. The number of times and the fifth pass increased significantly. The yellowing index of the control sample (A) (no stability additive) remained low because there was no stability additive to the color. Those skilled in the art will further understand and expect that the yellowing index of polyethylene samples stabilized only with vitamin E will be even greater than that of samples (B) and (C), as vitamin E is known to severely discolor the polymer matrix in the industry. Phenolic antioxidants such as IRGANOX® 1010 and CYANOX® 1790 reduce undesirable discoloration caused by the use of vitamin E as a stability additive.

因此,本發明之安定劑組合物及製程提供意外且優於當前已知且使用之彼等安定劑系統之優勢。該等實驗合起來顯示經本發明安定劑系統安定之有機材料具有經改良機械及流變性質,且本發明之安定劑組合物不會賦予添加其之材料不利的顏色特性。 Thus, the stabilizer compositions and processes of the present invention provide the advantages of accidental and superior to their stabilizer systems currently known and used. Together, these experiments show that the organic materials stabilized by the stabilizer system of the present invention have improved mechanical and rheological properties, and that the stabilizer compositions of the present invention do not impart adverse color characteristics to the materials to which they are added.

本申請案通篇已提及各種專利及/或科學參考文獻。該等公開案之揭示內容以引用的方式全文併入本文中,猶如寫入本文中一樣。鑒於上文說明及實例,熟習此項技術者將能夠不進行過多實驗即實踐本揭示內容。 Various patents and/or scientific references have been mentioned throughout the application. The disclosures of these publications are hereby incorporated by reference in their entirety as if they are incorporated herein. In view of the above description and examples, those skilled in the art will be able to practice the present disclosure without undue experimentation.

儘管前述說明已顯示、闡述並指出本發明教示之基本新 穎特徵,但應瞭解,熟習此項技術者可對所闡釋設備以及其用途以詳細形式進行各種省略、取代及改變,此並不背離本發明教示之範圍。因此,本發明教示之範圍不應限於前述論述,但應由隨附申請專利範圍界定。 Although the foregoing description has shown, illustrated, and pointed out that the teachings of the present invention are fundamentally new It is to be understood that those skilled in the art can make various omissions, substitutions and changes in the details of the present invention. Therefore, the scope of the present teachings should not be limited to the foregoing description, but should be defined by the scope of the accompanying claims.

圖1A-B圖解說明與或不與各種安定劑組合物(包括本發明之彼等)一起調配且經多道次擠出之聚丙烯樹脂之熔融指數結果。圖1A-(A):不含安定劑添加劑且經多道次擠出之聚丙烯樹脂;(B):含0.15%之本發明安定劑組合物(維生素E乙酸酯)且經多道次擠出之聚丙烯樹脂。圖1B-(A):不含安定添加劑且多道次擠出之聚丙烯樹脂;(B):含0.15%之維生素E乙酸酯且多道次擠出之聚丙烯樹脂;(C):含0.15%之維生素E且多道次擠出之聚丙烯樹脂;(D):含0.075%之維生素E及維生素E乙酸酯中之每一者且多道次擠出之聚丙烯樹脂。上文實例1提供關於實驗細節及結果之其他資訊。 1A-B illustrate melt index results for polypropylene resins formulated with or without multiple passivator compositions (including those of the present invention) and extruded in multiple passes. Figure 1A-(A): Polypropylene resin without a stabilizer additive and multi-pass extrusion; (B): 0.15% of the stabilizer composition of the present invention (vitamin E acetate) and multi-passage Extruded polypropylene resin. Figure 1B-(A): Polypropylene resin without stable additives and multi-pass extrusion; (B): Polypropylene resin containing 0.15% of vitamin E acetate and multi-pass extrusion; (C): Polypropylene resin containing 0.15% of vitamin E and multi-pass extrusion; (D): Polypropylene resin containing 0.075% of each of vitamin E and vitamin E acetate and multi-pass extrusion. Example 1 above provides additional information about the experimental details and results.

圖2圖解說明對與(C)或不與(B)本發明安定劑組合物一起調配且一次擠出之聚丙烯樹脂之機械性質(如藉由斷裂應變保持%/斷裂伸長率%來測定)之量測,如與未經處理(即未經擠出)之聚丙烯(A)相比。在上文實例2中提供其他實驗細節。 Figure 2 illustrates the mechanical properties of a polypropylene resin formulated with and without (B) the stabilizer composition of the present invention and extruded once (e.g., by % strain at break/% elongation at break) The measurement is as compared to the untreated (ie, unextruded) polypropylene (A). Additional experimental details are provided in Example 2 above.

圖3圖解說明與或不與各種安定劑組合物(包括本發明之彼等)一起調配且經多道次擠出之低密度聚乙烯樹脂之黃化指數。(A):不含安定添加劑且多道次擠出之聚乙烯樹 脂;(B):含IRGANOX® 1010(酚系抗氧化劑)且多道次擠出之聚乙烯樹脂;(C):含CYANOX® 1790(酚系抗氧化劑)且多道次擠出之聚乙烯樹脂;(D):含根據本發明之組合物及方法之維生素E乙酸酯且多道次擠出之聚乙烯樹脂。在上文實例3中提供其他實驗細節。 Figure 3 illustrates the yellowing index of a low density polyethylene resin formulated with or without various stabilizer compositions (including those of the present invention) and extruded in multiple passes. (A): Polyethylene resin without stable additives and multi-pass extrusion; (B): Polyethylene resin containing IRGANOX® 1010 (phenolic antioxidant) and multi-pass extrusion; (C): CYANOX ® 1790 (phenolic antioxidant) and multi-pass extruded polyethylene resin; (D): Polyethylene resin containing vitamin E acetate and multi-pass extrusion according to the composition and method of the present invention. Additional experimental details are provided in Example 3 above.

Claims (35)

一種安定劑組合物,其包含安定量之基於唍之式(V)化合物: 其中R21係選自COR28或Si(R29)3,其中R28係選自H或C1-C20烴基;且R29係選自C1-C12烴基或烷氧基;R22係在式V之芳香族部分之n=0個至3個位置處可相同或不同之取代基,且係獨立地選自H或C1-C12烴基;R23係選自H或C1-C12烴基;R24係選自H或C1-C20烴基;且R25至R27中之每一者係獨立地選自選自由H;C1-C12烴基;及OR30組成之群之成員,其中R30係選自H或C1-C12烴基;且R27係H或與R26一起形成=O之鍵。 a stabilizer composition based on an ampoule Compound of formula (V): Wherein R 21 is selected from the group consisting of COR 28 or Si(R 29 ) 3 , wherein R 28 is selected from H or C 1 -C 20 hydrocarbyl; and R 29 is selected from C 1 -C 12 hydrocarbyl or alkoxy; R 22 a substituent which may be the same or different at n=0 to 3 positions of the aromatic moiety of formula V, and is independently selected from H or a C 1 -C 12 hydrocarbon group; and R 23 is selected from H or C 1 a -C 12 hydrocarbyl group; R 24 is selected from H or a C 1 -C 20 hydrocarbyl group; and each of R 25 to R 27 is independently selected from the group consisting of H; C 1 -C 12 hydrocarbyl; and OR 30 A member of the group wherein R 30 is selected from H or a C 1 -C 12 hydrocarbyl group; and R 27 is H or together with R 26 forms a bond of =0. 如請求項1之安定劑組合物,其進一步包含至少一種選自有機亞磷酸酯或膦酸酯之群之化合物。 The stabilizer composition of claim 1 further comprising at least one compound selected from the group consisting of organophosphites or phosphonates. 如請求項2之安定劑組合物,其中該至少一種有機亞磷酸酯或膦酸酯係選自式1至7之化合物: 其中下標為整數且n係2、3或4;p係1或2;q係2或3;r係4至12;y係1、2 或3;且z係1至6;若n係2,則A1係C2-C18伸烷基;雜有氧、硫或-NR4-之C2-C12伸烷基;下式之基團 或伸苯基;若n係3,則A1係式-CrH2r-1-之基團;若n係4,則A1 若n係2,則A2係如針對A1所定義;B係直接鍵、-CH2-、-CHR4-、-CR1R4-、硫、C5-C7亞環烷基或在3、4及/或5位處經1至4個C1-C4烷基取代之亞環己基;若p係1,則D1係C1-C4烷基,且若p係2,則D1係-CH2OCH2-;若p係1,則D2係C1-C4烷基;若y係1,則E係C1-C18烷基、-OR1或鹵素;若y係2,則E係-O-A2-O-, 若y係3,則E係式R4C(CH2O-)3或N(CH2CH2O-)3之基團;Q係至少z價醇或酚之基團,此基團經由氧原子附接至磷原子;R1、R2及R3彼此獨立地係未經取代或經鹵素、-COOR4、-CN或-CONR4R4取代之C1-C18烷基;雜有氧、硫或-NR4-之C2-C18烷基;C7-C9苯基烷基;C5-C12環烷基、苯基或萘基;經鹵素、1個至3個具有總共1個至18個碳原子之烷基或烷氧基或經C7-C9苯基烷基取代之萘基或苯基;或下式之基團 其中m係在3至6之範圍內之整數;R4係氫、C1-C8烷基、C5-C12環烷基或C7-C9苯基烷基,R5及R6彼此獨立地係氫、C1-C8烷基或C5-C6環烷基,若q係2,則R7及R8彼此獨立地係C1-C4烷基或一起為2,3-去氫五亞甲基;且若q係3,則R7及R8係甲基;R14係氫、C1-C9烷基或環己基,R15係氫或甲基,且若存在兩個或更多個基團R14及R15,則該等基團相同或不同, X及Y各自係直接鍵或氧,Z係直接鍵、亞甲基、-C(R16)2-或硫,且R16係C1-C8烷基;式8之亞磷酸叁芳基酯: 其中R17係在式8之芳香族部分之0個至5個位置處相同或不同之取代基,且係獨立地選自選自由C1-C20烷基、C3-C20環烷基、C4-C20烷基環烷基、C6-C10芳基及C7-C20烷基芳基組成之群之成員;及其組合。 The stabilizer composition of claim 2, wherein the at least one organophosphite or phosphonate is selected from the group consisting of compounds of formulas 1 to 7: Wherein the subscript is an integer and n is 2, 3 or 4; p is 1 or 2; q is 2 or 3; r is 4 to 12; y is 1, 2 or 3; and z is 1 to 6; 2, then A 1 is a C 2 -C 18 alkylene group; a heteroatomous aerobic, sulfur or -NR 4 -C 2 -C 12 alkyl group; a group of the formula Or phenyl; if n is 3, the A 1 is a group of -C r H 2r-1 -; if n is 4, the A 1 is If n is 2, A 2 is as defined for A 1 ; B is a direct bond, -CH 2 -, -CHR 4 -, -CR 1 R 4 -, sulfur, C 5 -C 7 cycloalkylene or a cyclohexylene group substituted with 1 to 4 C 1 -C 4 alkyl groups at the 3, 4 and/or 5 positions; if the p system is 1, the D 1 is a C 1 -C 4 alkyl group, and if the p system is 2 , D 1 is -CH 2 OCH 2 -; if p is 1, D 2 is C 1 -C 4 alkyl; if y is 1, E is C 1 -C 18 alkyl, -OR 1 or halogen If y is 2, then E is -OA 2 -O-, and if y is 3, then E is a group of formula R 4 C(CH 2 O-) 3 or N(CH 2 CH 2 O-) 3 ; Q is a group of at least a z-valent alcohol or phenol which is attached to the phosphorus atom via an oxygen atom; R 1 , R 2 and R 3 are independently unsubstituted or halogen, -COOR 4 , -CN or -CONR 4 R 4 substituted C 1 -C 18 alkyl; hetero aerobic, sulfur or -NR 4 -C 2 -C 18 alkyl; C 7 -C 9 phenylalkyl; C 5 -C 12 ring An alkyl group, a phenyl group or a naphthyl group; a naphthyl group or a benzene group substituted by halogen, one to three alkyl groups or alkoxy groups having a total of from 1 to 18 carbon atoms or substituted with a C 7 -C 9 phenylalkyl group; a group; or a group of the formula Wherein m is an integer in the range of from 3 to 6; R 4 is hydrogen, C 1 -C 8 alkyl, C 5 -C 12 cycloalkyl or C 7 -C 9 phenylalkyl, R 5 and R 6 Independently from each other, hydrogen, C 1 -C 8 alkyl or C 5 -C 6 cycloalkyl, if q is 2, then R 7 and R 8 are independently C 1 -C 4 alkyl or 2 together. 3-dehydropentamethylene; and if q is 3, then R 7 and R 8 are methyl; R 14 is hydrogen, C 1 -C 9 alkyl or cyclohexyl, R 15 is hydrogen or methyl, and If two or more groups R 14 and R 15 are present , the groups are the same or different, X and Y are each a direct bond or oxygen, Z is a direct bond, a methylene group, -C(R 16 ) 2- or sulphur, and R 16 is C 1 -C 8 alkyl; arylene phosphite of formula 8: Wherein R 17 is the same or different substituent at 0 to 5 positions of the aromatic moiety of formula 8, and is independently selected from the group consisting of C 1 -C 20 alkyl, C 3 -C 20 cycloalkyl, a member of the group consisting of C 4 -C 20 alkylcycloalkyl, C 6 -C 10 aryl and C 7 -C 20 alkylaryl; and combinations thereof. 如請求項3之安定劑組合物,其中該有機亞磷酸酯或膦酸酯係選自:亞磷酸三苯酯;亞磷酸二苯基烷基酯;亞磷酸苯基二烷基酯;亞磷酸三月桂基酯;亞磷酸三-十八烷基酯;二硬脂醯基新戊四醇亞磷酸酯;亞磷酸叁(2,4-二-第三-丁基苯基)酯;亞磷酸叁(壬基苯基)酯;式(A)、(B)、(C)、(D)、(E)、(F)、(G)、(H)、(J)、(K)及(L)之化合物: 2-丁基-2-乙基-1,3-丙二醇2,4,6-三-第三-丁基苯酚亞磷酸酯、雙-(2,6-二-第三-丁基-4-甲基苯基)新戊四醇二亞磷酸酯、2-丁基-2-乙基-1,3-丙二醇2,4-二-異丙苯基苯酚 亞磷酸酯、2-丁基-2-乙基-1,3-丙二醇4-甲基-2,6-二-第三-丁基苯酚亞磷酸酯及雙-(2,4,6-三-第三-丁基-苯基)新戊四醇二亞磷酸酯。 The stabilizer composition of claim 3, wherein the organophosphite or phosphonate is selected from the group consisting of: triphenyl phosphite; diphenylalkyl phosphite; phenyl dialkyl phosphite; phosphorous acid Trilauryl ester; tri-octadecyl phosphite; distearyl decyl neopentyl phosphite; bismuth phosphite (2,4-di-tert-butylphenyl) ester;叁(nonylphenyl) ester; formula (A), (B), (C), (D), (E), (F), (G), (H), (J), (K) and Compound of (L): 2-butyl-2-ethyl-1,3-propanediol 2,4,6-tri-tert-butylphenol phosphite, bis-(2,6-di-t-butyl-4- Methylphenyl) pentaerythritol diphosphite, 2-butyl-2-ethyl-1,3-propanediol 2,4-di-cumylphenol phosphite, 2-butyl-2 -ethyl-1,3-propanediol 4-methyl-2,6-di-tertiary-butylphenol phosphite and bis-(2,4,6-tri-tert-butyl-phenyl) Neopentyl alcohol diphosphite. 如請求項3至4中任一項之安定劑組合物,其中該至少一種有機亞磷酸酯或膦酸酯係選自亞磷酸叁(2,4-二-第三-丁基苯基)酯(IRGAFOS® 168);雙(2,4-二異丙苯基苯基)新戊四醇二亞磷酸酯(DOVERPHOS® S9228);及4,4'-伸聯苯基-二膦酸四(2,4-二-第三-丁基苯基)酯(IRGAFOS® P-EPQ)。 The stabilizer composition according to any one of claims 3 to 4, wherein the at least one organic phosphite or phosphonate is selected from the group consisting of bismuth (2,4-di-tert-butylphenyl) phosphite (IRGAFOS® 168); bis(2,4-diisopropylphenylphenyl)neopentitol diphosphite (DOVERPHOS® S9228); and 4,4'-extended biphenyl-diphosphonic acid tetra ( 2,4-di-t-butylphenyl) ester (IRGAFOS® P-EPQ). 如請求項1至4中任一項之安定劑組合物,其進一步包含至少一種受阻酚化合物。 The stabilizer composition of any one of claims 1 to 4, further comprising at least one hindered phenol compound. 如請求項6之安定劑組合物,其中該至少一種受阻酚化合物包含式(IVa)、(IVb)或(IVc)中之一或多者之分子片段: 其中R18係選自H或C1-4烴基;R19及R20中之每一者係獨立地選自氫或C1-C20烴基;且R37係選自C1-C12烴基。 The stabilizer composition of claim 6, wherein the at least one hindered phenol compound comprises a molecular fragment of one or more of formula (IVa), (IVb) or (IVc): Wherein R 18 is selected from H or C 1-4 hydrocarbyl; each of R 19 and R 20 is independently selected from hydrogen or C 1 -C 20 hydrocarbyl; and R 37 is selected from C 1 -C 12 hydrocarbyl . 如請求項7之安定劑組合物,其中R18及R37中之每一者係獨立地選自甲基或第三丁基。 The stabilizer composition of claim 7, wherein each of R 18 and R 37 is independently selected from methyl or tert-butyl. 如請求項6之安定劑組合物,其中該至少一種受阻酚化合物係選自選自由以下組成之群之成員:(1,3,5-叁(4-第三-丁基-3-羥基-2,6-二甲基苄基)-1,3,5-三嗪-2,4,6-(1H,3H,5H)-三酮;1,1,3-叁(2'-甲基-4'-羥基-5'-第三-丁基苯基)丁烷;三乙二醇雙[3-(3-第三-丁基-4-羥基-5-甲基苯基)丙酸酯];4,4'-硫基雙(2-第三-丁基-5-甲基苯酚);2,2'-硫基二伸乙基雙[3-(3-第三-丁基-4-羥基-5-甲基苯基)丙酸酯];3-(3'-第三-丁基-4'-羥基-5'-甲基苯基)丙酸十八烷基酯;四亞甲基(3-第三-丁基-4-羥基-5-甲基氫化桂皮酸酯)甲烷;N,N'-六亞甲基雙[3-(3-第三-丁基-4-羥基-5-甲基苯基)丙醯胺];硫基二丙酸二(4-第三丁基-3-羥基-2,6-二甲基苄基)酯;及3,5-二-(第三)-丁基-4-羥基氫化桂皮酸十八烷基酯。 The stabilizer composition of claim 6, wherein the at least one hindered phenol compound is selected from the group consisting of: (1,3,5-fluorene (4-tert-butyl-3-hydroxy-2) ,6-dimethylbenzyl)-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione; 1,1,3-anthracene (2'-methyl- 4'-hydroxy-5'-tris-butylphenyl)butane; triethylene glycol bis[3-(3-tris-butyl-4-hydroxy-5-methylphenyl)propionate 4,4'-thiobis(2-tris-butyl-5-methylphenol); 2,2'-thiodiethylidene bis[3-(3-tri-butyl- 4-hydroxy-5-methylphenyl)propionate]; octadecyl 3-(3'-tris-butyl-4'-hydroxy-5'-methylphenyl)propanoate; Methylene (3-tert-butyl-4-hydroxy-5-methylhydrocinnamate) methane; N,N'-hexamethylenebis[3-(3-tri-butyl-4) -hydroxy-5-methylphenyl)propanamide]; bis(4-tert-butyl-3-hydroxy-2,6-dimethylbenzyl) thiodipropionate; and 3,5- Di-(tri)-butyl-4-hydroxyhydrocinnamate octadecyl ester. 如請求項1之安定劑組合物,其中R22在至少一種情況下存在且係甲基。 The stabilizer composition of claim 1, wherein R 22 is present in at least one instance and is methyl. 如請求項1之安定劑組合物,其中R24係C1-C18烴基。 The stabilizer composition of claim 1, wherein R 24 is a C 1 -C 18 hydrocarbyl group. 如請求項1之安定劑組合物,其中該基於唍之化合物係式(Va)之維生素E乙酸酯 或其異構體及/或混合物。 The stabilizer composition of claim 1, wherein the Vitamin E acetate of formula (Va) Or isomers and/or mixtures thereof. 如請求項1之安定劑組合物,其中該基於唍之化合物係包含基於唍之式V化合物與另一基於唍之化合物之化合物摻合物。 The stabilizer composition of claim 1, wherein the 唍 compounds are based on Compound of formula V and another based A compound blend of a compound of hydrazine. 如請求項1之安定劑組合物,其中該基於唍之化合物係以該安定劑組合物之總重量之0.001重量%至5.0重量%存在。 The stabilizer composition of claim 1, wherein the The bismuth compound is present in an amount from 0.001% to 5.0% by weight based on the total weight of the stabilizer composition. 如請求項14之安定劑組合物,其中該基於唍之化合物係以該安定劑組合物之總重量之0.01重量%至1.0重量%存在。 The stabilizer composition of claim 14, wherein the based The ruthenium compound is present in an amount from 0.01% to 1.0% by weight based on the total weight of the stabilizer composition. 如請求項1之安定劑組合物,其進一步包含有效量之選自選自由以下組成之群之成員的光安定劑:受阻胺光安定劑、受阻羥基苯甲酸酯、酚鎳、紫外光安定劑及其組合。 The stabilizer composition of claim 1, further comprising an effective amount of a light stabilizer selected from the group consisting of: a hindered amine light stabilizer, a hindered hydroxybenzoate, a phenol nickel, an ultraviolet stabilizer And their combinations. 如請求項16之安定劑組合物,其中該光安定劑係受阻胺光安定劑化合物,其包含式(VI)之分子片段: 其中R62係選自選自由以下組成之群之成員:氫;OH;C1- C20烴基;-CH2CN;C1-C12醯基;及C1-C18烷氧基;R65係選自選自由氫;及C1-C8烴基組成之群之成員;且R60、R61、R63及R64中之每一者係獨立地選自C1-C20烴基,或R60及R61及/或R63及R64與其所附接之碳一起形成C5-C10環烷基;或式(VIa)之分子片段 其中m係1至2之整數;R39係選自選自由以下組成之群之成員:氫;OH;C1-C20烴基;-CH2CN;C1-C12醯基;及C1-C18烷氧基;且G1至G4中之每一者係獨立地選自C1-C20烴基。 The stabilizer composition of claim 16, wherein the light stabilizer is a hindered amine light stabilizer compound comprising a molecular fragment of formula (VI): Wherein R 62 is selected from the group consisting of: hydrogen; OH; C 1 - C 20 hydrocarbyl; -CH 2 CN; C 1 -C 12 mercapto; and C 1 -C 18 alkoxy; R 65 And is selected from the group consisting of hydrogen; and a C 1 -C 8 hydrocarbon group; and each of R 60 , R 61 , R 63 and R 64 is independently selected from a C 1 -C 20 hydrocarbon group, or R 60 and R 61 and/or R 63 and R 64 together with the carbon to which they are attached form a C 5 -C 10 cycloalkyl group; or a molecular fragment of formula (VIa) Wherein m is an integer from 1 to 2; R 39 is selected from members selected from the group consisting of hydrogen; OH; C 1 -C 20 hydrocarbyl; -CH 2 CN; C 1 -C 12 mercapto; and C 1 - C 18 alkoxy; and each of G 1 to G 4 is independently selected from a C 1 -C 20 hydrocarbyl group. 如請求項16或17之安定劑組合物,其中該受阻胺光安定劑係選自選自由以下組成之群之成員:癸二酸雙(2,2,6,6-四甲基六氫吡啶-4-基)酯;琥珀酸雙(2,2,6,6-四甲基六氫吡啶-4-基)酯;癸二酸雙(1,2,2,6,6-五甲基六氫吡啶-4-基)酯;癸二酸雙(1-辛氧基-2,2,6,6-四甲基六氫吡啶-4-基)酯;正-丁基3,5-二-第三-丁基-4-羥基苄基丙二酸雙(1,2,2,6,6-五甲基六氫吡啶-4-基)酯;1-(2-羥基乙基)-2,2,6,6-四甲基-4-羥基六氫吡啶與琥珀酸之縮合物; 硬脂酸2,2,6,6-四甲基六氫吡啶-4-基酯;十二烷酸2,2,6,6-四甲基六氫吡啶-4-基酯;硬脂酸1,2,2,6,6-五甲基六氫吡啶-4-基酯;十二烷酸1,2,2,6,6-五甲基六氫吡啶-4-基酯;N,N'-雙(2,2,6,6-四甲基六氫吡啶-4-基)六亞甲基二胺與4-第三-辛基胺基-2,6-二氯-1,3,5-三嗪之縮合物;氮基三乙酸叁(2,2,6,6-四甲基六氫吡啶-4-基)酯;1,2,3,4-丁烷四甲酸四(2,2,6,6-四甲基六氫吡啶-4-基)酯;4-苯甲醯-2,2,6,6-四甲基六氫吡啶;4-硬脂醯基氧基-2,2,6,6-四甲基六氫吡啶;2-正-丁基-2-(2-羥基-3,5-二-第三-丁基苄基)丙二酸雙(1,2,2,6,6-五甲基六氫吡啶基)酯;3-正-辛基-7,7,9,9-四甲基-1,3,8-三氮雜螺[4.5]癸烷-2,4-二酮;癸二酸雙(1-辛氧基-2,2,6,6-四甲基六氫吡啶基)酯;琥珀酸雙(1-辛氧基-2,2,6,6-四甲基六氫吡啶基)酯;N,N'-雙(2,2,6,6-四甲基六氫吡啶-4-基)六亞甲基二胺與4-嗎啉基-2,6-二氯-1,3,5-三嗪之縮合物;2-氯-4,6-雙(4-正-丁基胺基-2,2,6,6-四甲基六氫吡啶基)-1,3,5-三嗪與1,2-雙(3-胺基丙基胺基)乙烷之縮合物;2-氯-4,6-雙(4-正-丁基胺基-1,2,2,6,6-五甲基六氫吡啶基)-1,3,5-三嗪與1,2-雙-(3-胺基丙基胺基)乙烷之縮合物;8-乙醯基-3-十二烷基-7,7,9,9-四甲基-1,3,8-三氮雜螺[4.5]癸烷-2,4-二酮;3-十二烷基-1-(2,2,6,6-四甲基六氫吡啶-4-基)吡咯啶-2,5-二酮;3-十二烷基-1-(1-乙醯基-2,2,6,6-四甲基六氫吡啶-4-基)吡咯啶-2,5-二酮;3-十二烷基-1-(1,2,2,6,6-五甲基六氫吡啶-4-基)吡咯啶-2,5-二 酮;4-十六烷氧基-2,2,6,6-四甲基六氫吡啶與4-硬脂醯基氧基-2,2,6,6-四甲基六氫吡啶之混合物;N,N'-雙(2,2,6,6-四甲基六氫吡啶-4-基)六亞甲基二胺與4-環己基胺基-2,6-二氯-1,3,5-三嗪之縮合物;1,2-雙(3-胺基丙基胺基)乙烷、2,4,6-三氯-1,3,5-三嗪與4-丁基胺基-2,2,6,6-四甲基六氫吡啶之縮合物;2-十一烷基-7,7,9,9-四甲基-1-氧雜-3,8-二氮雜-4-側氧基螺[4.5]癸烷;側氧基-六氫吡嗪基-三嗪;7,7,9,9-四甲基-2-環十一烷基-1-氧雜-3,8-二氮雜-4-側氧基螺[4.5]癸烷與環氧氯丙烷之反應產物;丁烷-1,2,3,4-四甲酸四(2,2,6,6-四甲基-4-六氫吡啶基)酯;1,2,3,4-丁烷四甲酸四(1,2,2,6,6-五甲基-4-六氫吡啶基)酯;1,2,3,4-丁烷四甲酸1,2,2,6,6-五甲基-4-六氫吡啶基十三烷基酯;1,2,3,4-丁烷四甲酸2,2,6,6-四甲基-4-六氫吡啶基十三烷基酯;1,2,3,4-丁烷四甲酸、2,2,6,6-四甲基-2,4,8,10-四氧雜螺[5.5]-十一烷-3,9-二乙醇與1,2,2,6,6-五甲基-4-六氫吡啶基酯之聚合物;1,2,3,4-丁烷四甲酸、2,2,6,6-四甲基-2,4,8,10-四氧雜螺[5.5]-十一烷-3,9-二乙醇與2,2,6,6-四甲基-4-六氫吡啶基酯之聚合物;碳酸雙(1-十一烷氧基-2,2,6,6-四甲基六氫吡啶-4-基)酯;1-(2-羥基-2-甲基丙氧基)-2,2,6,6-四甲基-4-六氫吡啶醇;1-(2-羥基-2-甲基丙氧基)-4-十八醯基氧基-2,2,6,6-四甲基六氫吡啶;1-(4-十八醯基氧基-2,2,6,6-四甲基六氫吡啶-1-基氧基)-2-十八醯基氧基-2-甲基丙烷;1-(2-羥基乙基)-2,2,6,6-四甲基-4-六氫 吡啶醇;1-(2-羥基乙基)-2,2,6,6-四甲基-4-六氫吡啶醇與琥珀酸二甲酯之反應產物;2,2,4,4-四甲基-7-氧雜-3,20-二氮雜二螺[5.1.11.2]二十一烷-21-酮;2,2,6,6-四甲基-4-六氫吡啶醇與高脂肪酸之酯;3-十二烷基-1-(2,2,6,6-四甲基-4-六氫吡啶基)吡咯啶-2,5-二酮;1-十八烷基-1H-吡咯-2,5-二酮與(1-甲基乙烯基)苯及1-(2,2,6,6-四甲基-4-六氫吡啶基)-1H-吡咯-2,5-二酮之聚合物;1,1',1"-[1,3,5-三嗪-2,4,6-三基叁[(環己基亞胺基)-2,1-乙烷二基]]叁[3,3,5,5-四甲基-六氫吡嗪酮];1,1',1"-[1,3,5-三嗪-2,4,6-三基叁[(環己基亞胺基)-2,1-乙烷二基]]叁[3,3,4,5,5-五甲基-六氫吡嗪酮];7,7,9,9-四甲基-2-環十一烷基-1-氧雜-3,8-二氮雜-4-側氧基螺[4.5]癸烷與環氧氯丙烷之反應產物;N,N'-雙(2,2,6,6-四甲基六氫吡啶-4-基)六亞甲基二胺與4-環己基胺基-2,6-二氯-1,3,5-三嗪之縮合物;1,2-雙(3-胺基丙基胺基)乙烷、2,4,6-三氯-1,3,5-三嗪及4-丁基胺基-2,2,6,6-四甲基六氫吡啶之縮合物;N,N'-雙(2,2,6,6-四甲基六氫吡啶-4-基)六亞甲基二胺與4-嗎啉基-2,6-二氯-1,3,5-三嗪之縮合物;2-氯-4,6-雙(4-正-丁基胺基-2,2,6,6-四甲基六氫吡啶基)-1,3,5-三嗪與1,2-雙(3-胺基丙基胺基)乙烷之縮合物;2-氯-4,6-雙(4-正-丁基胺基-1,2,2,6,6-五甲基六氫吡啶基)-1,3,5-三嗪與1,2-雙-(3-胺基丙基胺基)乙烷之縮合物;2-[(2-羥基乙基)胺基]-4,6-雙[N-(1-環己氧基-2,2,6,6-四甲基六氫吡啶-4-基)丁基胺基-1,3,5-三嗪;丙二酸[(4-甲氧基苯基)-亞甲基]- 雙-(1,2,2,6,6-五甲基-4-六氫吡啶基)酯;1,2,3,4-丁烷四甲酸四(2,2,6,6-四甲基六氫吡啶-4-基)酯;3,5-雙(1,1-二甲基乙基)-4-羥基-苯丙酸1-[2-[3-[3,5-雙(1,1-二甲基乙基)-4-羥基苯基]-1-側氧基丙氧基]乙基]-2,2,6,6-四甲基-4-六氫吡啶基酯;N-(1-辛氧基-2,2,6,6-四甲基六氫吡啶-4-基)-N'-十二烷基草醯胺;氮基三乙酸叁(2,2,6,6-四甲基六氫吡啶-4-基)酯;1,5-二氧雜螺{5,5}十一烷-3,3-二甲酸雙(1,2,2,6,6-五甲基-4-六氫吡啶基)酯:1,5-二氧雜螺{5,5}十一烷-3,3-二甲酸雙(2,2,6,6-四甲基-4-六氫吡啶基)酯;1-(2-羥基乙基)-2,2,6,6-四甲基-4-羥基六氫吡啶與琥珀酸之縮合物;N,N'-雙(2,2,6,6-四甲基六氫吡啶-4-基)六亞甲基二胺與4-第三-辛基胺基-2,6-二氯-1,3,5-三嗪之縮合物;1,2,3,4-丁烷四甲酸1,2,2,6,6-五甲基-4-六氫吡啶基十三烷基酯;1,2,3,4-丁烷四甲酸四(2,2,6,6-四甲基六氫吡啶-4-基)酯;1,2,3,4-丁烷四甲酸2,2,6,6-四甲基-4-六氫吡啶基十三烷基酯;1,2,3,4-丁烷四甲酸四(1,2,2,6,6-五甲基六氫吡啶-4-基)酯;2,2,4,4-四甲基-21-側氧基-7-氧雜-3.20-二氮雜螺(5.1.11.2)-二十一烷-20-丙酸-十二烷基酯與2,2,4,4-四甲基-21-側氧基-7-氧雜-3.20-二氮雜螺(5.1.11.2)-二十一烷-20-丙酸-十四烷基酯之混合物;六氫-2,6-雙(2,2,6,6-四甲基-4-六氫吡啶基)-1H,4H,5H,8H-2,3a,4a,6,7a,8a-六氮雜環戊并[def]茀-4,8-二酮;聚甲基[丙基-3-氧基(2',2',6',6'-四甲基-4,4'-六氫吡啶基)]矽氧烷;聚甲基[丙基-3-氧基(1',2',2',6',6'- 五甲基-4,4'-六氫吡啶基)]矽氧烷;甲基丙烯酸甲酯與丙烯酸乙酯及丙烯酸2,2,6,6-四甲基六氫吡啶-4-基酯之共聚物;C20至C24混合α-烯烴與(2,2,6,6-四甲基六氫吡啶-4-基)琥珀醯亞胺之共聚物;1,2,3,4-丁烷四甲酸、β,β,β',β'-四甲基-2,4,8,10-四氧雜螺[5.5]十一烷-3,9-二乙醇與1,2,2,6,6-五甲基-4-六氫吡啶基酯之聚合物;1,2,3,4-丁烷四甲酸、β,β,β',β'-四甲基-2,4,8,10-四氧雜螺[5.5]十一烷-3,9-二乙醇與2,2,6,6-四甲基-4-六氫吡啶基酯共聚物之聚合物;N,N'-雙(2,2,6,6-四甲基-4-六氫吡啶基)1,3-苯二甲醯胺;1,1'-(1,10-二側氧基-1,10-癸烷二基)-雙(六氫-2,2,4,4,6-五甲基嘧啶);N-(1-乙醯基-2,2,6,6-四甲基六氫吡啶基)-N'-十二烷基乙烷二醯胺;N,N'-1,6-己烷二基雙[N-(2,2,6,6-四甲基-4-六氫吡啶基)甲醯胺;1,3:2,4-雙-O-(2,2,6,6-四甲基-4-亞六氫吡啶基)-D-葡萄糖醇;2,2,4,4-四甲基-7-氧雜-3,20-二氮雜-21-側氧基-二螺[5.1.11.2]二十一烷;2-甲基-N-(2,2,6,6-四甲基-4-六氫吡啶基)-2-[(2,2,6,6-四甲基-4-六氫吡啶基)胺基]-丙醯胺;2,2,4,4-四甲基-21-側氧基-7-氧雜-3,20-二氮雜二螺[5.1.11.2]二十一烷-20-丙酸十二烷基酯;N-(2,2,6,6-四甲基六氫吡啶-4-基)-β-胺基丙酸十二烷基酯;N-(2,2,6,6-四甲基六氫吡啶-4-基)-N'-胺基草醯胺;N-(2,2,6,6-四甲基-4-六氫吡啶基)-3-[(2,2,6,6-四甲基-4-六氫吡啶基)胺基]-丙醯胺;4-十六烷氧基-2,2,6,6-四甲基六氫吡啶與4-硬脂醯基氧基-2,2,6,6-四甲基六氫 吡啶之混合物;3-十二烷基-1-(1,2,2,6,6-五甲基六氫吡啶-4-基)吡咯啶-2,5-二酮;3-十二烷基-1-(1-乙醯基-2,2,6,6-五甲基六氫吡啶-4-基)吡咯啶-2,5-二酮;琥珀酸雙(2,2,6,6-四甲基六氫吡啶-4-基)酯;正-丁基3,5-二-第三-丁基-4-羥基苄基丙二酸雙(1,2,2,6,6-五甲基六氫吡啶-4-基)酯;氮基三乙酸叁(2,2,6,6-四甲基六氫吡啶-4-基)酯;1,1'-(1,2-乙烷二基)雙(3,3,5,5-四甲基六氫吡嗪酮);4-苯甲醯-2,2,6,6-四甲基六氫吡啶;4-硬脂醯基氧基-2,2,6,6-四甲基六氫吡啶;2-正-丁基-2-(2-羥基-3,5-二-第三-丁基苄基)丙二酸雙(1,2,2,6,6-五甲基六氫吡啶基)酯;3-正-辛基-7,7,9,9-四甲基-1,3,8-三氮雜螺[4.5]癸烷-2,4-二酮;癸二酸雙(1-辛氧基-2,2,6,6-四甲基六氫吡啶基)酯;琥珀酸雙(1-辛氧基-2,2,6,6-四甲基六氫吡啶基)酯;8-乙醯基-3-十二烷基-7,7,9,9-四甲基-1,3,8-三氮雜螺[4.5]癸烷-2,4-二酮;3-十二烷基-1-(2,2,6,6-四甲基六氫吡啶-4-基)吡咯啶-2,5-二酮;3-十二烷基-1-(1-乙醯基-2,2,6,6-四甲基六氫吡啶-4-基)吡咯啶-2,5-二酮;3-十二烷基-1-(1,2,2,6,6-五甲基六氫吡啶-4-基)吡咯啶-2,5-二酮;4-十六烷氧基-2,2,6,6-四甲基六氫吡啶與4-硬脂醯基氧基-2,2,6,6-四甲基六氫吡啶之混合物;2-十一烷基-7,7,9,9-四甲基-1-氧雜-3,8-二氮雜-4-側氧基螺[4.5]癸烷;1,5-二氧雜螺{5,5}十一烷-3,3-二甲酸雙(2,2,6,6-四甲基-4-六氫吡啶基)酯及1,5-二氧雜螺{5,5}十一烷-3,3-二甲酸雙(1,2,2,6,6-五甲基-4-六氫吡啶基)酯;N1-(β-羥 基乙基)3,3-五亞甲基-5,5-二甲基六氫吡嗪-2-酮;N1-第三-辛基-3,3,5,5-四甲基-二氮呯-2-酮;N1-第三-辛基-3,3-五亞甲基-5,5-六亞甲基-二氮呯-2-酮;N1-第三-辛基-3,3-五亞甲基-5,5-二甲基六氫吡嗪-2-酮;反式-1,2-環己烷-雙-(N1-5,5-二甲基-3,3-五亞甲基-2-六氫吡嗪酮);反式-1,2-環己烷-雙-(N1-3,3,5,5-二螺五亞甲基-2-六氫吡嗪酮);N1-異丙基-1,4-二氮雜二螺-(3,3,5,5)五亞甲基-2-六氫吡嗪酮;N1-異丙基-1,4-二氮雜二螺-3,3-五亞甲基-5,5-四亞甲基-2-六氫吡嗪酮;N1-異丙基-5,5-二甲基-3,3-五亞甲基-2-六氫吡嗪酮;反式-1,2-環己烷-雙-N1-(二甲基-3,3-五亞甲基-2-六氫吡嗪酮);N1-辛基-5,5-二甲基-3,3-五亞甲基-1,4-二氮呯-2-酮;及N1-辛基-1,4-二氮雜二螺-(3,3,5,5)五亞甲基-1,5-二氮呯-2-酮。 The stabilizer composition of claim 16 or 17, wherein the hindered amine light stabilizer is selected from the group consisting of: azelaic acid bis(2,2,6,6-tetramethylhexahydropyridine- 4-yl)ester; bis(2,2,6,6-tetramethylhexahydropyridin-4-yl) succinate; bis(1,2,2,6,6-pentamethyl-6) sebacate Hydropyridin-4-yl)ester; bis(1-octyloxy-2,2,6,6-tetramethylhexahydropyridin-4-yl) sebacate; n-butyl 3,5-di -T-butyl-4-hydroxybenzylmalonate bis(1,2,2,6,6-pentamethylhexahydropyridin-4-yl) ester; 1-(2-hydroxyethyl)- a condensate of 2,2,6,6-tetramethyl-4-hydroxyhexahydropyridine with succinic acid; 2,2,6,6-tetramethylhexahydropyridin-4-yl stearate; 2,2,6,6-tetramethylhexahydropyridin-4-yl alkanoate; 1,2,2,6,6-pentamethylhexahydropyridin-4-yl stearate; dodecane Acid 1,2,2,6,6-pentamethylhexahydropyridin-4-yl ester; N,N'-bis(2,2,6,6-tetramethylhexahydropyridin-4-yl)6 a condensate of methylene diamine with 4-tris-octylamino-2,6-dichloro-1,3,5-triazine; bismuth triacetate (2,2,6,6-tetra Methylhexahydropyridin-4-yl)ester; 1,2,3,4-butanetetracarboxylic acid tetrakis(2,2,6,6-tetramethylhexahydropyridine-4- Ester; 4-benzylidene-2,2,6,6-tetramethylhexahydropyridine; 4-stearyl hydroxy-2,2,6,6-tetramethylhexahydropyridine; n-Butyl-2-(2-hydroxy-3,5-di-tri-butylbenzyl)malonic acid bis(1,2,2,6,6-pentamethylhexahydropyridyl) ester 3-n-octyl-7,7,9,9-tetramethyl-1,3,8-triazaspiro[4.5]decane-2,4-dione; azelaic acid bis(1- Octyloxy-2,2,6,6-tetramethylhexahydropyridinyl ester; bis(1-octyloxy-2,2,6,6-tetramethylhexahydropyridyl) succinate; N,N'-bis(2,2,6,6-tetramethylhexahydropyridin-4-yl)hexamethylenediamine and 4-morpholinyl-2,6-dichloro-1,3, a condensate of 5-triazine; 2-chloro-4,6-bis(4-n-butylamino-2,2,6,6-tetramethylhexahydropyridinyl)-1,3,5- a condensate of a triazine with 1,2-bis(3-aminopropylamino)ethane; 2-chloro-4,6-bis(4-n-butylamino-1,2,2,6 a condensate of 6-pentamethylhexahydropyridyl)-1,3,5-triazine with 1,2-bis-(3-aminopropylamino)ethane; 8-ethylindolyl-3 -dodecyl-7,7,9,9-tetramethyl-1,3,8-triazaspiro[4.5]decane-2,4-dione; 3-dodecyl-1- (2,2,6,6-tetramethylhexahydropyridin-4-yl)pyrrolidine-2,5-dione; 3-dodecyl-1-(1-ethenyl-2,2, 6,6 -tetramethylhexahydropyridin-4-yl)pyrrolidine-2,5-dione; 3-dodecyl-1-(1,2,2,6,6-pentamethylhexahydropyridine-4 -yl)pyrrolidine-2,5-dione; 4-hexadecyloxy-2,2,6,6-tetramethylhexahydropyridine and 4-stearylpurinyl-2,2,6 a mixture of 6-tetramethylhexahydropyridine; N,N'-bis(2,2,6,6-tetramethylhexahydropyridin-4-yl)hexamethylenediamine and 4-cyclohexylamine a condensate of benzyl-2,6-dichloro-1,3,5-triazine; 1,2-bis(3-aminopropylamino)ethane, 2,4,6-trichloro-1, a condensate of 3,5-triazine with 4-butylamino-2,2,6,6-tetramethylhexahydropyridine; 2-undecyl-7,7,9,9-tetramethyl -1-oxa-3,8-diaza-4-oneoxyspiro[4.5]decane; pendant oxy-hexahydropyrazinyl-triazine; 7,7,9,9-tetramethyl Reaction product of 2-cycloundecyl-1-oxa-3,8-diaza-4-oxooxyspiro[4.5]decane with epichlorohydrin; butane-1,2,3 , 4-(2,6,6,6-tetramethyl-4-hexahydropyridyl) 4-tetracarboxylic acid; 1,2,3,4-butanetetracarboxylic acid tetrakis (1,2,2,6, 6-pentamethyl-4-hexahydropyridinyl ester; 1,2,3,4-butanetetracarboxylic acid 1,2,2,6,6-pentamethyl-4-hexahydropyridyltridecane Base; 1,2,3,4-butanetetracarboxylic acid 2,2,6,6-tetramethyl-4-hexahydro Pyridyltridecyl ester; 1,2,3,4-butanetetracarboxylic acid, 2,2,6,6-tetramethyl-2,4,8,10-tetraoxaspiro[5.5]-ten a polymer of monoalkyl-3,9-diethanol and 1,2,2,6,6-pentamethyl-4-hexahydropyridyl ester; 1,2,3,4-butanetetracarboxylic acid, 2, 2,6,6-tetramethyl-2,4,8,10-tetraoxaspiro[5.5]-undecane-3,9-diethanol and 2,2,6,6-tetramethyl-4 a polymer of hexahydropyridyl ester; bis(1-undecyloxy-2,2,6,6-tetramethylhexahydropyridin-4-yl) carbonate; 1-(2-hydroxy-2) -methylpropoxy)-2,2,6,6-tetramethyl-4-hexahydropyridinol; 1-(2-hydroxy-2-methylpropoxy)-4-octadecyloxy -2,2,6,6-tetramethylhexahydropyridine; 1-(4-octadecyloxy-2,2,6,6-tetramethylhexahydropyridin-1-yloxy) -2-octadecyloxy-2-methylpropane; 1-(2-hydroxyethyl)-2,2,6,6-tetramethyl-4-hexahydropyridinol; 1-(2- Reaction product of hydroxyethyl)-2,2,6,6-tetramethyl-4-hexahydropyridinol with dimethyl succinate; 2,2,4,4-tetramethyl-7-oxa- 3,20-diazabispiro[5.1.11.2]icosane-21-one; ester of 2,2,6,6-tetramethyl-4-hexahydropyridinol with high fatty acid; 3-ten Dialkyl-1-(2,2,6,6-tetramethyl-4-hexahydropyridyl) L-pyridine-2,5-dione; 1-octadecyl-1H-pyrrole-2,5-dione with (1-methylvinyl)benzene and 1-(2,2,6,6-tetra a polymer of methyl-4-hexahydropyridyl)-1H-pyrrole-2,5-dione; 1,1',1"-[1,3,5-triazine-2,4,6-three Base [[cyclohexylimido]-2,1-ethanediyl]]indole [3,3,5,5-tetramethyl-hexahydropyrazinone]; 1,1',1"- [1,3,5-triazine-2,4,6-triyloxime [(cyclohexylimylidene)-2,1-ethanediyl]]indole [3,3,4,5,5- Pentamethyl-hexahydropyrazinone; 7,7,9,9-tetramethyl-2-cycloundecyl-1-oxa-3,8-diaza-4-oneoxy snail [4.5] Reaction product of decane with epichlorohydrin; N,N'-bis(2,2,6,6-tetramethylhexahydropyridin-4-yl)hexamethylenediamine and 4-ring a condensate of hexylamino-2,6-dichloro-1,3,5-triazine; 1,2-bis(3-aminopropylamino)ethane, 2,4,6-trichloro- Condensate of 1,3,5-triazine and 4-butylamino-2,2,6,6-tetramethylhexahydropyridine; N,N'-bis(2,2,6,6-four a condensate of methylhexahydropyridin-4-yl)hexamethylenediamine with 4-morpholinyl-2,6-dichloro-1,3,5-triazine; 2-chloro-4,6- Bis(4-n-butylamino-2,2,6,6-tetramethylhexahydropyridyl)-1,3,5-triazine with 1,2-bis(3-aminopropylamine Ethane Condensate; 2-chloro-4,6-bis(4-n-butylamino-1,2,2,6,6-pentamethylhexahydropyridinyl)-1,3,5-triazine a condensate of 1,2-bis-(3-aminopropylamino)ethane; 2-[(2-hydroxyethyl)amino]-4,6-bis[N-(1-cyclohexyloxy) -2,2,6,6-tetramethylhexahydropyridin-4-yl)butylamino-1,3,5-triazine; malonic acid [(4-methoxyphenyl)- Methyl]-bis-(1,2,2,6,6-pentamethyl-4-hexahydropyridyl) ester; 1,2,3,4-butanetetracarboxylic acid tetrakis(2,2,6, 6-tetramethylhexahydropyridin-4-yl)ester; 3,5-bis(1,1-dimethylethyl)-4-hydroxy-phenylpropionic acid 1-[2-[3-[3, 5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-1-oxopropoxy]ethyl]-2,2,6,6-tetramethyl-4-hexa Hydropyridyl ester; N-(1-octyloxy-2,2,6,6-tetramethylhexahydropyridin-4-yl)-N'-dodecyloxacin; hydrazine triacetate (2,2,6,6-tetramethylhexahydropyridin-4-yl) ester; 1,5-dioxaspiro{5,5}undecane-3,3-dicarboxylic acid bis (1,2 ,2,6,6-pentamethyl-4-hexahydropyridinyl): 1,5-dioxaspiro{5,5}undecane-3,3-dicarboxylic acid bis(2,2,6 ,6-tetramethyl-4-hexahydropyridyl) condensate of 1-(2-hydroxyethyl)-2,2,6,6-tetramethyl-4-hydroxyhexahydropyridine and succinic acid N,N'-bis(2,2,6,6-tetramethylhexahydropyridin-4-yl)hexamethylenediamine and 4-tris-octylamino-2,6-dichloro- a condensate of 1,3,5-triazine; 1,2,3,4-butanetetracarboxylic acid 1,2,2,6,6-pentamethyl-4-hexahydropyridyltridecyl ester; 1,2,3,4-butanetetracarboxylic acid tetrakis(2,2,6,6-tetramethylhexahydropyridin-4-yl) ester; 1,2,3,4-butanetetracarboxylic acid 2,2 6,6-tetramethyl-4-hexahydropyridyltridecyl ester; 1,2,3,4-butanetetracarboxylic acid tetrakis(1,2,2,6,6-pentamethylhexahydro Pyridin-4-yl) ester; 2,2,4,4-tetramethyl-21-oxo-7-oxa-3.20-diazaspiro (5.1.11.2)-icosane-20- Propionic acid-dodecyl ester and 2,2,4,4-tetramethyl-21-oxo-7-oxa-3.20-diazaspiro (5.1.11.2)-icosane-20 a mixture of propionic acid-tetradecyl ester; hexahydro-2,6-bis(2,2,6,6-tetramethyl-4-hexahydropyridyl)-1H, 4H, 5H, 8H-2 , 3a, 4a, 6, 7a, 8a-hexazacyclo[def]indole-4,8-dione; polymethyl [propyl-3-oxy (2', 2', 6', 6'-tetramethyl-4,4'-hexahydropyridyl)]oxane; polymethyl[propyl-3-oxy (1',2',2',6',6'- Methyl-4,4'-hexahydropyridinyl)]oxane; methyl methacrylate with ethyl acrylate and acrylic acid 2,2,6,6- A copolymer of methyl hexahydro-pyridin-4-yl ester of; C 20 to C 24 α- olefin and mixed (hexahydro-2,2,6,6-tetramethyl-4-yl) succinate of (PEI) copolymer 1,2,3,4-butanetetracarboxylic acid, β,β,β',β'-tetramethyl-2,4,8,10-tetraoxaspiro[5.5]undecane-3, a polymer of 9-diethanol and 1,2,2,6,6-pentamethyl-4-hexahydropyridyl ester; 1,2,3,4-butanetetracarboxylic acid, β,β,β', ''-Tetramethyl-2,4,8,10-tetraoxaspiro[5.5]undecane-3,9-diethanol and 2,2,6,6-tetramethyl-4-hexahydropyridine a polymer of a base ester copolymer; N,N'-bis(2,2,6,6-tetramethyl-4-hexahydropyridinyl)1,3-benzenedimethylamine;1,1'-(1,10-di-oxy-1,10-decanediyl)-bis(hexahydro-2,2,4,4,6-pentamethylpyrimidine); N-(1-ethenyl-2 , 2,6,6-tetramethylhexahydropyridinyl)-N'-dodecylethanediamine;N,N'-1,6-hexanediyl bis[N-(2,2 ,6,6-tetramethyl-4-hexahydropyridinyl)carbenamide; 1,3:2,4-bis-O-(2,2,6,6-tetramethyl-4-hexahydrogen Pyridyl)-D-glucitol; 2,2,4,4-tetramethyl-7-oxa-3,20-diaza-21-sideoxy-dispiro[5.1.11.2] Twenty-one Alkane; 2-methyl-N-(2,2,6,6-tetramethyl-4-hexahydropyridinyl)-2-[(2,2,6,6-tetramethyl- 4-hexahydropyridyl)amino]-propionamine; 2,2,4,4-tetramethyl-21-oxy-7-oxa-3,20-diazabispiro[5.1. 11.2] Dodecyl-20-propionic acid lauryl ester; N-(2,2,6,6-tetramethylhexahydropyridin-4-yl)-β-aminopropionic acid dodecyl N-(2,2,6,6-tetramethylhexahydropyridin-4-yl)-N'-aminoglyoxime; N-(2,2,6,6-tetramethyl-4 -hexahydropyridyl)-3-[(2,2,6,6-tetramethyl-4-hexahydropyridinyl)amino]-propionamide; 4-hexadecyloxy-2,2, a mixture of 6,6-tetramethylhexahydropyridine and 4-stearylnonyloxy-2,2,6,6-tetramethylhexahydropyridine; 3-dodecyl-1-(1,2 ,2,6,6-pentamethylhexahydropyridin-4-yl)pyrrolidine-2,5-dione; 3-dodecyl-1-(1-ethenyl-2,2,6, 6-pentamethylhexahydropyridin-4-yl)pyrrolidine-2,5-dione; bis(2,2,6,6-tetramethylhexahydropyridin-4-yl) succinate; Butyl 3,5-di-tertiary-butyl-4-hydroxybenzylmalonate bis(1,2,2,6,6-pentamethylhexahydropyridin-4-yl) ester; nitrogen group III Barium acetate (2,2,6,6-tetramethylhexahydropyridin-4-yl) ester; 1,1'-(1,2-ethanediyl)bis (3,3,5,5-tetra Methylhexahydropyrazinone; 4-benzylidene-2,2,6,6-tetramethylhexahydropyridine; 4-hard fat 2-oxy-2,2,6,6-tetramethylhexahydropyridine; 2-n-butyl-2-(2-hydroxy-3,5-di-tertiary-butylbenzyl)malonic acid Bis(1,2,2,6,6-pentamethylhexahydropyridyl)ester; 3-n-octyl-7,7,9,9-tetramethyl-1,3,8-triaza Spiro[4.5]decane-2,4-dione; bis(1-octyloxy-2,2,6,6-tetramethylhexahydropyridyl) sebacate; bis(1-octyl) succinate Oxy-2,2,6,6-tetramethylhexahydropyridyl); 8-ethenyl-3-dodecyl-7,7,9,9-tetramethyl-1,3, 8-triazaspiro[4.5]decane-2,4-dione; 3-dodecyl-1-(2,2,6,6-tetramethylhexahydropyridin-4-yl)pyrrolidine -2,5-dione; 3-dodecyl-1-(1-ethylindenyl-2,2,6,6-tetramethylhexahydropyridin-4-yl)pyrrolidine-2,5- Diketone; 3-dodecyl-1-(1,2,2,6,6-pentamethylhexahydropyridin-4-yl)pyrrolidine-2,5-dione; 4-hexadecane a mixture of benzyl-2,2,6,6-tetramethylhexahydropyridine and 4-stearylnonyloxy-2,2,6,6-tetramethylhexahydropyridine; 2-undecyl- 7,7,9,9-tetramethyl-1-oxa-3,8-diaza-4-oxooxyspiro[4.5]decane; 1,5-dioxaspiro{5,5} Undecyl-3,3-dicarboxylic acid bis(2,2,6,6-tetramethyl-4-hexahydropyridyl) and 1,5-dioxaspiro {5,5} Alkoxy-3,3-dicarboxylic acid bis (1,2,2,6,6-pentamethyl-4-piperidinyl) ester; N 1 - (β- hydroxyethyl) 3,3-pentamethylene -5,5-dimethylhexahydropyrazin-2-one; N 1 -tris-octyl-3,3,5,5-tetramethyl-diazepin-2-one; N 1 - Third-octyl-3,3-pentamethylene-5,5-hexamethylene-diazepin-2-one; N 1 -tris-octyl-3,3-pentamethylene- 5,5-Dimethylhexahydropyrazin-2-one; trans-1,2-cyclohexane-bis-(N 1 -5,5-dimethyl-3,3-pentamethylene- 2-hexahydropyrazinone); trans-1,2-cyclohexane-bis-(N 1 -3,3,5,5-dispiro-pentamethylene-2-hexahydropyrazinone); N 1 -isopropyl-1,4-diazabispiro-(3,3,5,5) pentamethylene-2-hexahydropyrazinone; N 1 -isopropyl-1,4- Diazabisspiro-3,3-pentamethylene-5,5-tetramethylene-2-hexahydropyrazinone; N 1 -isopropyl-5,5-dimethyl-3,3 - pentamethylene-2-hexahydropyrazinone; trans-1,2-cyclohexane-bis-N 1 -(dimethyl-3,3-pentamethylene-2-hexahydropyrazine Ketone); N 1 -octyl-5,5-dimethyl-3,3-pentamethylene-1,4-diazepin-2-one; and N 1 -octyl-1,4-di Aza-bispiro-(3,3,5,5)pentamethylene-1,5-diazepin-2-one. 如請求項16之安定劑組合物,其中該光安定劑係選自選自由2-羥基二苯甲酮化合物、2-(2'-羥基苯基)苯并三唑化合物、2-(2'-羥基苯基)-1,3,5-三嗪化合物及其組合組成之群之成員的紫外光吸收劑。 The stabilizer composition of claim 16, wherein the light stabilizer is selected from the group consisting of a 2-hydroxybenzophenone compound, a 2-(2'-hydroxyphenyl)benzotriazole compound, and 2-(2'- An ultraviolet light absorber of a member of the group consisting of hydroxyphenyl)-1,3,5-triazine compounds and combinations thereof. 如請求項19之安定劑組合物,其中該紫外光吸收劑係式(VII)之2-(2'-羥基苯基)-1,3,5-三嗪化合物: 其中R34及R35中之每一者係獨立地選自選自由視情況經取代之C6-C10芳基、C1-C10烴基取代之胺基、C1-C10醯基及C1-C10烷氧基組成之群之成員;且R36係在式VII之苯氧基部分之0個至4個位置處相同或不同之取代基,且在每一情況下係獨立地選自選自由羥基、C1-C12烴基、C1-C12烷氧基、C1-C12烷氧基酯及C1-C12醯基組成之群之成員。 The stabilizer composition of claim 19, wherein the ultraviolet light absorber is a 2-(2'-hydroxyphenyl)-1,3,5-triazine compound of the formula (VII): Wherein each of R 34 and R 35 is independently selected from the group consisting of an optionally substituted C 6 -C 10 aryl group, a C 1 -C 10 hydrocarbon group substituted amino group, a C 1 -C 10 fluorenyl group, and a C group. a member of the group consisting of 1 -C 10 alkoxy groups; and R 36 is the same or different substituent at the 0 to 4 positions of the phenoxy moiety of formula VII, and is independently selected in each case From a member selected from the group consisting of a hydroxyl group, a C 1 -C 12 hydrocarbon group, a C 1 -C 12 alkoxy group, a C 1 -C 12 alkoxy ester, and a C 1 -C 12 fluorenyl group. 如請求項19或20中任一項之安定劑組合物,其中該2-(2'-羥基苯基)-1,3,5-三嗪化合物係選自選自由以下組成之群之成員:4,6-雙-(2,4-二甲基苯基)-2-(2-羥基-4-辛氧基苯基)-對稱-三嗪(Cyasorb® 1164,自Cytec Industries有限公司購得);4,6-雙-(2,4-二甲基苯基)-2-(2,4-二羥基苯基)-對稱-三嗪;2,4-雙(2,4-二羥基苯基)-6-(4-氯苯基)-對稱-三嗪;2,4-雙[2-羥基-4-(2-羥基-乙氧基)苯基]-6-(4-氯苯基)-對稱-三嗪;2,4-雙[2-羥基-4-(2-羥基-4-(2-羥基-乙氧基)苯基]-6-(2,4-二甲基苯基)-對稱-三嗪;2,4-雙[2-羥 基-4-(2-羥基乙氧基)苯基]-6-(4-溴苯基)-對稱-三嗪;2,4-雙[2-羥基-4-(2-乙醯氧基乙氧基)苯基]-6-(4-氯苯基)-對稱-三嗪;2,4-雙(2,4-二羥基苯基)-6-(2,4-二甲基苯基)-對稱-三嗪;2,4-雙(4-聯苯基)-6-[2-羥基-4-[(辛氧基羰基)亞乙基氧基]苯基]-對稱-三嗪;2,4-雙(4-聯苯基)-6-[2-羥基-4-(2-乙基己氧基)苯基]-對稱-三嗪;2-苯基-4-[2-羥基-4-(3-第二-丁氧基-2-羥基丙氧基)苯基]-6-[2-羥基-4-(3-第二-戊氧基-2-羥基丙氧基)苯基]-對稱-三嗪;2,4-雙(2,4-二甲基苯基)-6-[2-羥基-4(-3-苄氧基-2-羥基丙氧基)苯基]-對稱-三嗪;2,4-雙(2-羥基-4-正-丁氧基苯基)-6-(2,4-二-正-丁氧基苯基)-對稱-三嗪;2,4-雙(2,4-二甲基苯基)-6-[2-羥基-4-(3-壬氧基-2-羥基丙氧基)-5-α-異丙苯基苯基]-對稱-三嗪;亞甲基雙-{2,4-雙(2,4-二甲基苯基)-6-[2-羥基-4-(3-丁氧基-2-羥基丙氧基)苯基]-對稱-三嗪};在3:5'、5:5'及3:3'位處以5:4:1比率橋連之亞甲基橋連二聚體混合物;2,4,6-叁(2-羥基-4-異辛氧基羰基異亞丙基氧基-苯基)-對稱-三嗪;2,4-雙(2,4-二甲基苯基)-6-(2-羥基-4-己氧基-5-α-異丙苯基苯基)-對稱-三嗪;2-(2,4,6-三甲基苯基)-4,6-雙[2-羥基-4-(3-丁氧基-2-羥基丙氧基)苯基]-對稱-三嗪;2,4,6-叁[2-羥基-4-(3-第二-丁氧基-2-羥基丙氧基)-苯基]-對稱-三嗪;4,6-雙-(2,4-二甲基苯基)-2-(2-羥基-4-(3-十二烷氧基-2-羥基丙氧基)苯基)-對稱-三嗪與4,6-雙-(2,4-二甲基苯基)-2-(2-羥基-4-(3-十三烷氧基-2-羥基丙氧基)苯基)-對稱-三嗪之混合物 (Tinuvin® 400,自Ciba Specialty Chemicals公司購得);4,6-雙-(2,4-二甲基苯基)-2-(2-羥基-4(3-(2-乙基己氧基)-2-羥基丙氧基)-苯基)-對稱-三嗪;4,6-二苯基-2-(4-己氧基-2-羥基苯基)-對稱-三嗪;及其組合。 The stabilizer composition according to any one of claims 19 or 20, wherein the 2-(2'-hydroxyphenyl)-1,3,5-triazine compound is selected from the group consisting of: 4 ,6-bis-(2,4-dimethylphenyl)-2-(2-hydroxy-4-octyloxyphenyl)-symmetric-triazine (Cyasorb® 1164, available from Cytec Industries, Inc.) 4,6-bis-(2,4-dimethylphenyl)-2-(2,4-dihydroxyphenyl)-symmetric-triazine; 2,4-bis(2,4-dihydroxybenzene 6-(4-chlorophenyl)-symmetric-triazine; 2,4-bis[2-hydroxy-4-(2-hydroxy-ethoxy)phenyl]-6-(4-chlorobenzene Base)-symmetric-triazine; 2,4-bis[2-hydroxy-4-(2-hydroxy-4-(2-hydroxy-ethoxy)phenyl]-6-(2,4-dimethyl Phenyl)-symmetric-triazine; 2,4-bis[2-hydroxyl 4-(2-hydroxyethoxy)phenyl]-6-(4-bromophenyl)-symmetric-triazine; 2,4-bis[2-hydroxy-4-(2-ethyloxy) Ethoxy)phenyl]-6-(4-chlorophenyl)-symmetric-triazine; 2,4-bis(2,4-dihydroxyphenyl)-6-(2,4-dimethylbenzene Base)-symmetric-triazine; 2,4-bis(4-biphenyl)-6-[2-hydroxy-4-[(octyloxycarbonyl)ethyleneoxy]phenyl]-symmetric-three Bis; 2,4-bis(4-biphenyl)-6-[2-hydroxy-4-(2-ethylhexyloxy)phenyl]-symmetric-triazine; 2-phenyl-4-[ 2-hydroxy-4-(3-second-butoxy-2-hydroxypropoxy)phenyl]-6-[2-hydroxy-4-(3-second-pentyloxy-2-hydroxypropane) Oxy)phenyl]-symmetric-triazine; 2,4-bis(2,4-dimethylphenyl)-6-[2-hydroxy-4(-3-benzyloxy-2-hydroxypropoxyl) Phenyl]-symmetric-triazine; 2,4-bis(2-hydroxy-4-n-butoxyphenyl)-6-(2,4-di-n-butoxyphenyl)- Symmetrical-triazine; 2,4-bis(2,4-dimethylphenyl)-6-[2-hydroxy-4-(3-decyloxy-2-hydroxypropoxy)-5-α- Isopropylphenyl phenyl]-symmetric-triazine; methylene bis-{2,4-bis(2,4-dimethylphenyl)-6-[2-hydroxy-4-(3-butoxy) Benzyl-2-hydroxypropoxy)phenyl]-symmetric-triazine}; ratio of 5:4:1 at 3:5', 5:5' and 3:3' positions a bridged methylene bridged dimer mixture; 2,4,6-anthracene (2-hydroxy-4-isooctyloxycarbonylisopropylideneoxy-phenyl)-symmetric-triazine; 4-bis(2,4-dimethylphenyl)-6-(2-hydroxy-4-hexyloxy-5-α-isopropylphenylphenyl)-symmetric-triazine; 2-(2, 4,6-trimethylphenyl)-4,6-bis[2-hydroxy-4-(3-butoxy-2-hydroxypropoxy)phenyl]-symmetric-triazine; 2,4, 6-叁[2-hydroxy-4-(3-second-butoxy-2-hydroxypropoxy)-phenyl]-symmetric-triazine; 4,6-bis-(2,4-dimethyl Phenyl)-2-(2-hydroxy-4-(3-dodecyloxy-2-hydroxypropoxy)phenyl)-symmetric-triazine with 4,6-bis-(2,4- a mixture of dimethylphenyl)-2-(2-hydroxy-4-(3-tridecyloxy-2-hydroxypropoxy)phenyl)-symmetric-triazine (Tinuvin® 400, available from Ciba Specialty Chemicals); 4,6-bis-(2,4-dimethylphenyl)-2-(2-hydroxy-4(3-(2-ethylhexyloxy) 2-hydroxypropoxy)-phenyl)-symmetric-triazine; 4,6-diphenyl-2-(4-hexyloxy-2-hydroxyphenyl)-symmetric-triazine; Its combination. 如請求項16之安定劑組合物,其中該光安定劑係如請求項17或18所定義之受阻胺光安定劑及如請求項20或21所定義之紫外光吸收劑。 The stabilizer composition of claim 16, wherein the light stabilizer is a hindered amine light stabilizer as defined in claim 17 or 18 and an ultraviolet light absorber as defined in claim 20 or 21. 如請求項1之安定劑組合物,其進一步包含至少一種選自選自由以下組成之群之成員的化合物:式(VIII)之羥基胺化合物: 其中T1係選自選自由視情況經取代之C1-C36烴基、視情況經取代之C5-C12環烷基及視情況經取代之C7-C9芳烷基組成之群之成員;且T2係選自氫或T1;及式(IX)之三級胺氧化物化合物: 其中 W1及W2中之每一者係獨立地選自C6-C36烴基,該C6-C36烴基選自選自由以下組成之群之成員:直鏈或具支鏈C6-C36烷基、C6-C12芳基、C7-C36芳烷基、C7-C36烷芳基、C5-C36環烷基、C6-C36烷基環烷基;及C6-C36環烷基烷基;W3係選自C1-C36烴基,該C1-C36烴基選自選自由以下組成之群之成員:直鏈或具支鏈C1-C36烷基、C6-C12芳基、C7-C36芳烷基、C7-C36烷芳基、C5-C36環烷基、C6-C36烷基環烷基;及C6-C36環烷基烷基;限制條件係W1、W2及W3中之至少一者含有β碳-氫鍵;且其中該等烷基、芳烷基、烷芳基、環烷基、烷基環烷基及環烷基烷基可雜有1個至16個選自選自由以下組成之群之成員的基團:-O-、-S-、-SO-、-SO2-、-COO-、-OCO-、-CO-、-NW4-、-CONW4-及-NW4CO-,或其中該等烷基、芳烷基、烷芳基、環烷基、烷基環烷基及環烷基烷基可經1個至16個選自選自由以下組成之群之成員的基團取代:-OW4、-SW4、-COOW4、-OCOW4、-COW4、-N(W4)2、-CON(W4)2、-NW4COW4及含有基團-C(CH3)(CH2Rx)NL(CH2Rx)(CH3)C-之5-及6-員環,或其中該等烷基、芳烷基、烷芳基、環烷基、烷基環烷基及環烷基烷基雜有上文所提及該等基團並經其取代;且其中W4係選自氫或C1-C8烷基; Rx係選自氫或甲基;且L係選自C1-C30烷基;-C(O)R部分或-OR部分,其中R係C1-C30直鏈或具支鏈烷基;且其中該等芳基可經選自由1個至3個鹵素基團、C1-C8烷基、C1-C8烷氧基及其組合組成之群之成員取代。 The stabilizer composition of claim 1 further comprising at least one compound selected from the group consisting of: a hydroxylamine compound of formula (VIII): Wherein T 1 is selected from the group consisting of a C 1 -C 36 hydrocarbon group optionally substituted, a C 5 -C 12 cycloalkyl group optionally substituted, and optionally a C 7 -C 9 aralkyl group. a member; and T 2 is selected from hydrogen or T 1 ; and a tertiary amine oxide compound of formula (IX): Wherein each of W 1 and W 2 are independently selected in the C 6 -C 36 hydrocarbon, C 6 -C 36 hydrocarbon group which is selected from the group of optional members of the group consisting of: linear or branched C 6 -C 36 alkyl, C 6 -C 12 aryl, C 7 -C 36 aralkyl, C 7 -C 36 alkaryl, C 5 -C 36 cycloalkyl, C 6 -C 36 alkylcycloalkyl; and C 6 -C 36 cycloalkylalkyl; W 3 is selected from C 1 -C 36 hydrocarbyl C 1 -C 36 hydrocarbon selected from the group consisting of the group members managed consisting of: linear or branched C 1 - C 36 alkyl, C 6 -C 12 aryl, C 7 -C 36 aralkyl, C 7 -C 36 alkaryl, C 5 -C 36 cycloalkyl, C 6 -C 36 alkylcycloalkyl And a C 6 -C 36 cycloalkylalkyl group; the constraint is that at least one of W 1 , W 2 and W 3 contains a β carbon-hydrogen bond; and wherein the alkyl group, the aralkyl group, the alkaryl group And a cycloalkyl group, an alkylcycloalkyl group, and a cycloalkylalkyl group may have 1 to 16 groups selected from members selected from the group consisting of -O-, -S-, -SO-, - SO 2 -, - COO -, - OCO -, - CO -, - NW 4 -, - CONW 4 - and -NW 4 CO-, or wherein such alkyl, aralkyl, alkaryl, cycloalkyl, , alkylcycloalkyl and cycloalkylalkyl groups can be passed through 1 to 16 are substituted with a group selected from members selected from the group consisting of -OW 4 , -SW 4 , -COOW 4 , -OCOW 4 , -COW 4 , -N(W 4 ) 2 , -CON(W 4 ) 2 , -NW 4 COW 4 and a 5- and 6-membered ring containing a group -C(CH 3 )(CH 2 R x )NL(CH 2 R x )(CH 3 )C-, or wherein the alkane a base, an aralkyl group, an alkylaryl group, a cycloalkyl group, an alkylcycloalkyl group, and a cycloalkylalkyl group having the same groups as mentioned above and substituted therewith; and wherein the W 4 group is selected from hydrogen or C 1 -C 8 alkyl; R x is selected from hydrogen or methyl; and L is selected from C 1 -C 30 alkyl; -C(O)R moiety or -OR moiety, wherein R is C 1 -C 30 linear or branched alkyl; and wherein the aryl groups may be selected from the group consisting of 1 to 3 halogen groups, C 1 -C 8 alkyl groups, C 1 -C 8 alkoxy groups, and combinations thereof Replaced by members of the group. 如請求項23之安定劑組合物,其中該式(VIII)化合物係N,N-二烴基羥基胺,其中T1及T2中之每一者係獨立地選自選自由以下組成之群之成員:苄基、乙基、辛基、月桂基、十二烷基、十四烷基、十六烷基、十七烷基及十八烷基;或其中T1及T2中之每一者係氫化牛脂胺中所發現之烷基混合物。 The stabilizer composition of claim 23, wherein the compound of formula (VIII) is an N,N-dihydrocarbylhydroxylamine, wherein each of T 1 and T 2 is independently selected from members selected from the group consisting of : benzyl, ethyl, octyl, lauryl, dodecyl, tetradecyl, hexadecyl, heptadecyl and octadecyl; or wherein each of T 1 and T 2 A mixture of alkyl groups found in hydrogenated tallow amines. 如請求項23或24之安定劑組合物,其中該式(VIII)化合物係選自選自由以下組成之群之成員的N,N-二烴基羥基胺:N,N-二苄基羥基胺;N,N-二乙基羥基胺;N,N-二辛基羥基胺;N,N-二月桂基羥基胺;N,N-二-十二烷基羥基胺;N,N-二-十四烷基羥基胺;N,N-二-十六烷基羥基胺;N,N-二-十八烷基羥基胺;N-十六烷基-N-十四烷基羥基胺;N-十六烷基-N-十七烷基羥基胺;N-十六烷基-N-十八烷基羥基胺;N-十七烷基-N-十八烷基羥基胺;及N,N-二(氫化牛脂)羥基胺。 The stabilizer composition of claim 23 or 24, wherein the compound of formula (VIII) is selected from the group consisting of N,N-dihydrocarbylhydroxylamines selected from the group consisting of: N,N-dibenzylhydroxylamine; , N-diethylhydroxylamine; N,N-dioctylhydroxylamine; N,N-dilauroylhydroxylamine; N,N-di-dodecylhydroxylamine; N,N-di-tetradecyl Alkylhydroxylamine; N,N-di-hexadecylhydroxylamine; N,N-di-octadecylhydroxylamine; N-hexadecyl-N-tetradecylhydroxylamine; N-ten Hexa-N-heptadecylhydroxylamine; N-hexadecyl-N-octadecylhydroxylamine; N-heptadecyl-N-octadecylhydroxylamine; and N,N- Di(hydrogenated tallow) hydroxylamine. 如請求項1之安定劑組合物,其進一步包含至少一種選自選自由以下組成之群之成員的化合物:共添加劑;生育酚化合物;成核劑;填充劑;強化劑;聚合物添加劑;及其組合。 The stabilizer composition of claim 1, further comprising at least one compound selected from the group consisting of: a co-additive; a tocopherol compound; a nucleating agent; a filler; a strengthening agent; a polymer additive; combination. 如請求項26之安定劑組合物,其中該生育酚化合物係選自選自由以下組成之群之成員:α-生育酚、β-生育酚、γ-生育酚、δ-生育酚、其異構體、相關生育三烯酚及其混合物。 The stabilizer composition of claim 26, wherein the tocopherol compound is selected from the group consisting of: alpha-tocopherol, beta-tocopherol, gamma-tocopherol, delta-tocopherol, isomers thereof , related tocotrienols and mixtures thereof. 一種母料組合物,其包含如請求項1之安定劑組合物及與欲安定有機材料相同或相容之有機材料。 A masterbatch composition comprising the stabilizer composition of claim 1 and an organic material that is the same or compatible with the organic material to be stabilized. 一種產生模製物件之方法,該方法包含將聚合有機材料及聚合物安定量之如請求項1之安定劑組合物或如請求項28之母料組合物添加至用於實施工業模製之器件或過程中;及藉助該工業模製過程使經安定聚合有機材料循環。 A method of producing a molded article, the method comprising adding a polymerized organic material and a polymer to a stabilizer composition as claimed in claim 1 or a masterbatch composition as claimed in claim 28 to a device for performing industrial molding Or in the process; and by means of the industrial molding process, the stabilized polymeric organic material is recycled. 如請求項29之方法,其中該工業模製過程或器件係選自射出模製、旋轉模製、吹塑模製、捲對捲模製、金屬射出模製、壓縮模製、轉移模製、浸漬模製、氣體輔助模製、嵌入射出模製、微模製、反應射出模製及雙料射出模製。 The method of claim 29, wherein the industrial molding process or device is selected from the group consisting of injection molding, rotational molding, blow molding, roll-to-roll molding, metal injection molding, compression molding, transfer molding, Dip molding, gas assisted molding, embedded injection molding, micro molding, reactive injection molding, and dual injection molding. 如請求項29至30中任一項之方法,其中該安定劑組合物係以該欲安定有機材料之總重量之0.001重量%至65.0重量%存在。 The method of any one of claims 29 to 30, wherein the stabilizer composition is present in an amount of from 0.001% to 65.0% by weight based on the total weight of the organic material to be stabilized. 如請求項31之方法,其中該安定劑組合物係以該欲安定有機材料之總重量之0.01重量%至25重量%存在。 The method of claim 31, wherein the stabilizer composition is present in an amount from 0.01% to 25% by weight based on the total weight of the organic material to be stabilized. 如請求項32之方法,其中該安定劑組合物係以該欲安定有機材料之總重量之0.01重量%至10重量%存在。 The method of claim 32, wherein the stabilizer composition is present in an amount from 0.01% to 10% by weight based on the total weight of the organic material to be stabilized. 如請求項29至30中任一項之方法,其中該欲安定有機材 料係選自選自由以下組成之群之成員:聚烯烴、聚酯、聚醚、聚酮、聚醯胺、天然及合成橡膠、聚胺基甲酸酯、聚苯乙烯、高耐衝擊聚苯乙烯、聚丙烯酸酯、聚甲基丙烯酸酯、聚縮醛、聚丙烯腈、聚丁二烯、聚苯乙烯、丙烯腈-丁二烯-苯乙烯、苯乙烯丙烯腈、丙烯酸酯苯乙烯丙烯腈、乙酸丁酸纖維素、纖維素聚合物、聚醯亞胺、聚醯胺醯亞胺、聚醚醯亞胺、聚苯硫醚、聚二氧苯聚碸、聚醚碸、聚氯乙烯、聚碳酸酯、聚酮、脂肪族聚酮、熱塑性烯烴、胺基樹脂交聯之聚丙烯酸酯及聚酯、聚異氰酸酯交聯之聚酯及聚丙烯酸酯、酚/甲醛、脲/甲醛及三聚氰胺/甲醛樹脂、乾性及非乾性醇酸樹脂、醇酸樹脂、聚酯樹脂、與三聚氰胺樹脂交聯之丙烯酸酯樹脂、脲樹脂、異氰酸酯、異氰尿酸酯、胺基甲酸酯、環氧樹脂、衍生自脂肪族、環脂肪族、雜環及芳香族縮水甘油基化合物之與酸酐或胺交聯之交聯環氧樹脂、聚矽氧烷、邁克爾加成聚合物(Michael addition polymer)、胺、具有活化不飽和亞甲基化合物之封端之胺、具有活化不飽和亞甲基化合物之酮亞胺、與不飽和丙烯酸聚乙醯乙酸酯樹脂組合之聚酮亞胺、與不飽和丙烯酸樹脂組合之聚酮亞胺、輻射可固化組合物、環氧三聚氰胺樹脂、有機染料、化妝品、基於纖維素之紙調配物、照相膠片紙、纖維、蠟及油墨。 The method of any one of claims 29 to 30, wherein the desired organic material is The material is selected from the group consisting of polyolefin, polyester, polyether, polyketone, polyamine, natural and synthetic rubber, polyurethane, polystyrene, high impact polystyrene , polyacrylate, polymethacrylate, polyacetal, polyacrylonitrile, polybutadiene, polystyrene, acrylonitrile-butadiene-styrene, styrene acrylonitrile, acrylate styrene acrylonitrile, Cellulose acetate butyrate, cellulose polymer, polyimine, polyamidimide, polyether phthalimide, polyphenylene sulfide, polydioxanthene, polyether oxime, polyvinyl chloride, poly Carbonate, polyketone, aliphatic polyketone, thermoplastic olefin, amino resin crosslinked polyacrylate and polyester, polyisocyanate crosslinked polyester and polyacrylate, phenol/formaldehyde, urea/formaldehyde and melamine/formaldehyde Resin, dry and non-dry alkyd resin, alkyd resin, polyester resin, acrylate resin crosslinked with melamine resin, urea resin, isocyanate, isocyanurate, urethane, epoxy resin, derivative From aliphatic, cycloaliphatic, heterocyclic and aromatic a crosslinked epoxy resin, a polyoxyalkylene oxide, a Michael addition polymer, an amine, a blocked amine having an activated unsaturated methylene compound, having a glyceryl compound crosslinked with an acid anhydride or an amine, having A ketimine that activates an unsaturated methylene compound, a polyketimine in combination with an unsaturated acrylic acid polyacetate resin, a polyketimine in combination with an unsaturated acrylic resin, a radiation curable composition, an epoxy Melamine resins, organic dyes, cosmetics, cellulose-based paper formulations, photographic film paper, fibers, waxes and inks. 如請求項34之方法,其中該欲安定有機材料係選自選自由以下組成之群之成員的聚烯烴聚合物:i)單烯烴之聚 合物,其選自聚丙烯、聚異丁烯、聚丁-1-烯、聚-4-甲基戊-1-烯;ii)二烯烴之聚合物,其選自聚異戊二烯或聚丁二烯;iii)環烯烴之聚合物,其選自環戊烯及降冰片烯;iv)聚乙烯,其選自視情況交聯之聚乙烯、高密度聚乙烯(HDPE)、高密度及高分子量聚乙烯(HDPE-HMW)、高密度及超高分子量聚乙烯(HDPE-UHMW)、中等密度聚乙烯(MDPE)、低密度聚乙烯(LDPE)、直鏈低密度聚乙烯(LLDPE)、極低密度聚乙烯(VLDPE)及超低密度聚乙烯(ULDPE);v)其共聚物;及vi)其混合物。 The method of claim 34, wherein the material to be stabilized is selected from the group consisting of polyolefin polymers selected from the group consisting of: i) polymerization of monoolefins a compound selected from the group consisting of polypropylene, polyisobutylene, polybutene-1-ene, poly-4-methylpent-1-ene; ii) a polymer of a diene selected from the group consisting of polyisoprene or polybutadiene a diene; iii) a polymer of a cyclic olefin selected from the group consisting of cyclopentene and norbornene; iv) a polyethylene selected from the group consisting of crosslinked polyethylene, high density polyethylene (HDPE), high density and high Molecular weight polyethylene (HDPE-HMW), high density and ultra high molecular weight polyethylene (HDPE-UHMW), medium density polyethylene (MDPE), low density polyethylene (LDPE), linear low density polyethylene (LLDPE), pole Low density polyethylene (VLDPE) and ultra low density polyethylene (ULDPE); v) copolymers thereof; and vi) mixtures thereof.
TW101121208A 2012-06-13 2012-06-13 Stabilizer compositions containing substituted chroman compounds and methods of use TWI637017B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW101121208A TWI637017B (en) 2012-06-13 2012-06-13 Stabilizer compositions containing substituted chroman compounds and methods of use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW101121208A TWI637017B (en) 2012-06-13 2012-06-13 Stabilizer compositions containing substituted chroman compounds and methods of use

Publications (2)

Publication Number Publication Date
TW201350529A true TW201350529A (en) 2013-12-16
TWI637017B TWI637017B (en) 2018-10-01

Family

ID=50157863

Family Applications (1)

Application Number Title Priority Date Filing Date
TW101121208A TWI637017B (en) 2012-06-13 2012-06-13 Stabilizer compositions containing substituted chroman compounds and methods of use

Country Status (1)

Country Link
TW (1) TWI637017B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5218008A (en) * 1991-11-13 1993-06-08 The Dow Chemical Company Polyethers stabilized with 6-chromanol derivatives
IT1289935B1 (en) * 1997-02-20 1998-10-19 Great Lakes Chemical Italia SOLID FORM OF A STABILIZER FOR ORGANIC POLYMERS
NL1014465C2 (en) * 1999-03-01 2002-01-29 Ciba Sc Holding Ag Stabilizer combination for the rotomolding process.

Also Published As

Publication number Publication date
TWI637017B (en) 2018-10-01

Similar Documents

Publication Publication Date Title
AU2018217320B2 (en) Processing additives and uses of same in rotational molding
US20220153959A1 (en) Polyolefin compositions containing substituted chroman compounds and molded articles produced therefrom
JP6794333B2 (en) Stabilizer Compositions Containing Substituted Chroman Compounds and Methods of Use
BR112015001445B1 (en) fluorine picolinoyl fluorides, and their processes
TWI637018B (en) Process for producing molded articles
TWI637017B (en) Stabilizer compositions containing substituted chroman compounds and methods of use

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees